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ABSTRACT 
Major Depressive Disorder (MDD) is a stress-related disorder characterised by over-
activation of the hypo-thalamic pituitary axis (HP A) (Arborelius & Owens, 1999; 
Nofzinger et al., 2000). Dysregulation of this system causes disturbances in 
behaviour, mood, cognition, and diurnal and circadian regulation of appetite and 
sleep-wake patterns. Abnormal electroencephalography (EEG) is also a common 
feature, with increased left midfrontal alpha indicating underactivity of the left 
frontal cortex relative to the right (Henriques & Davidson, 1991; Tomarken & 
Keener, 1998). Photic stimulation (PS) elicits cortical photic driving responses 
which can be used to 'entrain' the EEG, and produce rhythms conducive to relaxation 
and sleep onset, or conversely, to activate and 'switch on' the cortex in readiness for 
cognitive work. In addition, photic stimulation produces reliable anxiolytic effects, 
which can be used to reduce hyperarousal, and assist in the re-establishment of 
homeostatic balance, with the potential to be effective in the treatment of stress 
related disorders such as MDD. 
Two studies explored the clinical utility of PS as a therapeutic tool in the treatment of 
mood and sleep disorder. Study 1 compared audiovisual stimulation (A VS) at 5Hz, 
13Hz, and 22Hz to autogenic relaxation in a non-clinical sample of thirty, in a 
repeated measures (12 sessions), single blind, controlled design. A VS produced 
immediate relaxation responses as effectively as autogenic relaxation, with 
reductions in heart rate and skin conductance during stimulation, but with no 
evidence of long-term training effects on physiological arousal or EEG. Main effects 
for mood (PANAS) were found. Negative affect decreased accompanied by 
unexpected decreases in positive affect over sessions. Interaction effects were small 
and non-significant with trends showing enhanced positive affect and subjective 
relaxation with l 3Hz A VS, while A VS at 22Hz tended to increase arousal. 
Depression and anxiety symptoms were significantly decreased (SCL-90-R), even in 
a non-clinical sample. 
Study 2 used a double blind, placebo controlled, repeated measures design. Sixty 
participants with MDD and accompanying insomnia received PS of 5Hz, 13Hz, 
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22Hz, or continuous light, while a wait list group received no treatment. Participants 
used a Lightmask TM at home for 20 minutes each evening over a period of 28 days 
while maintaining sleep and mood diaries. Measures of EEG, mood (PANAS) and 
depression (BDI-II) were taken at baseline, following 2 weeks of PS, after 4 weeks 
of PS, and at follow-up, 2 months post light therapy. Anxiety (SCL-90-R) was 
assessed at baseline and follow-up only. 
Entrainment responses were observed in the majority of participants but were 
unrelated to mood. Davidson's pattern of alpha asymmetry in depression was found 
with increased left midfrontal alpha, relative to the right. Main effects were 
prominent, with improvements in depression, anxiety, and symptom severity, plus 
increases in positive affect and decreases in negative affect over time. These 
improvements were independent of group membership. Similarly, sleep efficiency 
improved, night wakings decreased, and waking mood increased, for all groups over 
time, but with no change in sleep onset latencies. Five hertz PS appeared to offer 
slightly greater benefit for sleep disturbance. 
This research extends and contributes to current know ledge on the clinical 
application of PS, with the use of placebo controlled, random allocation, double-
blind procedures. Results showed that PS induces immediate relaxation responses 
that contribute to treatment outcomes. Entrainment effects, however, did not 
enhance treatment outcomes. Strong placebo and non-specific therapeutic effects 
were present in both studies as both placebo and control groups showed 
improvements similar to active PS. In conclusion, PS elicits immediate relaxation 
responses, which according to Benson (1975) are essential in the treatment of stress-
related disorders. 
CHAPTER 1 
'Stress, EEG, and photic stimulation'. 
1.1 Introduction 
Stress is a part of everyday life. Selye (1976) defined stress as "the nonspecific 
response of the body to any demand" (p. 55). What he was describing was a 
generalized physiological reaction to stressors in the environment or arising from 
within the organism, caused by some internal cue. When confronted with threat or 
challenge the resulting 'stress' response includes an immediate 'alarm reaction' or 
generalized arousal caused by sympathetic nervous system excitation; heart and 
respiratory rate increase, blood pressure rises, the pupils dilate, the sweat glands are 
activated, blood glucose levels rise, blood is redirected from digestive functions to 
peripheral muscles of action, which gives rise to the feeling of 'butterflies' in the 
stomach, we may feel apprehensive, fearful or agitated, and even become hyper-
vigilant These responses are highly adaptive if the organism needs to flee from 
threat or face it and fight. 
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The stress response itself is fairly universal, but what we perceive as 'stressful' is not. 
Lazarus and Folkman (1984) refined Selye's definition of stress saying that stress is 
dependent on our 'appraisal' of the situation. Primary appraisal involves assessing 
whether or not a stressor is in fact a threat to well-being and therefore warrants 
action or 'coping'. Next, in secondary appraisal, we appraise whether or not we have 
the coping resources available to deal with the perceived stressor. Adaptation occurs 
when we successfully manage to deal with the stressor (Lazarus, 1991 a; Lazarus & 
Folkman, 1984). If we don't manage to adapt and reduce the threat posed by the 
stressor, the stress response continues. 
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When stress is persistent and becomes chronic, according to Selye, during the 'stage 
of resistance', the organism adapts to the heightened level of 'stress', but not without 
a cost to the organism. There may be mood and sleep disturbances, loss of appetite, 
diminished libido, and compromised immune response, to name just a few. 
Persistence of stressors, both environmental and psychological, and their 
concomitant physiological stress reactions, can eventually lead to exhaustion, which 
is the end stage of Selye's "General Adaptation Syndrome". The relaxation response 
helps to counter the effects of chronic stress and restore the body to optimum 
functioning (Benson, 1975, 1985; Everly & Benson, 1989). 
Herbert Benson (1975) defined relaxation as a generalised reduction in physiological 
arousal characterised by a decrease in heart rate, respiratory rate, oxygen 
consumption, muscle tension, blood pressure, and enhancement of brainwave activity 
within the alpha bandwidth. He reviewed many relaxation and meditation techniques 
and found that relaxation responses were induced by a few simple requirements: a 
quiet place free from external distractions, a repetitive word or phrase on which to 
focus in order to distract the mind, the adoption of a 'passive' attitude, and finally, a 
comfortable position that will facilitate the release of muscle tension. Traditional 
relaxation methods such as progressive muscle relaxation (Bernstein & Borkovec, 
1973); autogenic relaxation, breath counting, yoga stretches, meditation (Arambula, 
Peper, Kawakami, & Gibney, 2001; Banquet, 1973; Fenwick et al., 1977; Kwon, 
Hahm, & Rhi, 1996; Orme-Johnson, 1973; West, 1980), biofeedback techniques 
using electromyography, temperature, or skin conductance, (Schwartz, 1987), and 
more recently, EEG biofeedback (Abarbanel, 1995; Banquet, 1973 ; Bird, Newton, 
Sheer, & Ford, 1978; Lubar, 1989; Moore, 2000; Rozelle & Budzynski, 1995; 
Sterman, 1986, 1998; Sterman & Friar, 1972; Sterman, Macdonald, & Stone, 1974) 
and respiratory sinus arrhythmia training (Gevirtz, 1999; Lehrer, Vaschillo, & 
Vaschillo, 2000) meet some or all of Benson's criteria for induction of relaxation. 
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Relaxation techniques aim to re-establish homeostasis by reducing sympathetic 
nervous system input while enhancing parasympathetic nervous system activation in 
an attempt to override arousal mechanisms which cause stress and strain on the 
system (Benson, 1975, 1985). Many of these techniques, however, require a 
substantial investment of time and effort before the skills are acquired and the 
beneficial effects of relaxation can be realised. In our busy industrialised 
communities, there is an increasing demand for quick and easy relaxation therapies 
that will enable us to manage the stressors in our lives. 
Mind machines or brainwave synchronisers are increasingly popular, require no 
learning, and claim to induce states of profound calm, or of heightened arousal, 
quickly and effortlessly. In accordance with Benson's prescription for relaxation, 
they provide repetitive stimuli, such as light and sound pulses, which distract the 
mind from its constant stream of thoughts and images. With the use of headphones 
and eyeglasses, they isolate the individual from their environment to create a 'quiet' 
personal space free from the influence of external input. Through the process of 
'brainwave entrainment', certain frequencies of light and sound pulses act to 'pull' 
the brain into a relaxed state by creating brainwave frequencies which are normally 
associated with relaxation or altered states of consciousness with resultant reductions 
in muscle tension and enhanced well-being as the parasympathetic nervous system 
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takes predominance (Dieter & Weinstein, 1995; Shealy et al. , 1990). Therefore, 
entrainment of the human electroencephalogram (EEG) can be achieved using photic 
or auditory stimulation that entices the EEG to respond in synchrony with the 
frequency of stimulation (Davis, 193 9; Toman, 1941; Wada, N anbu, Jiang, Koshino, 
& Hashimoto, 1996; Wada, Nanbu, Kadoshima et al., 1996; Wada, Takizawa, & 
Yamaguchi, 1995; Wada, Takizawaw, Kitazawa, Zheng-Yan, & Yamaguchi, 1994). 
Depending on the frequency of stimulation used different states of arousal and 
consciousness can be induced, as the human EEG tends to reflect different states of 
arousal and mood. 
1.2 Human electroencephalography 
The human EEG is a complex combination of synchronous and desynchronous 
cortical electrical activity with a wide spectral range. Early in his research, Berger 
(1929) noted that the different oscillations of the human brain were associated with 
different states of activation or arousal. With the help of techniques such as Fast 
Fourier Transformations, which today can be done effortlessly with computer 
software, the seemingly chaotic nature of the EEG could be decomposed into its 
various bandwidths. While there is no universal system for defining EEG bands, 
there is a general consensus that different EEG bandwidths are associated with 
different states of consciousness, mood, or levels of cortical activation. 
Low frequencies within the delta bandwidth (0-4Hz) denote a cortex with minimal 
neuronal activity and consequently these are found during deep sleep, during coma, 
or seen in focal cortical areas following cerebral injury (Niedermeyer, 1993; Schaul, 
1998). Theta ( 4-7Hz) activity is the dominant frequency found in children and 
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diminishes with age as the brain matures, although normal adult levels of theta may 
not be present in the EEG until age 25-30 years (Niedermeyer, 1993). Theta is 
associated with drowsiness (Lafrance & Dumont, 2000; Mulholland, 1995), increases 
during meditative states (Aftanas & Golocheikine, 2002; Kwon et al., 1996; 
Schacter, 1977; West, 1980), and is a necessary precursor to sleep onset (Lafrance & 
Dumont, 2000; Lafrance, Paquet, & Dumont, 2002; Strijkstra, Beersma, Drayer, 
Halbesma, & Daan, 2003). Theta usually signifies cortical deactivation, and its 
presence during task engagement can indicate problems with normal cortical 
functioning (Linden, Habib, & Radojevic, 1996; Lubar, 1991; Lubar & Lubar, 1984; 
Monastra et al., 1999; Ohashi, 1994). Conversely, recent evidence shows the 
presence of synchronised theta during the encoding process of memory performance, 
but with high theta power at rest being predictive of poor memory performance 
(Klimesch, 1999). In one study, low theta power, sometimes accompanied by an 
excess of beta power, was associated with psychiatric illness such as unipolar 
depression, bipolar disorder, alcohol and substance abuse, and mental disorders due 
to general medical condition (Coutin-Churchman et al., 2003). 
The alpha rhythm (8- l 3Hz) is the dominant EEG frequency present in occipital leads 
when resting quietly with eyes closed (Basar, Schiirmann, Basar-Eroglu, & Karakas, 
1997; Berger, 1976 reprint of 1934; Hammond, 2002; Niedermeyer, 1993, 1997). 
The majority of healthy adults show attenuation of peak occipital alpha on opening 
the eyes, when stimulating the visual cortex, or during cognitive work (Basar et al., 
1997; Micheloyannis, Papanikolaou, Bizas, Stam, & Simos, 2002; Neuper & 
Pfurtscheller, 2001; Niedermeyer, 1993, 1997; Williamson, Kaufman, Lu, Wang, & 
Karron, 1997). In exception, recent evidence in memory research shows 
synchronisation of the upper alpha bands during encoding (Klimesch, Doppelmayr, 
Schwaiger, Auinger, & Winkler, 1999). 
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Alpha is a synchronous sinusoidal rhythm usually associated with a state of 
deactivation or 'rest', is often seen between periods of task engagement (Steriade, 
Gloor, Llinas, Lopes da Silva, & Mesulam, 1990; Sterman, Mann, Kaiser, & 
Suyenobu, 1994; Williamson et al., 1997) and is associated with relaxation (Banquet, 
1973; Marshall & Bentler, 1976; Morse, Martin, Merrick, & Dubin, 1977; 
Shimokochi, 1996; West, 1980) and positive mood states (Brown, 1970, 1971; 
Nowlis & Kamiya, 1970). When alpha is present during relaxation it is characterised 
by subjective feelings of 'relaxed alertness' in anticipatory readiness for the next 
cognitive task, rather than a state of relaxed drowsiness (Basar et al., 1997; 
Klimesch, 1999; Klimesch, Doppelmayr, Pachinger, & Ripper, 1997; Pfurtscheller, 
Stancak, & Neuper, 1996). The majority of healthy individuals have dominant alpha 
frequencies close to the 1 0Hz bandwidth (Basar et al., 1997; Boudrot, 1972; 
Hammond, 2002; Jabbari, Russo, & Russo, 2000; Niedermeyer, 1993, 1997; Toman, 
1941; Walter, 1953), but individuals with higher resting alpha frequencies (> 1 0Hz) 
have been found to perform better on memory tasks (Klimesch, 1999; Klimesch et 
al. , 1997; Vogt, Klimesch, & Doppelmayr, 1998). In other research, photic 
stimulation at 1 0Hz, which enhances EEG power in the alpha range, was shown to 
improve memory performance and offered hope that photic stimulation could be 
used to enhance memory in conditions such as Alzheimer's Disease (Williams, 
2001). 
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Beta frequencies (> 14Hz), on the other hand, are associated with brain activation and 
reflect the activity of many cortical neuronal pools. They are desynchronous 
rhythms (Neuper & Pfurtscheller, 2001; Niedermeyer & Lopes Da Silva, 1993; 
Pfurtscheller, 1992; Steriade et al., 1990) and are present during active task 
engagement, attentional processes (Basar-Eroglu, Stuber, Schurmann, Stadler, & 
Basar, 1996; Micheloyannis et al., 2002; Ray & Cole, 1985; Wrobel, 2000) and 
physiological arousal (Bonnet & Arand, 2001; Lim et al., 1996). They are positively 
correlated with anxiety (Heller, Nitschke, Etienne, & Miller, 1997; Pizzagalli et al., 
2002), and inversely related to sleep quality (Nofzinger et al., 2000). Relaxation has 
been shown to attenuate frontal beta rhythms (Jacobs, Benson, & Friedman, 1996). 
1.3 What is brainwave entrainment? 
Brainwave entrainment or photic driving refers to "synchronisation of the EEG 
rhythm with the frequency identical, or harmonically related to the frequency of 
photic stimulation" (Wada, 1994, p. 24 7). Using rhythmic repetitive stimuli to 
entrain the brain and induce altered states of consciousness is not new. For 
thousands of years humankind has sought ways by which to induce relaxed states or 
achieve altered states of awareness in attempts to either escape from the realities of 
everyday life, or to access the deep recesses of the mind (Lex, 1979). Drumming, 
chanting, rhythmic dancing, listening to music, or staring into a campfire all have 
mesmerizing effects, and can be used to either arouse the nervous system or induce 
deep states of relaxation. What is common amongst these types of sensory 
stimulation is the effect they have on the brain. Rhythmic, pulsing, repetitive stimuli 
have the ability to entrain the brain, by enticing it to respond in kind through the 
production of steady state evoked potentials which are recruited and spread to distal 
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cortical areas, causing the cortex to behave in a synchronous manner. Thus the brain 
can be lulled into a state of disengagement and eventually, drowsiness. Rhythmic 
repetitive stimuli are the key elements of relaxation therapy as they serve to distract 
the mind from its incessant internal dialogue and bring it to a point of focused and 
relaxed awareness (Benson, 1975). Relaxation is a process of disengagement, which 
is evident in brainwave activity when recording the human EEG, and is quickly 
evoked by brainwave entrainment techniques (Glicksohn, 1986; Morse & Chow, 
1993; Ossebaard, 2000; von Gizycki et al., 1998). 
1.4 History of brainwave entrainment and photic stimulation 
Hans Berger (1873-1941) was the first to describe in detail the EEG in humans. In 
his first publication "On the Electroencephalogram of Man" (1929), Berger described 
two main rhythms; a rhythm which oscillated at 10-11 hertz (Hz) which was present 
during rest and was later called the alpha rhythm, and a smaller faster rhythm 
oscillating at 20-30Hz, which he later called beta, and which was present during 
mental exercise and concentration, thus showing the presence of desynchronous 
brainwave activity during active task engagement (Berger, 1976 reprint of 1934). 
Adrian and Matthews (1934) replicated Berger's work and concluded that the 'Berger 
rhythm', or alpha rhythm as we know it, originated in the occipital cortex and was 
present with the eyes closed, or with the eyes open, looking at a uniform field. In 
other words, occipital alpha was an indication that the brain was at 'rest', with 
minimal cognitive processing occurring. In contrast, higher beta rhythms were 
associated with stimulation of the visual cortex and denoted cortical work. In their 
seminal work, Adrian and Matthews were the first to show that light flicker could 
9 
produce frequency following effects in the occipital cortex. They demonstrated 
occipital photic driving responses to light flicker predominately in the 1 OHz 
frequency band, but also at frequencies as high as 25Hz, and also described harmonic 
and sub-harmonic responses in the cortex. 
The 'frequency fallowing effect' became a well known phenomenon as subsequent 
researchers replicated and refined Adrian and Matthews work (Mundy-Castle, 1953; 
Toman, 1941; Ulett, 1953; Ulett, Gleser, Winokur, & Lawler, 1953; Ulett & 
Johnson, 1958; Walter & Walter, 1949). In 1941, Toman established that photic 
driving responses were not confined to occipital visual areas, but in some subjects 
were present at the vertex. While he demonstrated photic driving to light flicker 
from 8 to 25Hz, he found that the best responses were found in frequencies at or near 
the dominant alpha frequency. Toman also noted that photic driving responses had a 
similar morphology to auditory driving responses which had been described by 
Davis (1939). Davis showed that auditory driving responses were present not only in 
primary auditory cortex, but were capable of recruitment across the cortex. 
Grey Walter (1949) was interested in the clinical applications of photic stimulation 
including its ability to detect abnormal brain functioning, such as epilepsy, and 
became a founding father of clinical neurophysiology. He was one of the first to 
correlate mood states with various EEG rhythms and frequencies of photically 
evoked brainwave patterns, and to explore the associated subjective mental imagery 
that often accompanies visual stimulation. He found that dysphoria correlated with 
parieto-temporal theta, a slow, high amplitude wave which signals cortical 
deactivation. In one subject he was able to induce unpleasant feelings using 1 l-16Hz 
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photic stimulation which increased theta activity via the effects of sub-harmonics. 
He also elucidated, in the human EEG, the effects of harmonics which are present 
not only in the area of cortex being stimulated, but are also recruited to other cortical 
regions where they give rise to sensations associated with these areas (Walter, 1953; 
Walter & Walter, 1949). Subsequent work by Mundy-Castle (1953) found clear 
evidence of recruitment of photic driving responses across the cortex and into frontal 
areas not only at fundamental frequencies of stimulation, but also at harmonic and 
sub-harmonic frequencies of the first, second and sometimes third order. 
The clinical usefulness of photic driving was further elucidated by Ulett and 
colleagues (1953, 1958), who discovered that photic driving responses were related 
to anxiety levels. They found that high anxiety subjects showed greater harmonic 
responses in their EEG and reported feeling more uncomfortable and dysphoric 
during photic stimulation than their low anxiety counterparts. Shagass (1955) 
attempted to use photic stimulation responsivity to differentiate between anxiety and 
depression. He found that females showed higher photic stimulation responses than 
males and that anxious female subjects had greater EEG responses to 15Hz light 
flicker than did non-anxious depressed female subjects. He also found that photic 
stimulation response varied with mood states within individuals and that there was a 
tendency towards higher photic driving responses during anxious states, and 
decreased responses during relaxed states. 
A common finding in the early work of photic driving and EEG was the large 
amount of variation in photic driving responses, across both clinical samples (Ulett, 
1953; Ulett et al., 1953; Ulett & Johnson, 1958; Walter & Walter, 1949), and 
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between individuals (Mundy-Castle, 1953; Shagass, 1955; Toman, 1941; Walter & 
Walter, 1949). Some researchers found that resting alpha EEG predicted the photic 
stimulation response, while others did not. Ulett (1958) proposed that there was a 
limit to the amount of cortical reactivity possible, and that subjects with high resting 
alpha states would show reduced photic driving responses in comparison to subjects 
with low resting alpha amplitude, who had more physiological leeway. While early 
attempts were made to use EEG photic driving to differentiate clinical states, results 
were not consistent and clear diagnostic patterns did not emerge. 
Another common finding among studies was that photic stimulation elicited a wide 
variety of subjective experiences, such as vivid visual imagery (Freedman & Marks, 
1965), a disrupted sense of time, kinaesthetic sensations of swaying, rolling, or 
spinning, and also effects on mood states, with some subjects reporting positive 
changes in mood while others reported unpleasant mood changes (Mundy-Castle, 
1953; Ulett et al., 1953; Walter, 1953; Walter & Walter, 1949). 
In summary, early research revealed that intermittent photic stimulation could be 
used to 'drive' the cortex at the frequency of stimulus presentation. In the EEGs of a 
significant proportion of subjects studied, photic driving and harmonic responses 
were commonly seen, predominantly in occipital sites, and recruitment of the 
response across the cortex was seen in many individuals. Early research established 
that it was possible to use photic driving to induce a wide range of illusory sensory 
perceptions, vivid images, relaxa~ion responses, and often effects on mood states. 
While the size of photic stimulation responses varied widely, early research showed 
that photic stimulation could be used to increase EEG amplitude within particular 
bandwidths. 
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Contemporary work in the area of brainwave entrainment and EEG has replicated 
and vastly expanded early research and continues to explore the therapeutic utility of 
photic and auditory driving, its ability to influence EEG patterns, produce relaxation 
responses, and shift mood states (Salansky, Fedotchev, & Bonndar, 1998). Recent 
research has substantiated earlier claims that cortically evoked auditory or visual 
potentials elicited in primary sensory cortex can be used to enhance EEG power in 
particular bandwidths (Basar & Schurmann, 1994; Brandt, 1997; Herrmann, 2001; 
Schurmann, Baar-Eroglu, & Basar, 1997), which are then recruited to remote cortical 
areas (Dinse et al., 1997; Glicksohn, 1986; Neher, 1961; Pantev et al., 1991)~ 
increase cortical blood flow and metabolism (Diehl, Stodieck, Diehl, & Ringelstein, 
1996; Sappey-Marinier et ~1., 1992), and also impact on mood states (Anderson, 
Legg, & Ridout, 1997; Brauchli, Michel, & Zeier, 1995; Lane, Kasian, Owens, & 
Marsh, 1998; Ossebaard, 2000; Shealy et al., 1990; Ulett, 1953; von Gizycki et al., 
1998). 
Today, photic driving responsivity is used for a variety of diagnostic purposes. 
Photic stimulation at varying frequencies is used routinely in clinical neurology to 
induce paroxysmal EEG activity during EEG assessment for suspected epilepsy 
(Diehl et al., 1996; Takahashi, 1993). Abnormal photic driving responses have been 
found in Alzheimer's Disease (Kikuchi et al., 2002), migraine sufferers (Chorlton & 
Kane, 2000; De Tommaso, Tota, Crenco, & Puca, 1996), and schizophrenics (Jin, 
Castellanos, Solis, & Potkin, 2000; Jin et al., 1990; Jin, Potkin, Sandman, & Bunney, 
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1997; Wada et al., 1995). Enhanced photic driving responses have been 
demonstrated in depression (Jin et al., 1997), with reduced photic driving, closer to 
normal levels, observed on recovery (Pockberger, Petsche, Rappelsberger, Zidek, & 
Zapotoczky, 1985). Photic driving responses are dependent on brain maturity and 
brain function and therefore change across the lifespan, with larger responses in 
children and the elderly in comparison to adults in their middle years (Kikuchi, 
Wada, Koshino, Nanbu, & Hashimoto, 2000; Niedermeyer, 1993; Takahashi, 1993). 
Yet, across shorter time spans, photic driving responses are relatively stable and 
show high test re-test reliability (Fedotchev, Bondar, & Konovalov, 1990). 
It is still debatable today what baseline EEG parameters will predict photic driving 
reactivity. Recent research has revealed that those with higher resting alpha levels 
are more responsive to photic driving frequencies which resemble their own 
dominant resting alpha, while photic driving responses in individuals with low 
resting alpha frequencies tend to be smaller, and are less dependent on stimulation 
frequencies being in the vicinity of the peak alpha frequency (Pigeau & Frame, 1992; 
Rosenfeld, Reinhart, & Srivastava, 1997). In contrast, Basar and colleagues (1997) 
found that higher power in the 1 0Hz frequency band actually attenuated photic 
stimulation responses by 30%. Nevertheless, photic driving responses, of varying 
degrees, are seen in the majority of individuals, with recruitment of the response 
visible across the cortex (Lazarev, Simpson, Schubsky, & deAzevedo, 2001; 
Silberstein, 1995b ). 
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1.5 Photic stimulation, relaxation and mood 
The phenomenon of brainwave entrainment using photic or auditory stimuli is firmly 
established. However, the use of brainwave entrainment devices, such as mind-
machines or brainwave synchronisers for therapeutic purposes is yet to be fully 
researched. To date, brainwave entrainment, often at varying frequencies of 
stimulation for specific clinical purposes, has been used successfully in the treatment 
of migraine (Anderson, 1989; De Tommaso et al., 1996), attention and behavioural 
disorders (Joyce & Siever, 2000; Patrick, 1996), sleep disorders (Parks, Apathy, 
Woodger, & Allen, 1998), mood disorders (Anderson et al., 1997; Brauchli et al., 
1995; Kumano et al., 1996; Noton, 1997), anxiety reduction (Morse, 1994a; 
Ossebaard, 2000), enhancement of academic performance (Carter & Russell, 1993; 
Russell, 1997) and as tool for hypnotic induction (Kroger & Schneider, 1959). Thus 
there is increasing evidence that auditory and photic stimulation can be used .across a 
wide range of conditions and that it is well tolerated by most people. These studies 
used a variety of mind-machines and frequencies of stimulation, but most cannot 
directly attribute their positive results to changes in cortical activity caused by 
entrainment responses, because often, measures of EEG were omitted. However, 
most participants reported auditory-photic stimulation to be a positive experience 
that produced relaxation effects. 
Morse (1993, 1994) showed that brainwave synchronisers had powerful anxiolytic 
properties that could be used to reduce anxiety during stressful endodontic 
procedures. In dental patients he compared photic stimulation at 1 0Hz, with photic 
stimulation (1 0Hz) plus relaxing music, and a control group who received only 
verbal instructions. Those receiving photic stimulation with relaxing music or photic 
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stimulation alone, demonstrated greater relaxation responses, with decreases in heart 
rate, increases in skin resistance, and greater subjective reports of relaxation, than the 
control group (Morse, 1993; Morse & Chow, 1993). 
Further exploration by Morse ( 1994b) found that photic stimulation at 1 0Hz did 
indeed enhance cortical alpha rhythms and produced more synchronous alpha 
between frontal and occipital regions with a concomitant increase in skin resistance 
and a decrease in heart rate, in comparison to no stimulation (Morse, 1994b ). This 
supported Morse's earlier work (1993) and strongly suggested that the two photic 
stimulation groups in the previous study exhibited cortical entrainment within the 
alpha band alongside the demonstrated relaxation responses. While Morse's research 
is to be commended because he included a control group, it is difficult to determine 
the full extent to which placebo effects have contributed to the results. If he had 
included a sham condition, to control for the effect of using sophisticated equipment, 
which in itself may have contributed to the results, his findings would be more 
conv1nc1ng. 
In another naturalistic study, Ossebaard (2000) also found that photic stimulation had 
immediate anxiolytic properties, but did not appreciably impact long term on 
occupational burnout or anxiety over the course of the study. Forty-two employees 
from an addiction centre were allocated to two photic stimulation groups and 
exposed to either alpha ( '"': 1 0Hz) or beta ( ,_,25hz) stimulation and compared to a 
control group who received no therapy. Participants received between 7-16 sessions 
of photic stimulation over eight weeks, for up to 40 minutes at a time. Contrary to 
expectation, those receiving beta stimulation reported improvement in 'emotional 
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exhaustion' while those receiving alpha frequencies did not. On reflection, this is not 
inconsistent especially in a sample suffering from chronic anxiety and burnout. As 
described by Selye, after long term exposure to threat or environmental stressors, 
which clearly occurs in burnout, the body eventually gives up its hyper-aroused state 
and reaches a state of equilibrium: cortisol levels may decrease, and physiological 
reactivity diminishes (Chrousos & Gold, 1992; Selye, 1976, 1998). Rather than 
being over-aroused, individuals who are 'burnt out' are possibly beyond over-arousal, 
and in a state of non-reactivity. Thus beta stimulation may in fact act to 'energise' the 
system with a concomitant lift in mood state. As no attempt was made to measure 
EEG parameters in this study it was not possible to ascertain if the frequencies used 
in the study changed cortical functioning or merely operated as a relaxation tool by 
supplying 'repetitive' distracting stimuli, which induced relaxation responses. 
In other research, photic stimulation was found to be more effective than autogenic 
relaxation in decreasing arousal levels and inducing relaxation responses. Using a 
repeated measures design, Dieter and Weinstein (1995) compared photic stimulation 
at theta frequencies with autogenic relaxation delivered via a tape, in a small sample 
of six people. Evidence of photic driving was found with increased amplitude in 
theta and delta EEG. In addition, they observed EEG characteristics, such as sleep 
spindles and K-complexes, which are normally only seen during sleep. According to 
Dieter and Weinstein, subjects remained awake throughout the thirty minutes of 
photic stimulation suggesting that the unique effects experienced during photic 
stimulation were due to the stimulation itself, and not because participants dozed off 
during the therapy. Participants found the experience of photic stimulation to be 
pleasant, and reported marked changes in mood and accompanying visual imagery, 
which were not present during autogenic relaxation. 
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These findings are consistent with other studies which also found that photic 
stimulation reduced arousal, increased drowsiness, and produced hypnagogic type 
images similar to those experienced during the early stages of sleep (von Gizycki et 
al., 1997; von Gizycki et al., 1998). Von Gizycki showed that photic stimulation 
impacted on mood, but not necessarily towards a positive valence, but simply 
because it increased sleepiness and reduced arousal. Similarly to Dieter and 
Weinstein, von Gizycki concluded that photic stimulation produced altered states of 
consciousness that resembled the early stages of sleep, thereby making it a 
potentially useful tool in the treatment of sleep onset insomnia. 
Brauchli and colleagues (Brauchli, 1993; Brauchli et al., 1995) offer further support 
for the mood enhancing and stress reducing qualities of photic stimulation. In an 
initial study Brauchli (1993) compared audiovisual stimulation with a simple 
relaxation method, such as listening to taped 'sounds of nature'. In this study, both 
relaxation and audiovisual stimulation effectively reduced physiological arousal with 
decreases in muscle tension, heart rate, skin conductivity, and a reduction in salivary 
cortisol. Greater mood effects were found for audiovisual stimulation with 
participants reporting feeling 'warmer and calmer', in comparison to simple 
relaxation, but no differences were found between the two methods in their ability to 
induce relaxation responses. In this study, it is not possible to attribute the anxiolytic 
and mood enhancing qualities of audiovisual stimulation to entrainment, as EEG was 
not recorded, and while immediate relaxation responses were found for both 
techniques, the long term effects of audiovisual stimulation and relaxation on mood 
and arousal were also not assessed. 
In subsequent research, Brauchli, Michel, and Zeier ( 199 5) found that audiovisual 
stimulation of varying frequencies, patterns, and intensities impacted differentially 
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on subjective mood. They exposed 20 male subjects to three different audiovisual 
programs, i) a 'low' variation program, with a constant and stable audiovisual 
frequency presented to both eyes simultaneously, ii) a 'high' variation program 
comprising a high degree of variability in audiovisual frequencies, temporal 
presentations of stimuli, pattern of light flicker, stimulus intensity, and shifts between 
right and left visual presentation, iii) a 'high-low' program, which shifted between 
high and low variation programs. Participants preferred the combination of high and 
low variation, because it was variable and maintained interest, but was not over 
stimulating. Subjects reported feeling more 'warm', 'comfortable', 'peaceful', and 
'calmer', after the high-low program, but in contrast, felt 'bored' after the low-no 
variation program, and 'aroused' after the high intensity and very changeable, high 
variation program. 
It is difficult to assess direct entrainment effects in this study, as it assessed the 
impact of highly variable patterns of audiovisual stimuli on the EEG. Alpha 
attenuation was observed across all audiovisual programs indicating cortical 
activation. This was possibly related to a combination of auditory-photic driving 
responses and cognitive processing of the novel sensory stimuli being presented. 
Nevertheless, auditory-photic stimulation that was novel and not overly arousing, 
induced positive mood changes after a short program of only seven minutes. 
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Further evidence for the use of photic stimulation to enhance mood was found when 
positive mood changes were noted in a sample of seventeen women using photic 
stimulation at 30Hz for the treatment of pre-menstrual disorder (Anderson et al., 
1997). Anderson et al. reported a 76% decrease in pre-menstrual symptoms, with 
significant reductions in physical and cognitive symptoms, depression, anxiety, 
fatigue, and irritability, after 3months of regular photic stimulation for at least fifteen 
minutes a day. This study, however, was limited in a number of ways. Firstly, 
because there were no EEG measures, the presence of entrainment effects could not 
be assessed. Secondly, because of the omission of a control group, it was not 
possible to ascertain the extent to which placebo effects contributed to the effects 
observed. Nevertheless, Anderson did observe significant decreases in symptoms, 
including reductions in anxiety and depression, possibly due to a combination of 
cortical entrainment effects, placebo effects, and relaxation responses induced by 
photic stimulation. 
In contrast, Walach (1998) found that audiovisual stimulation, and cranial electric 
stimulation, were no better than placebo at enhancing well-being and eliciting 
relaxation responses. Employing a repeated measures design, thirty six volunteers 
were exposed to audiovisual stimulation (at 7.83Hz), cranial electrical stimulation (at 
7.83Hz) and sham stimulation (electric stimulation device without stimulating) for 
twenty five minutes, over a number of days. All conditions elicited relaxation 
responses, including the baseline rest condition, with decreases in skin conductance 
observed after each session, but no differences were observed between groups. 
Audiovisual stimulation, however, produced more mystical experiences with subjects 
reporting a diffusion of boundaries between the self and the environment, and 
reduced 'emotional tension', in comparison to those exposed to cranial electrical 
stimulation or sham stimulation. 
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Placebo effects in this study were significant with subjects in the sham condition 
reporting relaxation responses similar to active experimental conditions. Other 
research has shown that the use of sophisticated equipment can elicit strong placebo 
effects which can match active treatments (Ho, Hashish, Salmon, Freeman, & 
Harvey, 1988). A shortcoming in Walach's study, however, was the omission of 
EEG evidence to determine if the entrainment devices used were actually 'entraining' 
the brain and producing enhancements in cortical activity at desired frequencies. 
In summary, both early and contemporary research have shown that the cortex can be 
entrained using light or sound pulses of varying frequencies. A major assumption of 
brainwave entrainment therapy is that by artificially driving the brain into particular 
rhythms, particular mood states, which are usually associated with these rhythms, 
will be generated. For example, if the brain is coaxed into increased synchrony 
within the alpha bandwidth, then a subjective state of relaxed awareness should 
follow. It is well established that audiovisual stimulation produces vivid visual 
ilnagery in many people (Freedman & Marks, 1965; Glicksohn, 1986; Richardson & 
McAndrew, 1990; Stwertka, 1993), and that theta or alpha rhythms often elicit 
physiological relaxation with accompanying feelings of drowsiness, 'letting go', and 
increased calm (Dieter & Weinstein, 1995; Joyce & Siever, 2000; Kumano et al., 
1996; Morse, 1993, 1994a; Ossebaard, 2000; Parks et al., 1998; Rosenfeld, 1997; 
Rosenfeld et al., 1997; Shealy et al., 1990; von Gizycki et al., 1997; von Gizycki et 
al., 1998). 
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The therapeutic utility of photic stimulation, however, remains equivocal. Some 
studies, for example (Dieter & Weinstein, 1995), have shown audiovisual stimulation 
to be superior to traditional relaxation methods in its ability to produce relaxation 
responses and induce positive mood states, while others, such as Walach (1998), 
have not. Other studies have used only very short exposure times to entrainment 
stimuli and shown that photic driving elicits immediate mood and relaxation effects 
(Brauchli et al., 1995; von Gizycki et al., 1997; von Gizycki et al., 1998), while other 
studies have employed repeated measures designs with longer exposure times and 
found photic stimulation to be no better than placebo (Walach, 1998). Brainwave 
synchronisers have been shown to have immediate anxiolytic effects (Morse, 1993, 
1994a; Ossebaard, 2000), but there is limited support for their ability to produce 
long-term, enduring therapeutic changes in the psychologically distressed 
(Ossebaard, 2000). 
In the therapeutic arena, it is widely accepted that relaxation is a skill that requires 
time, practice, and effort to achieve mastery. Practice facilitates 're-training' of the 
autonomic nervous system by repeatedly activating parasympathetic responses, 
reducing sympathetic activation, and re-establishing homeostatic balance (Argras, 
Taylor, Kraemer, Allen, & Schneider, 1980; Benson, 1975, 1985; Lehrer, 1997; 
Lehrer et al., 2000). In contrast to traditional relaxation therapies, photic stimulation 
requires no effort to attain mastery. Rather, it effortlessly elicits a relaxation 
response using a centrally mediated mechanism of brainwave entrainment, as 
opposed to relaxation techniques such as progressive muscle relaxation, which use 
peripherally mediated mechanisms. Couple this with important elements of 
relaxation, such as distracting rhythmic stimuli, isolation from external 
environmental cues, and reduced muscle tone which accompanies the relaxation 
response, and brainwave entrainment techniques have the potential to be powerful 
clinical tools. 
1.6 Summary 
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Mind machines which use light and sound stimuli for brainwave entrainment are 
commercially available, portable, relatively inexpensive, and offer a quick and easy 
means of providing treatment for stress and stress related disorders in a wide range of 
contexts. In addition, in a busy modem world that is fascinated by technology they 
are attractive and effective coping tools that can assist with the management of 
increasing daily stressors. The popularity of these devices, however, exceeds the 
research to support their effectiveness. While much of the current research using 
brainwave synchronizers reports them to be effective across a wide range of clinical 
applications, few studies have used control groups in order to gauge the extent to 
which placebo effects contribute to reported results. When control groups have been 
included, often expectancy effects are left un-addressed. The inclusion of a sham 
condition would effectively address this issue. In addition, other procedures, which 
improve experimental rigor, are often missing from clinical research, such as random 
allocation to experimental groups, and double blind procedures to control for 
experimenter bias. 
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In order to validate the use photic stimulation for therapeutic purposes, it is firstly 
necessary to address some of these shortcomings. In the next chapter, two important 
questions are asked; first, 'Are brainwave synchronizers as effective as traditional 
relaxation techniques in their ability to induce relaxation responses?' and second, 'if 
they do produce relaxation effects, are these effects dependent on demonstrable 
cortical driving responses, or does brainwave entrainment merely act as a relaxation 
aid because it provides a distracting repetitive rhythmic stimulus, and assists to 
minimise sensory input from environmental sources?' 
CHAPTER2 
Study 1: 'Effects of audiovisual stimulation on mood, arousal, and EEG'. 
2.1 Introduction 
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Previous research has found that photic stimulation can elicit relaxation responses 
and induce different mood states (Brauchli et al., 1995; Dieter & Weinstein, 1995; 
Glicksohn, 1986; Mundy-Castle, 1953; Noton, 1997; Richardson & McAndrew, 
1990; von Gizycki et al., 1998). Through the process of entrainment, photic 
stimulation acts to captivate cortical EEG, and pull it into synchrony with the 
presenting stimulus. As a result, EEG power is increased, not only at the frequency 
of stimulation, but also within distal bands of EEG harmonically related to the 
original stimulus, with concomitant changes in mood and physiological arousal. 
As discussed in Chapter 1, many studies attest to the anxiolytic effects of photic 
stimulation, and have shown that it quickly induces relaxation responses, and 
increases brainwave activity in alpha and theta bandwidths, which are EEG rhythms 
associated with relaxation and cortical deactivation (Brauchli, 1993; Dieter & 
Weinstein, 1995; Kumano et al., 1996; Morse, 1993, 1994b). Morse investigated the 
anxiety reducing abilities of photic stimulation in patients undergoing root canal 
therapy. He compared 1 OHz photic stimulation, photic stimulation combined with 
relaxing music, and a control group, who received no additional intervention. Those 
who chose to use the brainwave synchroniser, with or without relaxing music, 
demonstrated significantly greater relaxation responses, even during a potentially 
stressful procedure. Dieter and Weinstein (1995) found photic stimulation to be 
superior to autogenic relaxation, as it produced deeper relaxation, increased theta and 
delta EEG activity, plus induced vivid visual imagery similar to that found in the 
hypnagogic state. This study was consistent with other research which found that 
photic stimulation increased drowsiness and produced altered states of 
consciousness, with the potential to be an effective tool for treating insomnia 
(Glicksohn, 1986; von Gizycki et al., 1997; von Gizycki et al., 1998). 
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Other studies have assessed the therapeutic effectiveness of mind machines on 
arousal and psychological distress. Anderson, Legg and Ridout (1997) demonstrated 
that daily, long term use (2-4 months) of photic stimulation dramatically reduced 
premenstrual symptoms in a group of women suffering from premenstrual dysphoric 
disorder. Conversely, Ossebaard (2000) found that audiovisual stimulation, · 
presented twice a week, for up to eight weeks, reliably produced immediate 
relaxation effects during stimulation, but did not have an enduring impact on 
psychological distress in a group suffering from occupational burnout. 
Much of this research, however, used either single trial paradigms, or short exposure 
times to the entraining stimulus, or both. Research which has attempted to assess the 
therapeutic effects of photic stimulation of longer duration (15-40 mins) with 
repeated exposures (7-60 sessions) were either methodologically flawed because of 
omission of control groups (Anderson et al. , 1997; Noton, 1997), or found photic 
stimulation gave immediate benefit, but failed to produce long-term therapeutic 
change over time (Ossebaard, 2000). There is a paucity of research investigating the 
effects of repeated exposure to an entrainment stimulus of longer duration on 
psychological and physiological variables, while controlling for placebo and 
relaxation effects, in order to fully assess the therapeutic utility of A VS. To date, 
there is little evidence to show that photic stimulation, like relaxation therapy, 
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produces carry-over or training effects which create permanent reductions in arousal 
mechanisms, thereby re-establishing physiological homeostasis, and also 
substantiating its effectiveness in the treatment of arousal disorders. 
To address some of the shortcomings of previous studies the current study will 
include the following, i) randomised allocation of participants to experimental trials, 
ii) control of relaxation and placebo effects with the inclusion of control and 
relaxation conditions, and iii) use of a repeated measures design over many sessions 
in order to fully assess the clinical utility of brainwave entrainment techniques. 
This initial study adds to previous research by exposing participants to extended 
periods of various A VS frequencies, over a number of trials, while measuring key 
physiological variables known to reliably reflect changes in arousal; such as heart 
rate (Lucini et al., 1997; Sakakibara, Takeuchi, & Hayano, 1994; Scher, Furedy, & 
Heslegrave, 1985; Vaschillo, Lehrer, Rishe, & Konstantinov, 2002), skin 
conductance (Heller, Nitschke, & Lindsay, 1997; Lim et al., 1996; Montgomery, 
1998), EEG; and also mood, in an attempt to see if prolonged and regular exposure 
to photic stimulation will have enduring effects on mood and arousal. Consequently, 
if photic stimulation can be shown to have beneficial and enduring effects on mood, 
with concomitant reductions in physiological arousal, this will pave the way for the 
use of entrainment technologies as clinical tools in the treatment of arousal and mood 
disorders. 
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2.2 Aims of Study 1 
As discussed in Chapter 1, photic driving is a well established phenomenon (Mundy-
Castle, 1953; Toman, 1941), which can be used to reduce arousal and generate 
different mood states by 'driving' the brain into particular rhythms (Dieter & 
Weinstein, 1995; Richardson & McAndrew, 1990; von Gizycki et al., 1998). The 
current study employed a single blind, controlled, repeated measures design to 
investigate the effects of three audiovisual frequencies, 5Hz (theta), 13Hz (alpha), 
and 22Hz (beta), on mood and physiological arousal, in comparison to relaxation. 
There were two main aims of this initial study. First, to determine if photic 
stimulation is superior to a simple relaxation technique, such as autogenic relaxation, 
in its ability to produce relaxation responses with enduring effects over time. 
Second, to ascertain which particular photic stimulation frequencies are more 
conducive to the production of relaxation responses and positive mood states. 
2.3 Hypotheses 
2.3.1 Heart rate, skin conductance, & subjective relaxation: Reductions in 
physiological arousal were anticipated for all participants, as they were required to 
sit quietly in a darkened room for up to forty minutes during each recording session. 
As discussed in Chapter 1, EEG frequencies in the theta and alpha ranges signal 
cortical deactivation (Niedermeyer, 1993; Steriade et al., 1990), and are present 
during relaxed states (Aftanas, Varlamov, Pavlov, Makhnev, & Reva, 2002; Marshall 
& Bentler, 1976; West, 1980). Beta frequencies, on the other hand, indicate cortical 
arousal and are often associated with physiological arousal and anxiety (Bonnet & 
Arand, 2001; Nofzinger et al. , 2000). 
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In the current study, therefore, it was anticipated, that brainwave entrainment at 
alpha and theta frequencies would induce greater relaxation responses than 
entrainment within the beta bandwidth. Given that relaxation is associated with 
alpha and theta states, it was predicted that the theta, alpha, and relaxation groups 
would experience greater reductions in arousal, as evidenced by reduced heart rate 
and skin conductance during the active experimental phase, than the beta or control 
groups. Congruent with this hypothesis, it was anticipated that the theta, alpha and 
relaxation groups would report higher levels of subjective relaxation than the beta or 
control groups, across experimental sessions. 
2.3.2 Mood, automatic thinking, and psychological status: In alignment with 
previous research which found that theta and alpha rhythms in particular, often elicit 
relaxation responses and positive, pleasant feeling states (Anderson et al., 1997; 
Brauchli, 1993; Brauchli et al., 1995; Brown, 1970, 1971; Glicksohn, 1986; Kumano 
et al., 1996; Morse, 1993; Noton, 1997; Nowlis & Kamiya, 1970; Shealy et al., 1990; 
von Gizycki et al., 1997; von Gizycki et al., 1998) it was predicted there would be 
greater mood enhancements for the alpha, theta and relaxation groups than for the 
beta and control conditions. 
In addition, it was anticipated that as relaxation responses were elicited and mood 
shifted towards a more positive valence, that automatic thinking would also shift 
towards the positive pole. Negative automatic thoughts often accompany dysphoria 
and are the object of therapy in cognitive behavioural models (Beck, 1995). As 
mood shifts towards a more positive valence, concomitant shifts in thinking are also 
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observed (Abela & D'Alessandro, 2002; Ellis & Harper, 1961; Kendall, 1992; 
Kendall, Howard, & Hays, 1989; Smith, Haynes, Lazarus, & Pope, 1993). If 
changes in automatic thinking can be demonstrated alongside shifts in mood towards 
the positive valence in the current study, using a non-clinical sample, this would give 
further credence for the utility of brainwave entrainment tec_hniques as therapeutic 
tools. Given the superiority of theta and alpha rhythms to bring forth relaxation 
responses, and their association with positive mood states, it was anticipated that the 
theta, alpha, and relaxation groups would experience greater reductions in negative 
affect and negative thinking, and larger increases in positive affect and positive 
thinking, than the beta and control groups during experimental trials. Concomitantly, 
it was predicted that depression, anxiety, and symptom severity scores, as measured 
by the Symptom Checklist 90-R (Derogatis, 1977), would decrease more for the 
theta, alpha, and relaxation groups, than for the beta and control conditions. 
2.3.3 Electroencephalography (EEG): The response of the occipital cortex to light 
flicker has been well documented with photic driving observed in response to 
frequencies between 5 to 90Hz (Fedotchev et al., 1990; Herrmann, 2001; Lazarev et 
al., 2001; Mundy-Castle, 1953; Silberstein, 1995b; Takahashi, 1993; Toman, 1941 ). 
Optimal driving responses, however, are usually seen at frequencies nearest to the 
clients' own dominant alpha frequency which lies within the 8- l 2Hz range 
(Pockberger et al., 1985; Toman, 1941). Therefore, it was anticipated that evidence 
of frequency following would be seen in the posterior cortex at entrainment · 
frequencies (5Hz, 13Hz or 22Hz), with observable increases from baseline in EEG 
magnitude at the stimulus frequency. 
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Finally, the study aimed to assess if repeated and regular exposure to photic 
stimulation would produce carryover or 'training effects' persisting beyond the 
intervention sessions, with sustained positive changes in mood status and decreases 
in heart rate and skin conductance. It was anticipated that entrainment responses, 
that is increased EEG amplitude at frequencies of stimulation, would be contingent 
on the stimulus itself. However, if evidence of increased magnitude in occipital EEG 
at entrainment frequencies is found at follow-up, in the absence of photic 
stimulation, this would give further validation for the use of photic stimulation as a 
clinical tool, showing enduring EEG changes which persist beyond the intervention 
phase. 
2.4 Method 
2.4.1 Participants: The sample comprised thirty adult participants, 10 males and 20 
females, drawn from the pool of first year psychology students at the Australian 
National University, and from the wider community. Many respondents received 
course credit points for their participation. Participants from the wider community 
responded to advertisements placed around the university campus, or placed in a 
number of local health clinics. The age range of participants was from 18 to 59 
years, with 70% of participants aged 32yrs or younger. 
In order to minimise risk to participants, remove the effects of medication on EEG 
recordings, and, as much as possible, to obtain a sample free from psychopathology, 
participants were excluded from the study if they had a history of epilepsy or if they 
were currently taking antidepressant, sedative or neuroleptic medication. 
Nevertheless, 17% (n=6) of participants had Symptom Checklist 90-R (SCL-90-R) 
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depression T-scores greater than 60, and 27% (n=9) had SCL-90-R anxiety T-scores 
greater than 60. In addition, at baseline 10% (n=4) of participants had a global 
severity index T-scores > 63, thus identifying them as 'positive risks' for pathology 
(Derogatis, 1977). 
2.5 Design 
A 5xl 4 mixed, single blind, controlled design was employed. The thirty participants 
were randomly allocated to one of 5 groups; a control group who received no active 
stimuli, a relaxation group who listened to a 20 minute autogenic relaxation tape, or 
one of three audiovisual stimulation (A VS) groups: theta, alpha or beta, who 
received stimulation at the following frequencies 5Hz, 13Hz and 22Hz respectively. 
Initial baseline measures were obtained, followed by 12 intervention sessions, and 
finally, a follow-up session two weeks after completion of the experimental phase. 
Measures of electroencephalography (EEG), skin conductance, heart rate, subjective 
relaxation, daily hassles and mood were taken at all sessions. Additional measures 
of psychological status ( depression, anxiety, and symptom severity), and positive and 
negative automatic thoughts were obtained at baseline and follow-up sessions. 
2.6 Measures 
Demographic information, measures of mood, automatic thoughts, daily hassles, 
subjective relaxation, and health behaviours and were presented together in the 
'Thoughts Emotions and Health Questionnaire' (see Appendix A). On subsequent 
assessments a shorter version of this questionnaire, which omitted previously 
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obtained demographic details, was used. Specifically, the questionnaire assessed the 
following variables: 
2.6.1 Mood: Mood was assessed using the Positive and Negative Affect Schedule 
(PANAS) developed by Watson and Clark (1988) (see Appendix A, 'Thoughts, 
Emotions and Health Questionnaire', p. 1 ). This is a 20 item scale with 10 items 
assessing positive affect and 10 items assessing negative affect. Respondents were 
asked to indicate, on 5 point Likert scale (1 = very slightly or not at all; 5= extremely) 
the extent to which they endorsed each item. At baseline and follow-up participants 
were instructed to indicate the extent to which each item described how they felt 'on 
average in the last week'. During experimental trials, sessions 2-12, participants 
were instructed to indicate the extent to which each item described how they felt on 
average since the last session. 
Positive and negative affect are purported to be orthogonal constructs (Diener & 
Emmons, 1985; Watson, Clark, & Tellegen, 1988). Factor analysis of the schedule 
across a number of administrations, was generally consistent with this with a strong 
positive factor emerging, and a weaker dichotomous negative factor which often 
comprised an additional lower-order 'arousal' type factor containing the adjectives 
'afraid', 'scared' or 'nervous'. This finding is consistent with Molloy (2001) and 
others who also found positive affect to be robust and negative affect to be 
comprised of an additional 'afraid' type factor (Glenn & Molloy, 2000; Killgore, 
2000; Molloy, Pallant, & Aristotle, 2001 ). 
33 
The alpha reliability coefficients for the two scales in this current study were 0.90 for 
positive affect and 0.87 for negative affect (Cronbach, 1951). Correlations between 
negative and positive affect confirmed their independence in all but one analysis. At 
initial assessment a significant negative correlation was found (r = -.57, p < .05) 
between the two subscales. However, all subsequent correlation coefficients showed 
no relationship between positive and negative affect with an average correlation of r 
= 0.03 (ranger= -0.10 to 0.16) p > .05. 
2.6.2 Daily Hassles: Daily hassles were assessed at each session because of their 
ability to impact on mood states. A selection of 32 central daily hassles were used 
from Gruen, Folkman and Lazarus' review of 'central daily hassles' (Gruen, 
Folkman et al. 1988) (see Appendix A, 'The Thoughts, Emotions and Health 
Questionnaire', p. 3). Respondents were told that "a 'hassle' is an irritant which 
annoys or bothers you; they can make you upset or angry, they can be minor irritants 
or fairly major pressures." They were then asked to indicate on a 5 point Likert scale 
(0 = none or not applicable, through to 4 = a great deal) "the extent to which each 
hassle has been or currently is problematic". Scores were then summed to obtain a 
'hassle intensity' score, range 0-99, for each session. 
2.6.3 Automatic Thoughts: As discussed above, automatic thinking was assessed 
in this study because of its association with mood. Positive mood states tend to be 
accompanied by positive automatic thinking, while negative mood states are 
characterised by negative automatic thinking. Positive and negative automatic 
thoughts were assessed at baseline and follow-up using both the Automatic Thoughts 
Questionnaire- Positive (ATQ-P), devised by Ingram and Wisnicki (1988), and the 
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original Automatic Thoughts Questionnaire (ATQ), by Hollon and Kendall (1980), 
which assesses negative automatic thinking. In total both scales comprised 60 items, 
30 positive and 30 negative self-referential thoughts, which were presented in a 
counterbalanced fashion. Respondents were asked to indicate on a 5 point Likert 
scale ( 1 = not at all, 5 = all the time) the frequency that each thought had occurred 
over the last week (see Appendix A, 'Thoughts, Emotions and Health Questionnaire', 
p. 2). 
Visual examination of baseline and follow-up scree plots showed two dominant 
factors. Factor analysis showed the presence of a strong positive thoughts factor at 
both baseline and follow-up. Inspection of the un-rotated principal components 
matrix showed all of the 30 positive baseline items loading strongly on the positive 
thoughts factor, with only one item, 'I won't give up', failing to load at follow-up. 
The factor structure for negative thoughts was less robust across the two 
measurements. At baseline, 'negative thoughts' was comprised of one main factor 
and two lower order factors. Varimax rotation did not improve item loadings. At 
follow-up, a more robust negative thoughts factor was observed with a main factor 
and two smaller lower-order factors comprising the items, 'my life's not going the 
way I want', 'I wish I were somewhere else', 'I've let people down', and a final factor 
with only one item; 'something has to change'. At follow-up only one negative 
thoughts item, 'I can't get started', failed to load on either scale. 
Alpha reliabilities for positive thoughts were 0.97 at baseline and 0.98 at follow-up 
and for negative thoughts, 0.88 at baseline and 0.87 at follow-up. Little 
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improvement in internal consistency of the scales was achieved with the removal of 
low-loading items, therefore all items were retained for final analysis. 
2.6.4 Psychological status: The Symptom checklist 90-R (SCL-90-R) (Derogatis, 
1977) was used to assess the psychological status of study participants and to assess 
the extent to which psychopathology may be present. The SCL-90-R is a 90 item 
inventory which has been extensively used on both 'normal' and clinical populations. 
It measures nine subscales including, Somatization, Obsessive-Compulsive, 
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid 
Ideation, and Psychotocism. It also includes three global symptom severity indices, 
the Global Symptoms severity index, the Positive Symptom Distress Index, and 
Positive Symptom Total. Respondents were asked to indicate on a 5 point Likert 
scale the extent to which they had been distressed or bothered by each of the 90 
listed problems over the last 7 days. 
The SCL-90-R reports good reliability and validity with alpha coefficients for 
internal consistency reported for the depression scale at 0.90 and for the anxiety 
scale, 0.88, and high test-retest reliability, 0.82 (Derogatis & Savitz, 1999). The 
subscales used in this study were depression, anxiety, and the global severity index 
and are measured as T-scores with mean of 50 and SD of 10. 
2.6.5 Lifestyle variables: Lifestyle variables, which have been shown to impact on 
mood, were assessed at baseline and follow-up sessions only. Respondents were 
asked to indicate if they had suffered any medical condition/s which had resulted in 
hospitalisation during the last year and experienced any major life events during the 
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last three months. Information was also sought about other lifestyle factors such as 
alcohol consumption, smoking behaviour, and the use of both prescribed and 
recreational drugs. In addition, given that it is widely reported that the phase of the 
menstrual cycle also impacts on mood (American Psychiatric Association, 1995; 
Mackenzie, Wilcox, & Baron, 1986), women were asked, at all sessions, to indicate 
the current week (1-4) of their menstrual cycle. Week one corresponded to the onset 
of menses, followed by subsequent weeks 2 and 3, with week 4 indicating the final 
week of the cycle or encompassing the remaining time until the beginning of the next 
cycle (see Appendix A, 'Thoughts, Emotions & Health Questionnaire', p. 3 - 4). 
Eighty seven percent of the sample reported that they had not had a medical 
condition in the last year resulting in hospitalisation. Forty per cent of the sample 
reported they had experienced a major life event in the last three months prior to 
commencing the study, such as university examinations, relationship break-ups, or 
stress related to work and finances. Most of the sample consumed alcohol less than 
twice per week and only 17% smoked ten or more cigarettes per day. Only seven 
(2 7%) of this predominately student population, reported using recreational drugs, 
with most of these claiming to use less than once per month. 
2.6.6 Subjective relaxation: Subjective relaxation was assessed at each session. 
Participants were asked to indicate on a 10 point Likert scale (1 = feeling very 
relaxed and calm, to 10 = feeling very anxious and uptight) how relaxed and calm, or 
anxious and uptight, they felt 'right now'. In order to obtain a measure for use in 
statistical analysis that was reflective of the descriptor 'subjective relaxation', this 
variable was reverse scored so that high scores corresponded with high levels of 
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relaxation and low scores with low scores of relaxation (see Appendix A, 'Thoughts, 
Emotions & Health Questionnaire', p. 5). 
2. 7 Apparatus 
All physiological data were recorded for twenty minutes at each session using an 
AMLAB data acquisition system with version 2.01B software. All data were 
sampled at 1 00Hz and saved to hard drive for subsequent analysis. 
2.7.1 Electroencephalogram (EEG): EEG was recorded using gold-cup Grass 
electrodes placed with Elefix™ electrode paste. All sites were prepared with alcohol 
prior to electrode placement in the following sequential montage, F3-Fpl, F4-Fp2, 
P3-O1, P4-02, and referenced to the right ear, according to the 10-20 International 
System (Jasper 1958; Homan, Herman et al. 1987). A 40Hz low-pass filter was 
used. Electrode impedances were kept below 1 0Kohms (Andreassi, 1995). See 
'Data Analysis' below, for a description of artifact removal and data reduction 
methods. 
2.7.2 Heart rate: Heart rate (beats per minute) was recorded using standard 
disposable pre-gelled 3M™ silver-silver chloride (Ag/ AgCl) electrodes. Electrodes 
were placed mid sub-clavicular on the left and right hand side of the chest wall with 
a left mid clavicular electrode placed over the 5-6th inter -costal space. The skin was 
prepared with alcohol prior to electrode placement. 
2.7.3 Skin conductance: Skin conductance was measured in micromhos and 
recorded using a pair of Ag/ AgCl 'wet' skin conductance sensors filled with .05M 
sodium chloride gel and applied to the volar surfaces of the 2nd and 3rd middle 
phalanges of the left hand. 
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2.7.4 Audiovisual stimulation (AVS): Because of the claim, made by Mind 
Machine manufacturers, that coupled photic and auditory stimulation enhances 
entrainment effects, audiovisual stimulation (A VS) was used in the current study. A 
portable light and sound machine (XCELR8R II) manufactured by 'Mind-gear'™ 
PTY. LTD was used to deliver audiovisual stimulation of either 5Hz, 13Hz, or 22Hz. 
White light was delivered via a set of goggles with integrated white light emitting 
diodes set at 25% intensity (,..., 8-10 Lux) in an attempt to obtain a level of light 
intensity tolerable by all participants. Auditory stimulation consisted of a pulsed 
single tone delivered simultaneously to both ears and was contingent with the light 
frequency and delivered via a set of headphones at a volume audible and comfortable 
for the client. 
2.7.5 Autogenic Relaxation: Participants in the relaxation group listened to twenty 
minutes of taped autogenic relaxation instructions delivered via the Mind-gear 
headphones. Tape instructions firstly asked participants to focus on the breath and to 
gradually slow and deepen their breathing. The adoption of a passive attitude to 
incoming thoughts was encouraged. Instructions then guided listeners through the 
body, from the head to the toes, focusing on letting go of tension and noticing areas 
of relaxation and calm. Finally, towards the end of the 20 minutes focus was again 
brought back to the breath and awareness placed on external stimuli and the client 
brought to an awake state (see Appendix B for relaxation script) . Participants were 
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seated semi-reclined in a chair, eyes closed with their legs resting on a footstool and 
wearing headphones and the light goggles but with no visual stimulation. 
2.8 Procedure 
Participants were seen individually and all sessions were conducted in a laboratory in 
the Psychology Department at the Australian National University. In order to 
maximise the effects of relaxation responses participants were asked to attend their 
12 intervention sessions up to 3 to 4 times a week over a three to four week period. 
In addition, because of 'time of day' effects on the EEG, sessions were scheduled as 
much as possible at the same time each day ( Cummings, Dane, Rhodes, Lynch, & 
Hughes, 2000; Sterman, 1998). While every attempt was made to adhere to this 
regime, not all participants could comply. 
Prior to assessment, participants were informed that the study was investigating the 
effects of relaxation and A VS on mood and other physiological variables. To control 
for expectancy effects all participants were told that there had been reports about the 
beneficial effects of A VS for the treatment of stress and other disorders and that the 
current research was being conducted because there was a paucity of controlled 
research to validate these claims. The procedure of 'random allocation to 
experimental groups' was explained. Participants were told they would not know the 
frequency of A VS stimulation they would receive, or the intended effects of this 
stimulation, until the end of the study. Recording procedures were explained, 
participants tights discussed, and informed consent obtained. Participants completed 
the 'Thoughts Emotions and Health Questionnaire' prior to the placement of 
electrodes and recording of physiological measures. Participants were seen 
individually over a period of 6-8 weeks for each subject with data collection for all 
subjects extending over a 9 month period (November 1997 to July, 1998). 
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In order to minimize arousal induced by attachment of recording equipment and the 
novelty of the situation, the first session included a twenty minute habituation phase. 
After attachment of sensors and testing of equipment, participants were instructed to 
sit quietly for twenty minutes with their eyes closed. Subsequent sessions included 
only ten minutes of habituation prior to recording as participants were more familiar 
with the experimental milieu and procedures (Andreassi, 1995). 
Participants were seated in an armchair in a semi-reclined position with their feet 
supported on a footstool, in a light attenuated room. All participants wore 
headphones and light goggles and sat with their eyes closed throughout the twenty 
minute recording period. During this time the control group received no stimulus, 
the relaxation group received instructions via the headphones, but no photic 
stimulation, while the A VS groups received pulsed sound via the headphones and 
photic stimulation via the light goggles at either 5Hz, 13Hz, or 22Hz. The 
experimenter was present in the same room throughout the recording procedure, 
seated away from the participant and observing occipital EEG tracings for evidence 
of increased slow wave activity that often precedes the onset of drowsiness. All 
participants were cued to stay awake ten minutes into the recording session, if 
however, there appeared to be an increase in slow wave activity in occipital leads at 
any time during the recording session, further cues were given. 
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2.9 Results 
2.9.1 Data analysis: To minimize the effects of artifact contamination the first and 
last minute of EEG data was ignored. Data were san1pled from five equidistant 
points that were determined a priori on the remaining 18 minutes of EEG trace. Left 
pre-frontal (Fp l -F3) raw EEG tracings were visually assessed by a trained technician 
for removal of eye movement and other artifact. Artifact contaminated EEG was 
removed from all leads at the same corresponding time epochs and the remaining 
raw EEG was subject to a Fast Fourier Transform. Further data reduction involved 
averaging across three consecutive 5.5 second epochs at or close to the five 
predetermined sampling points, yielding a total of 80-90 seconds of artifact free EEG 
from each session. In order to assess the effects of the three A VS frequencies ( 5Hz, 
13Hz, and 22Hz) on the EEG, three EEG variables encompassing these bandwidths 
were formed, i) 4-6Hz, ii) 12-14Hz, and iii) 21-23Hz. Similarly, heart rate and skin 
conductance data were extracted at the same 'time epochs' that the EEG data were 
collected. 
The assumptions of linearity, normal distribution and homogeneous variance, were 
checked graphically by means of residual plots. The data were also screened for 
outliers using Mahalanobis's distance and visual inspection of box plots. Original 
EEG data was measured in decibels ( dB). This data tended to be positively skewed, 
but transformation into microvolts (µ V) rendered the data more 'normal'. The 
transformed data were used in subsequent analysis. Data analysis was done using the 
SPSS V.10 statistical package. Repeated measures multivariate analyses of variance 
(MANOVA) was used to test hypotheses. Means and standard deviations for 
variables used in each MANOV A are located in Appendix C. 
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2.9.2 Heart rate & skin conductance: The main aim of this study was to 
determine if A VS was superior to relaxation in its ability to enhance mood and 
induce a relaxed state. Because of the length of time participants were required to sit 
quietly with their eyes closed it was predicted that all groups would experience a 
decrease in physiological arousal with decreases in heart rate and skin conductance 
over the twenty minute recording time (time effect). 
It was also hypothesised there would be greater reductions in heart rate and skin 
conductance for the theta, alpha, and relaxation groups compared to the beta and 
control groups across experimental sessions. To test these hypotheses separate three-
way MANOVA's were computed with group (control vs. relaxation vs. theta vs. 
alpha vs. beta) as the between groups variable, and time (sampling time 1-5) and 
session (1-14) as within-groups variables for both heart rate and skin conductance. 
There were no differences between groups at baseline for either heart rate or skin 
conductance. 
Analysis showed the expected decreases in physiological arousal over the twenty 
minute recording period with a significant main effect for time for both heart rate, 
F( 4,20) = 11.30, p < .05, 17 2 = .69, and skin conductance, F( 4,22) = 14.40, p < .05, 17 2 
= . 72. This effect was not influenced by group membership as indicated by non-
significant group by time interactions for both heart rate, F(l 6,92 = .93, p > .05, 17 2 = 
.14, and skin conductance, F(l 6,100) = 1. 70, p > .05, 17 2 = .21. As can be seen in 
Figure 2.1 , contrary to predictions, mean heart rate increased over the fourteen 
sessions for all groups regardless of a decrease during each individual recording 
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period, however this moderate to large main session effect was not statistically 
significant, F(l 3, 11) = 2.10, p > .05, 112 = . 71. 
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Figure 2.1 Mean heart rate at baseline (1), sessions 2-13, & follow-up (14), (n=30). 
It was predicted that the theta, alpha and relaxation groups would demonstrate 
greater reductions in arousal, as indicated by lower heart rate and skin conductance 
levels, than the beta or control conditions. As can be seen in Figure 2.2 skin 
conductance was variable across the fourteen sessions, with the beta group showing 
higher skin conductance levels than the other groups. Despite this, there was no 
main effect for session, F(l 3, 13) = 1.60, p > .05, 112 = .62, and contrary to 
predictions, neither heart rate nor skin conductance levels changed over the sessions 
as a function of group membership as evidenced by non-significant session by group 
interactions for both heart rate, F(52,56) = 1.02, p > .05; 112 = .48, and skin 
conductance, F(52,64) = 0.90, p > .05, 17 2 = .42. 
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Figure 2.2: Mean skin conductance at baseline (1), sessions 2-13, & follow-up (14), 
(n=30). 
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2.9.3 Subjective relaxation: It was also anticipated that the theta, alpha and 
relaxation groups would report higher levels of subjective relaxation than the beta or 
control conditions during experimental trials. This hypothesis was tested using a two 
way MANOV A with groups ( control, relaxation, theta, alpha and beta) as the 
between groups variable and session ( 1-14) as the within groups variable. This 
prediction was not supported (see Figure 2.3). While there was an increase in rated 
relaxation across sessions, as indicated by a significant main effect for session, 
F(13,13) = 3.13, p < .05, 112 = .76, this effect was not dependent on group 
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membership with a non-significant group by session interaction obtained, F(52, 64) = 
0.54, p > .05, 11 2 = .30. There was a significant main effect for group, however, F( 4, 
25) = 3.15, p < .05, 11 2 = .33. This was because the alpha group consistently reported 
higher subjective relaxation than any of the other groups across sessions. 
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Figure 2.3 Mean subjective relaxation at baseline (1), sessions 2-13, & follow-up 
(14), (n=30). 
2.9.4 Mood (PANAS): As can be seen in figures 2.4 and 2.5 changes in affect were 
evident for both positive and negative affect across the fourteen sessions, but not 
always in the intended directions. It was hypothesised that the theta, alpha and 
relaxation groups would report higher levels of positive affect and lower levels of 
negative affect than the beta or control groups during the experimental phase. 
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Separate three way MANOV A's were performed to test these predictions with group 
( control vs. relaxation vs. theta vs. alpha vs. beta) as the between groups variable, 
and session (1-14) and scale items (10 positive items or 10 negative items) as the 
within groups variables, for both positive affect and negative affect. 
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Figure 2.4 Mean positive affect at baseline (1 ), sessions 2-13, & follow-up (14), 
(n=30). 
Contrary to predictions positive affect generally declined over the fourteen sessions. 
This was statistically significant with a strong main effect for session revealed, 
F(l 3, 13) = 6.24, p < .05, 112 = .86. Exploration of this session effect revealed 
positive affect, regardless of group membership, was consistently lower at every 
session in comparison to baseline, F(l,25) =1.3 to 69.1, p < .05. There was, 
however, a trend in expected directions. For example, there was an increase in 
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positive affect for the alpha group after session 4, and a sustained decrease in 
positive affect for the beta group throughout their therapy sessions. These observed 
trends, however, were not significant with a non-significant main effect for group, 
F(4,25) = 1.64, p > .05, 11 2= .19, and no session by group interaction, F(52, 64) = 
1.04, p > .05, 11 2= .46, obtained. 
There was a main effect for items, F(9,17) = 9.3, p < .001, ri2= .83, signifying that 
certain items, such as 'interested', 'enthusiastic', 'inspired', 'proud', 'alert', 'active' and 
'determined' were endorsed more than others, but there was no item by group 
interaction, which indicated that A VS or relaxation did not elicit particular mood 
states over and above the other conditions, F(36,80) = 0.75, p > .05, 112= .25. 
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Figure 2.5 Mean negative affect at baseline (1), sessions 2-13, & follow-up (14), 
(n=30). 
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As can be seen in Figure 2.5 negative affect declined for all groups across the 
fourteen sessions. This was supported with a significant main effect for session, 
F(l3,13) = 2.61, p < .05, 17 2 = .72. Exploration of this effect showed that negative 
affect was consistently lower than baseline levels for every session except session 
two, F(l,25) = 5.80 to 33, p < .05. It was anticipated, however, that the theta, alpha 
and relaxation groups would show greater declines in negative affect than the beta 
and control groups during the active experimental trials. This was not supported, 
with only a small to moderate non-significant session by group interaction effect 
revealed, F(52,64) = 1.05, p > .05, 17 2 = .46, and no main effect for group, F(4,25) = 
0.41, p > .05, 17 2 = .06. There was a significant main effect for item, however, F(9, 
17) = 7.99, p < .05, 17 2 = .80, indicating that participants gave greater endorsement to 
adjectives, such as 'distressed', 'upset', 'irritable' and 'nervous', but this was not 
dependent on group membership, F(36,80) = 0.84, p > .05, 17 2 = .27. 
2.9.5 Psychological status (SCL-90-R): As a non-clinical sample was used in this 
study it was anticipated that minimal psychopathology would be present and all 
participants would be within 2 standard deviations from the norm. As reported 
above 25% of the sample had depression, anxiety or symptom severity T-scores 1 
standard deviation or more above the norm. Nevertheless, all participants were 
within 2 standard deviations of the norm, as expected. Despite the limited variability 
across scores, it was anticipated that depression, anxiety and symptom severity 
scores, plus negative automatic thinking, would decrease more for the theta, alpha 
and relaxation groups, because of enhanced relaxation and mood responses, in 
comparison to the beta and control groups. Congruent with this hypothesis, positive 
automatic thinking was predicted to increase more for the theta, alpha, and relaxation 
groups over and above that of the beta and control conditions. These predictions 
were assessed using separate 2-way repeated measures MANOV A's with group 
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( control vs. relaxation vs. theta vs. alpha vs. beta) as the between groups variable and 
session (baseline vs. follow-up) as the within groups variable, for each variable. 
There were no group differences in these variables at baseline. 
2.9.6 Depression: In keeping with the selection of a 'normal' sample it can be seen 
in Table 2.1, that depression levels were low and within 1 SD of the norm, for all 
groups at baseline. Indeed, the mean T-score for the alpha group was below the 
norm. There was a significant main effect for session, F(l,25) = 10.86, p < .05, 112 = 
.30, with a decrease in depression scores at follow-up for all but the alpha group. 
The predicted pattern of the theta, alpha and relaxation groups showing greater 
reductions in depression level than the beta and control conditions at follow-up was 
only partially demonstrated with the theta and relaxation groups showing greater 
change over time compared to the other groups. This effect, however, was not 
significant as indicated by a non-significant session by group interaction, F( 4,25) = 
2 1.17, p > .05, 11 = .16. 
Table 2.1 Mean depression (SCL-90-R) T-Scores at baseline and follow-up. 
Group 
Control 
Relaxation 
Theta 
Alpha 
Beta 
Baseline Follow-up 
Mean SD Mean 
56.8 8.6 50.6 
55 .5 
52.3 
47.5 
55.6 
9.6 
6.1 
9.7 
9.6 
48.6 
44.3 
48.8 
50.3 
SD 
12.4 
7.0 
6.8 
7.3 
7.5 
n=30 
50 
Depression correlated strongly with anxiety at both baseline and follow-up, r = .60 to 
. 70, p < .05. It also correlated strongly in expected directions with symptom severity, 
r = .80, p < .05; negative affect, r = .65, p < .05; and negative automatic thoughts, r = 
.70, p < .05; and moderately with hassles, r = .57, p < .05; positive affect, r -.43, p < 
.05; and positive automatic thoughts, r = -.36, p < .05, as anticipated (see Appendix 
D, 'Ranges of Pearson's correlation coefficients for Study 1 variables'). 
2.9.7 Anxiety: The results for anxiety paralleled those for depression in that 
baseline T-scores were within 1 SD of the norm with the alpha group exhibiting a 
mean T-score below the norm (see Table 2.2). There were no differences between 
groups at baseline as indicated by a non-significant main effect for group, F( 4,25) = 
.96, p > .05, 17 2 = .13. Anxiety levels declined from baseline to follow-up for all 
groups except the alpha group as indicated by a significant main effect for session, 
F(l ,25) = 11. 10, p < .05, 17 2 = .30. While the theta, relaxation and beta groups 
demonstrated greater reductions in anxiety than the alpha or control conditions at 
follow-up, this was not significant, F( 4,25) = 1.94, p > .05, 17 2 = .24. Hence, the 
expected pattern of greater reductions in anxiety for the relaxation, theta, and alpha 
groups relative to the beta and control conditions was not supported. 
Table 2.2 Mean anxiety (SCL-90-R) T-Scores at baseline and follow-up. 
Baseline Follow-up 
Group Mean SD Mean SD 
Control 53.3 10.5 52.8 11.5 
Relaxation 54.6 7.0 49.5 6.7 
Theta 55 .5 8.3 46.5 9.3 
Alpha 45.3 10.7 45.5 9.6 
Beta 57.8 8.3 49.8 7.8 
n=30 
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Anxiety correlated strongly with negative affect and negative automatic thoughts 
across sessions with a range of Pearson's correlation coefficients of r = .40 to . 72, p < 
.05 and r = .25, p > .05 tor= .52, p < .05, respectively. Smaller correlations were 
seen between anxiety and positive affect r = -.33, p > .05, positive automatic 
thoughts, r = -.25, p > .05, and hassles r = .39, p < .05. 
2.9.8 Symptom severity (Global Severity Index): As can be seen in Table 2.3, 
symptom severity decreased from baseline to follow-up as evidenced by a significant 
main effect for session, F(l ,25) = 26.44, p < .05, 17 2 = .51. This decrease was not 
dependent on group membership, however, with a non-significant session by group 
interaction revealed, F( 4,25) = 0. 99, p > . 05, 17 2 = .14. While the anticipated 
outcome of the theta, alpha, and relaxation groups showing greater reductions in 
symptom severity than the beta and control conditions, was not statistically 
supported, the alpha and theta groups, but not the relaxation group, did demonstrate 
greater reductions in symptom severity than the control condition. There was no 
main effect for group, F( 4,25) = 1. 05, p > . 05, 17 2 = .14. 
Table 2.3 Mean global severity index T-scores (SCL-90-R) at baseline and follow-
u. 
Baseline Follow-u12 
Grou12 Mean SD Mean SD 
Control 56.0 13.2 53.1 14.0 
Relaxation 56.5 8.4 51.5 6.9 
Theta 53.3 9.1 43.3 8.5 
Alpha 49.3 7.7 43.5 11.6 
Beta 56.2 4.9 49.8 2.3 
n=30 
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2.9.9 Positive automatic thoughts: With reference to table 2.4, contrary to 
predictions, but commensurate with the trend for positive affect, positive thinking 
decreased over the experimental period, with a significant main effect for session 
observed, F(l,25) = 10.70, p < .05, 17 2 = .30. There was no session by group 
interaction, however, F( 4,25) =0.29, p > .05, 17 2 = .04, and no main effect for group, 
F( 4,25) = 1.35, p > .05, 172 = .12. 
Table 2.4 Mean 12ositive thoughts (ATQ-P) at baseline and follow-u12. 
Baseline Follow-u12 
Grou12 Mean SD Mean SD 
Control 102.5 23.2 83.3 21.7 
Relaxation 82.8 29.3 72.5 34.8 
Theta 91.8 29.7 76.2 34.5 
Alpha 114.3 26.8 100.5 34.8 
Beta 77.6 25.0 71.0 36.9 
n=30 
2.8.10 Negative automatic thoughts: As can be seen in Table 2.5, negative 
automatic thoughts decreased over the course of the study for all groups. This was 
supported with a significant main effect for session, F(l,25) = 12.74, p < .05, 17 2 = 
.34. The theta, alpha, and relaxation groups did not show greater decreases in 
negative thinking than the beta or control conditions as indicated by a non-significant 
session by group interaction, F( 4,25) = .40, p > .05, 172 = .06. 
Table 2.5 Mean negative automatic thoughts (ATQ) at baseline and follow-u12. 
Grou12 
Control 
Relaxation 
Theta 
Alpha 
Beta 
Baseline Follow-u12 
Mean SD Mean 
50.1 11.6 41.2 
43.6 
42.6 
38.8 
47.8 
10.3 
14.8 
8.4 
8.8 
34.6 
34.0 
36.6 
39.6 
SD 
15.3 
3.5 
3.5 
5.8 
8.0 
n=30 
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2.9.11 Electroencephalography (EEG): EEG data were assessed prior to 
hypotheses testing to ensure that expected patterns of EEG amplitude were present. 
A four-way MANOV A with group ( control vs. relaxation vs. theta vs. alpha vs. beta) 
as the between groups variable, and session (1-14), site (Fpl-F3, Fp2-F4, P3-O1, P4-
O2), and band (theta, alpha, and beta) as the within groups variables was used to 
assess patterns in the EEG across the scalp and across sampled bandwidths. A main 
effect for band was revealed, F(2,18) = 97.42, p < .05, 11 2 = .91, showing the 
expected pattern of higher amplitude in lower frequencies (4-6Hz and 12-14Hz) and 
lower amplitudes in the 21-23Hz bandwidth. Also of relevance was the observed 
decrease in EEG amplitude across the scalp with lower amplitudes observed at the 
two frontal sites (Fpl-F3, Fp2-F4) and higher amplitudes in the two posterior leads 
(P3-01, P4-02) (Niedermeyer & Lopes Da Silva, 1993). This was supported by a 
significant main effect for site, F(3, 17) = 9.45, p < .05, 17 2 = .62. 
To test the hypothesis that there would be an increase in EEG amplitude at the 
frequency of A VS, separate two-way MANOV A's, with group ( control vs. relaxation 
vs. theta vs. alpha vs. beta) as the between groups variable, and session (1-14) as the 
within groups variable, were computed for each bandwidth. Because of missing data 
in some participants' EEG, due to either equipment failure or removal due to 
excessive artifact, a more complete MANOV A model could not be used. In order to 
assess the amount of entrainment across the occiput, the two occipital sites (P3-01 
and P4-02) were summed to obtain a single occipital measure. 
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Figure 2.6 Mean amplitude in occipital 4-6Hz at baseline (1), sessions 2-13, & 
follow-up (14). 
As can be seen in Figure 2.6, there appears to be a decrease in 4-6Hz for the 
relaxation and alpha groups across experimental sessions with a return to baseline 
levels at follow-up. The control, and theta groups appear to be relatively unchanged 
over time, while the beta group exhibits an increase then a decrease in this 
bandwidth. It was anticipated that the theta group would show increases in 4-6Hz in 
their EEG in response to the 5Hz AVS stimulation they were receiving. This was not 
found. There was no main effect for session, F(13,8) = 2.30, p > .05, 112= .79, and no · 
session by group interaction, F( 52,44) = .91, p > .05, 112= .51. In addition, there were 
no differences between groups as indicated by a non-significant main effect for 
groups, F(4,20) = 2.07, p > .05, 11 2 = .29. 
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Figure 2.7 Mean amplitude in occipital 12-14Hz at baseline (1), sessions 2-13, & 
follow-up (14). 
Similarly, for the alpha group, who received 13Hz A VS, there was little evidence of 
entrainment in the 12-14Hz bandwidth. As can be seen in Figure 2.7 there was a 
small increase in amplitude for the alpha group after session two, which was 
sustained until follow-up. Contrary to predictions, however, the theta group showed 
the highest amplitude of 12-14Hz in their EEG, which was sustained across sessions. 
These observed patterns were not statistically significant with no group effect 
present, F( 4,20) = 1.35, p > .05, 172 = .21, and no session by group interaction, 
F(52,44) = 0.83, p > .05, 17 2 = .50. 
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Figure 2.8 Mean amplitude in occipital 21-23Hz at baseline (1), sessions 2-13, & 
follow-up (14). 
Examination of Figure 2.8 shows those participants receiving 22Hz AVS (beta 
group) displayed a small increase in 21-23Hz amplitude after session four only to fall 
again to baseline levels by session eight. However, this small change is 
indistinguishable from the background of activity in other groups whereby amplitude 
in the 21-23Hz bandwidth was highly variable, within a restricted range, for all 
groups. There was no group effect revealed, F(4,21) = 0.59, p > .05, 11 2= .10, and no 
session by group interaction, F(52,48) = 1.13, p > .05, rt 2 = .55. Independent of 
group membership, amplitude in 21-23Hz did not vary significantly across sessions, 
F(13,9) = 2.70, p > .05, 11 2 = .80. Thus, there was no evidence to support the 
proposal that entrainment effects vvould be evident during A VS exposure and remain 
at follow-up. 
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To assess inter correlations between EEG and psychological variables, three global 
EEG measures, 'global theta', 'global alpha', and 'global beta', were computed by 
summing across all sites for each respective bandwidth. There was little consistent 
relationship between EEG and psychological variables across sessions with highly 
variable patterns observed (see Appendix D). Positive affect tended to correlate 
negatively with global theta and global alpha with a large range across sessions from 
no relationship to significant moderate relationships such as, r =-.40, p < .05 with 
global theta, and r =-.38, p < .05 with global alpha. A similar wide range of 
correlations was observed for global beta and positive affect, with a range from r = -
.02 to.32, p > .05. Thus positive affect was associated with low theta and low alpha, 
but unrelated to beta. Negative affect was positively related to global beta 
frequencies as hypothesised, r =-.33, p > .05 to .42, p < .05, but was unrelated to 
global theta, or global alpha, r =-.30 to .30, p > .05, across sessions. 
EEG did vary with menstrual cycle. Pearson's correlation coefficients across 
sessions between menstrual cycle and global theta and global alpha ranged from no 
relationship to moderate inverse relationships of, r = -.50, p < .05, and r = -.46, p < 
.05, respectively. There was no relationship between menstrual cycle and global 
beta. Thus analysis indicated that as the luteal phase of the menstrual cycle 
progressed, global theta and alpha tended to decrease. Converse to expectations, as 
women approached the end of their cycle, positive affect increased, r = .55, p < .05, 
while negative affect decreased, r = -.41, p < .05. 
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Pearson's correlation coefficients between heart rate and skin conductance ranged 
from non significant to moderate, r = -.04, p > .05, tor= .52, p < .05 across sessions. 
Both heart rate and skin conductance correlated with global EEG variables ranging 
from very small non-significant correlations to moderate correlations. For example, 
heart rate correlated with global theta, r = -.40, p < .05; global alpha, r = .38, p < .05, 
and global beta, r = .50, p < .05. Similarly, a range of small non significant to 
moderate correlations were found between skin conductance and global theta, r = 
.58, p < .05, global alpha, r = .43, p < .05, and global beta, r = .46, p < .05. Both 
heart rate and skin conductance were unrelated to positive affect, but moderately 
related to negative affect, r = .37 and .39, p < .05, respectively. 
2.10 Discussion of results 
The main aim of this study was to establish if brainwave entrainment was better than 
autogenic relaxation at inducing both physiological and self-reported reductions in 
arousal. It also sought to ascertain if various frequencies of A VS impacted on brain 
functioning and differentially affected relaxation and mood. Overall, the results do 
not support the contention that brainwave entrainment is superior to traditional 
relaxation methods. Analysis revealed only small to moderate non-significant 
session by group interaction effects, essentially indicating that the various 
experimental manipulations had little differential effect on mood and arousal. 
In line with predictions, relaxation responses were elicited for every group with 
demonstrated deceases in heart rate and skin conductance at each session. Congruent 
with these findings, self reported relaxation increased across the study period for all 
groups. There was no support for the prediction, however, that A VS and relaxation 
would enhance well-being, and elicit greater relaxation responses over and above 
sitting quietly with eyes closed, as only small differences were observed between 
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A VS, relaxation and control. Given these general relaxation effects during sessions, 
it may be expected that carry over or training effects, indicating a homeostatic 
change in autonomic functioning towards more parasympathetic activation, may 
have been found for all groups. This was not the case. Heart rate and skin 
conductance levels, while somewhat variable across sessions, remained relatively 
unchanged at follow-up for all groups. 
Evidence, however, that A VS of varying frequencies did behave in predicted 
directions can be found in the pattern of non-significant effects across certain 
variables. For example, the beta group, who received 22Hz A VS, was expected to 
demonstrate the least amount of physiological relaxation during stimulation. As can 
be seen in Figure 2.2, the beta group showed a consistent and sustained increase in 
skin conductance throughout the experimental phase suggesting higher sympathetic 
arousal than the other groups. While this disparity was not significantly different 
from the other groups, it was in the anticipated direction and possibly because of the 
different A VS frequency they were receiving. In support of this, the observed group 
by session interaction effect for skin conductance was quite moderate, 17 2 = .42, but 
with a reduced observed power of .80 reported. An experiment with dfl = 52 and 
df2=64, a confidence level of 90% and power of .90, should be able to detect an 
effect of r2= .33 or greater (Smithson, 2003). Some caution needs to be exercised, 
however. Given the large dfl relative to df2, SPSS has a tendency to over estimate 
the true effect size and observed power. Nevertheless, it is possible that this effect 
size may have been detected had the experiment had sufficient power. 
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Further to this point, the observed increase in skin conductance for the beta group 
was not accompanied by a similar increase in heart rate as might be expected. This 
may suggest that the increase seen in skin conductance for the beta group was not an 
increase in arousal per se. In this study, however, the relationship between skin 
conductance and heart rate was quite variable. During some sessions there was no 
relationship and at other sessions, a moderate relationship was present, r = .52, p < 
.05. This dissociation between physiological markers is not uncommon. In 
Claridge's (1967) discussion of 'specificity' he points out that different people can 
exhibit hyperarousal via different physiological modalities, for example, as an 
increase in blood pressure for one, or an increase in skin conductance for another, but 
not all physiological variables react in concert to an arousing stimulus. 
Further trends in predicted directions were found. For example, the alpha group 
consistently reported higher levels of subjective relaxation than the other groups 
across sessions (see Figure 2.3). Unfortunately, this difference was statistically 
significant at baseline, but not for subsequent sessions. The effect size for the 
session by group interaction for this variable was small to moderate, 172 = .30, but the 
observed power was extremely low, .5 . As previously discussed, an experiment with · 
adequate power, for example .90, and large degrees of freedom (52,64), is capable of 
detecting an effect size of r2 = .33. Given this, the observed effect may not have been 
large enough to reach significance even if the power of the study was optimal. 
Therefore, the evidence in the current study that alpha entrainment induced higher 
levels of subjective well-being is rather tenuous. 
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A further aim of the study was to see if entrainment responses could be observed in 
the EEG at the particular A VS frequencies used. Statistical analysis revealed little 
evidence of entrainment responses such as increases in EEG amplitude at frequencies 
of stimulation. This may have been because the entrainment frequencies used in the 
study were not within the dominant frequency range of 8-12Hz where entrainment 
responses are most likely to occur (Silberstein, 1995a; Toman, 1941 ). According to 
Pockberger (1985) response to light flicker is positively correlated with level of 
depression. This study was performed on a non-clinical sample with the majority of 
participants within one standard deviation of the norm. This restricted range in 
depression level may explain \vhy evidence for entrainment was not found. To fully 
explore frequency following and its relationship to mood, future research on a 
clinically depressed sample could use 1 OHz photic stimulation to assess whether 
participants respond to photic stimulation or not, and additionally, to ascertain if 
recovery from depression is associated with an attenuation of frequency following as 
purported by Pockberger (1985). 
To assess frequency following responses more thoroughly average EEG amplitude 
was computed across experimental trials ( sessions 2-13) for each bandwidth, 4-6Hz, 
12-14Hz, and 21-23Hz, and compared to baseline measures. Eight participants 
showed increases, not only at the bandwidth of their particular A VS stimulus, but 
also consistently across the other bandwidths investigated. In the 4-6Hz bandwidth, 
five participants from the theta group, three participants from the alpha group, five 
participants from the beta group, and only one participant from each of the control 
and relaxation groups displayed increases in EEG amplitude at this frequency. 
Essentially, only those in the active A VS groups demonstrated increased EEG 
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amplitude within this bandwidth. Those receiving 13 or 22Hz A VS who showed 
increases within the theta bandwidth, were possibly displaying sub-harmonic effects 
in response to their respective frequencies of stimulation. For example, sub-
harmonic responses in the theta bandwidth to l 3Hz and 22Hz A VS would be seen at 
6.5 and 5.5Hz respectively. 
For the 12-14 Hz bandwidth, a similar picture emerges. Four participants from each 
of the active A VS groups, alpha, theta, and beta, showed increases in EEG amplitude 
at this frequency across experimental trials, while only two from the control group 
and none from the relaxation group showed increases in EEG amplitude. Similarly, 
for the 2 l-23Hz bandwidth, four participants from the beta group, three from the 
alpha group, two from the theta group, two from the relaxation group and three from 
the control group showed increases in EEG amplitude in this bandwidth. 
It appears therefore, that more participants in the active A VS conditions displayed 
increases in EEG amplitude, not only at their particular frequency of A VS, but across 
the other EEG bandwidths of interest. Omnibus MANOV A, however, did not reveal 
these effects, because of small to moderate effects sizes, and insufficient power in 
the experimental design. Moderate session by group interactions were revealed, 17 2 = 
.52, .50, and .55 for the 4-6Hz, l 2-l 4Hz, and 2 l-23Hz bandwidths respectively, with 
power ranging between .72 to .86. An experiment with dfl =52, and df2=44, with a 
confidence level of 90%, and power of .90, however, should be capable of revealing 
an effect of r2= .40 or greater (Smithson, 2003). Given that this test has a large dfl 
relative to df2, it is likely that SPSS has overestimated the given effect size as 
previously discussed. However, it is possible, given adequate experimental power, 
that these interaction effects may have reached significance. 
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In line with predictions, negative affect declined over experimental trials, but 
contrary to predictions, positive affect also declined. The anticipated pattern of the 
alpha, theta and relaxation groups showing the greatest decreases in negative affect 
and greater increases in positive affect was not seen. It was, however, partially 
supported with the alpha group reporting greater positive affect over experimental 
trials and the beta group reporting less positive affect than the other groups. 
Relaxation appeared to have the most beneficial effect on negative affect, with 
greater declines observed for the relaxation group across sessions in comparison to 
the other groups. The effect sizes for the session by group interactions were 
moderate, r/= .46 for both positive and negative affect, but with insufficient power 
available to detect these, power= .80. As previously highlighted, if the power in 
these tests had been .90 or higher ( df 52,44), these interaction effects may have been 
detected. Either this experiment failed to detect these small effect sizes, or they were 
too small in the first instance to be detected. 
In the current study affect was related to EEG but not always in the directions 
suggested by the literature. Positive affect tended to be inversely related to theta and 
alpha. This finding contradicts previous research which claims that alpha is 
associated with positive mood states. Theta is purported to be associated with 
drowsiness and hypnagogic states, which some people may perceive as a negative 
rather than a positive experience. Negative affect, on the other hand, was unrelated 
to theta and alpha EEG, but positively related to beta frequencies. Beta has been 
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associated with anxiety states (Pizzagalli et al. , 2002). In this sample, however, 
anxiety did not mediate negative affect as anxiety was unrelated to beta activity. 
Rather, some other aspect of negative affect facilitated the relationship, possibly 
physiological arousal, as indicated by significant positive correlations between beta, 
heart rate, and skin conductivity. 
Of interest in this initial study, was the observed reduction in depression, anxiety, 
and symptom severity, in an essentially non-clinical sample. The expected trend of 
the theta, alpha and relaxation groups reporting greater reductions in depression and 
anxiety was not statistically supported. The alpha group commenced the study with 
depression and anxiety scores below the mean T-score of 50, and consequently were 
hampered by floor effects. Regression towards the mean dictates that this group may 
increase their scores over time purely by chance. This in fact occurred with a small 
trend back towards the mean for depression and little change in anxiety scores. The 
most benefit appeared to occur for the theta, relaxation, and beta groups who showed 
the greatest reductions in depression and anxiety over the course of the study, while 
minimal changes were observed for the control group. Session by group interactions 
for depression anxiety and symptom severity, however, were quite small and non 
significant. Nevertheless, it appears that those in the active therapy conditions 
experienced the greatest amount of change. 
2.11 Summary 
The main aim of this study was to ascertain if A VS was superior to traditional 
relaxation techniques in its ability to elicit both physiological and self reported 
relaxation responses. The results showed A VS to be as efficacious as relaxation in 
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its ability to induce relaxation responses and impact on mood. Small trends in 
expected directions were found. Alpha stimulation tended to make participants feel 
more relaxed, with increased positive affect, in comparison to relaxation, control, or 
the other A VS frequencies. This is consistent with previous research which reported 
alpha states to be associated with positive feelings, a sense of 'letting go' and 
increased well-being (Brown, 1970, 1971; Morse, 1993, 1994a; Nowlis & Kamiya, 
1970). Beta entrainment appeared to increase arousal, to a small degree, as predicted 
with lower positive affect and higher skin conductance levels observed for this 
group. Overall, however, while small trends were present, statistical evidence 
showing brainwave entrainment to be superior to relaxation therapy was not found. 
This is consistent with Walach (1998) who found that brainwave entrainment 
techniques faired no better than sham (participants sat quietly with their eyes closed 
for up to forty minutes) in its ability to enhance well-being and produce relaxation 
responses. In Walach's study, however, brainwave entrainment techniques were not 
equivalent to electrical stimulation or sham, as they did produce more visual imagery 
than the other conditions. 
In summary, the current study found audiovisual stimulation to be a reliable method 
for inducing immediate relaxation. It was found to be equally as efficacious as 
autogenic relaxation in its ability to produce decreases in physiological arousal and 
subjective relaxation, similar to that found in previous studies (Morse, 1993, 1994a; 
Ossebaard, 2000; Walach, 1998). In addition, A VS incorporates some of the 
necessary components of relaxation as described by Benson (1975) ; a repetitive 
stimulus on which to focus , and restriction of external stimuli, coupled with the 
added benefit of entrainment effects acting upon the cortex. In this study, however, 
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audiovisual stimulation, autogenic relaxation, and placebo, produced significant 
reductions in depression, anxiety and symptom severity, in a largely non-clinical 
sample, possibly augmented by relaxation responses, subtle entrainment effects, and 
other non-specific factors such as demand characteristics and positive expectancies. 
This study, like others, found audiovisual stimulation to be equally as effective as 
autogenic relaxation in its ability to elicit relaxation responses (Dieter & Weinstein, 
1995), but A VS differs from most relaxation therapies, because it is a passive 
procedure which induces relaxation responses with minimal effort. In contrast, 
relaxation techniques, require skill, effort, concentration, and practice, which 
requires motivation, in order to create the desired effects. Therefore, it is 
hypothesised, that brainwave entrainment may have greater clinical utility in the 
long-term treatment of arousal disorders, such as depression, because of its ease of 
use, and ability to quickly induce relaxation responses, it may overcome problems 
with compliance and motivation which are common in depression. The current study 
revealed small to moderate effect sizes using a non-clinical sample, therefore, 
stronger treatment effects are anticipated in the next study, which will use a sleep 
disturbed, clinically depressed sample, who will have a greater capacity to show 
improvement. 
In conclusion, therefore, brainwave entrainment techniques have the potential to be 
more effective than traditional relaxation therapies in the treatment of stress-related 
disorders, such as depression for several reasons. They have proven anxiolytic 
qualities, plus the ability to entrain the cortex into more conducive brainwave states. 
Finally, mind machines require no prior training, are easy to use, novel and popular 
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devices. They offer a coping strategy that can enhance treatment compliance and 
maximise treatment outcomes in often difficult to treat depressed individuals, who 
have difficulty applying adequate coping skills when dysphoric, sleep disturbed, and 
deficient in motivation. 
CHAPTER3 
'Depression defined as a stress-related disorder' 
"I like living. I have sometimes been wildly, 
despairingly, acutely miserable, racked with 
sorrow, but through it all I still know that just to be alive is a grand thing." 
- Agatha Christie (1890-1976) 
3.1 Introduction 
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Depression is on the increase in industrialised and developing countries and is the 
biggest cause of morbidity, functional impairment, and loss of productivity with a 
prediction of increasing social costs in the future (Murray & Lopez, 1997; Murray & 
Lopez, 1996b ). Agatha Christie poignantly describes the experience of depression. 
Pervasive sadness and loss of interest and pleasure in activities, most days, for at 
least two weeks are the main defining features of an episode of Major Depressive 
Disorder (MDD) as outlined by the American Psychiatric Association (AP A), 1995. 
In order to qualify for diagnosis, MDD also includes some of the following 
symptoms: loss of energy and fatigue, diminished appetitive and sexual drives, and 
sleep disturbance; cognitive symptoms such as memory impairment, difficulty 
concentrating and making decisions; behavioural features such as crying, agitation or 
conversely, psychomotor retardation; and finally, feelings of worthlessness, guilt or 
self-loathing. Suicidal ideations are common and can be indicative of the severity of 
the disorder. Not surprisingly, MDD causes mild to severely debilitating 
impairments to daily functioning (American Psychiatric Association, 1995). 
3.2 Prevalence of Major Depression 
Unipolar major depressive disorder (MDD) is usually a recurring chronic disorder 
which engenders personal suffering and huge social expense (Andrews, 2001; Angst, 
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Stassen, Clayton, & Angst, 2002; Brodaty, Luscombe, Peisah, Anstey, & Andrews, 
2001; Cassano & Fava, 2002; Druss, Rosenheck, & Sledge, 2000; Goldney, Fisher, 
Wilson, & Cheok, 2000; Herrman et al., 2002; Maj, Veltro, Pirozzi, Lobrace, & 
Magliano, 1992; Murray & Lopez, 1996a; Pincus & Pettit, 2001). According to the 
World Health Organisation report, 'The Global Burden of Disease' (1996), MDD is a 
major cause of disability in the world, accounting for 11 % of total disability, and is 
projected to be the leading cause of disability in females by 2020 (Murrary & Lopez, 
1996; Murray & Lopez, 1996a; Murray & Lopez, 1997). Lifetime prevalence rates 
for MDD in America and Western Europe range from 13.3 to 17.1 % (Carta et al., 
1995; Cassano & Fava, 2002). A similar picture has been found for Australia. In the 
'1997 National Survey of Mental Health and Wellbeing of Adults', approximately 6% 
of people reported suffering from an affective disorder and 9.5% reported suffering 
from an anxiety disorder in the 12 months preceding the survey. The survey found 
that women were nearly twice as likely to suffer from an anxiety or affective disorder 
than men (Australian Bureau of Statistics, 1998; Henderson, Andrews, & Hall, 
2000). This is consistent with other research in Australia (Byrne, 1980; Goldney et 
al., 2000), the United Kingdom (Jenkins et al., 1997), and the United States (Coryell, 
Endicott, & Keller, 1992; Desai & Jann, 2000; Wu & Anthony, 2000) which also 
reported higher prevalence rates of MDD for women. A common finding in mental 
health surveys and clinical practice is the comorbidity of anxiety and depressive 
illness which exacerbates the burden of suffering and increases societal costs 
(Devanand, 2002; Keller & Hanks, 1995; Kessler & Frank, 1997; Kessler et al., 
1994; Liebowitz, 1993; Sherbourne & Wells, 1997; Simon et al., 2003; Wittchen & 
Essau, 1993; Y erevanian, Koek, & Ramdev, 2001 ). 
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The high comorbidity of depression with anxiety, which is a disorder of arousal, 
reflects current thinking that depression is a stress-related disorder (Chrousos & 
Gold, 1992; Nestler et al., 2002). Contemporary research shows that hyper-arousal 
in MDD coexists with a dysregulated and over-active hypothalamic-pituitary-adrenal 
axis (HPA) resulting in chronically elevated glucocorticoids which have deleterious 
effects on brain tissue, emotions, and behaviour (Arborelius & Owens, 1999; 
Chrousos & Gold, 1992; Duman, Heniger, & Nestler, 1997; Everly & Benson, 1989; 
Gold, Drevets, Charney, & Drevets, 2002; Holsboer, 2000a; Light, Kothandapani, & 
Allen, 1998; Plotsky, Owens, & Nemeroff, 2000). As a direct consequence, MDD is 
typified by abnormalities in frontal and limbic brain structures (Drevets, 2000b, 
2003; Soares & Mann, 1997) which are reflected in unique EEG patterns of pre-
frontal under-activation (Davidson & Henriques, 2000; Davidson & Irwin, 1999; 
Davidson, Pizzagalli, Nitschke, & Putnam, 2002; Henriques & Davidson, 1991; 
Matousek, 1991 ). Sequelae of MDD include fatigue (Lavidor, Weller, & Babkoff, 
2002), sleep disturbance, impairments of thinking, memory and concentration, and 
mood disturbance (American Psychiatric Association, 1995; Austin et al., 1999; 
Brunello et al., 2000; Erickson, Drevets, & Schulkinb, 2003). 
3.3 Distinguishing between mood and depression 
Mood is transient and highly variable from moment to moment. Factor analyses of 
mood measures consistently reveal that mood is primarily composed of two main 
orthogonal factors, a positive factor and a negative factor (Diener & Emmons, 1985; 
Watson, Clark, & Tellegen, 1988). According to Clark and Watson (1991) negative 
affect refers to "the extent to which a person is feeling upset or unpleasantly engaged 
rather than peaceful". Positive affect, on the other hand, represents "the extent to 
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which a person feels zest for life" (p. 321) and is often associated with pleasant 
events (Stone, 1981). Valence of affect has been used to distinguish between anxiety 
and depression (Clark & Watson, 1991; Clark, Watson, & Mineka, 1994; Gencoz, 
2002; Watson, Clark, & Carey, 1988; Watson, Clark et al., 1995; Watson, Weber et 
al., 1995). Negative affect reflects a general level of subjective distress and is 
common to both anxiety and depression, while positive affect is negatively related to 
depression, but essentially unrelated to anxiety. Positive affect therefore effectively 
discriminates between depression and anxiety with depression comprised of high 
negative affect and low positive affect, while anxiety is exemplified by high negative 
affect only. Negative affect that is persistent, all-encompassing and interferes with 
daily functioning, becomes depression. 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) categorises 
anxiety and depression as separate constructs (American Psychiatric Association, 
1995). Depression is predominately characterised by mood disturbance while the 
major component of anxiety is fear. Yet despite this, and reflected in the observed 
correlations with positive and negative affect outlined above, anxiety and depression 
share affective components (negative affect or subjective distress) and are often 
comorbid (Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Clark & Watson, 
1991; Katon & Roy-Byrne, 1991; Keller & Hanks, 1995; Mineka, Watson, & Clark, 
1998; Nitschke, Heller, Imig, McDonald, & Miller, 2001; Rodney et al., 1997; 
Sherboume & Wells, 1997; Stahl, 1993; Watson, Clark et al., 1995; Watson, Weber 
et al., 1995; Wittchen, Schuster, & Lieb, 2001; Yerevanian et al., 2001). 
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3.4 Defining depression as a disorder of dysregulated arousal 
Lifetime comorbidity of anxiety with primary mood disorder has been found to be as 
high as 59% (Brown et al., 2001). Given this high comorbidity, and it is not 
surprising that contemporary models of affective illness implicate arousal systems in 
the pathogenesis of depression (Chrousos & Gold, 1992; Gold, Goodwin, & 
Chrousos, 1988; Leonard, 2002; Nestler, 1998). According to Everly and Benson 
(1989) a common neurological substrate underlies all stress-related disorders, 
including depression. Through repeated exposure to stressful stimuli the central 
nervous system becomes sensitised and permanently altered to be hyper-reactive to 
subsequent stimulation. Rich interconnectivity between the limbic system, the 
frontal cortex, and the locus coeruleus, means once the system has been 'charged', 
reverberating circuits within these systems work to maintain the heightened 
sensitivity with an abnormal preference for sympathetic activation (Everly & 
Benson, 1989; Post, 1992). In other words, the nervous system 'learns' to be 
chronically over-aroused and 'stressed' (Esch, Stefano, Fricchione, & Benson, 2002; 
Everly & Benson, 1989; van der Kolk, 2001 ). 
3.5 The stress response 
Exposure to a stressor, either environmental or psychological, activates two 
functionally connected arousal pathways, the sympathetic nervous system, and the 
hypothalamic-pituitary-adrenal (HP A) axis (K vetnansky et al., 1995). Acute stress 
responses are facilitated by the sympathetic nervous system via the release of 
norepinephrine (NE) from the locus coeruleus (LC) in the brainstem (Herman & 
Cullinan, 1997). Norepinephrine helps to prepare the body for fight or flight. As 
indicated in Chapter one, sympathetic activation increases heart rate, cardiac output, 
73 
and respiratory rate; it dilates the pupils, stimulates the release of glucose from the 
liver, suppresses digestion, sexual activity and immune responses. Furthermore, it 
redirects blood flow to muscles in readiness for action (Kandel, Schwartz, & J essell, 
1991). 
The appraisal of threat also activates the HP A system by the release of corticotropin 
releasing hormone ( CRH) and vasopressin from the para ventricular nucleus (PVN) in 
the hypothalamus (Clark & Kaiyala, 2003). Both CRH and vasopressin in tum 
stimulate the anterior pituitary to release adrenocorticotropin hormone or ACTH 
(Akil & Morano, 1995; Plotsky et al., 2000; Tsigos & Chrousos, 2002; Vermetten & 
Bremner, 2002). The main effector organ of ACTH is the adrenal cortex, which 
releases glucocorticoids, mainly cortisol, into the blood stream. The role of cortisol 
is to prepare the organism for 'fight or flight' with the intensity of the response 
modulated by the severity of perceived threat (Kopin, 1995). Cortisol stimulates 
arousal, focuses attention, increases metabolism to ensure an adequate supply of 
energy, and inhibits functions not necessary for immediate survival, such as immune 
responses (Chrousos, 1995; Stratakis & Chrousos, 1995), neuronal repair (Chrousos 
& Gold, 1992), and vegetative behaviours such as eating, sex, and sleeping (Dunn & 
Berridge, 1990; Heinrichs, Menzaghi, Pich, Britton, & Koob, 1995; V gontzas et al., 
2001). Cortisol also acts, via a negative feedback system, to decrease the production 
of CRH and therefore limit the stress response (Kandel et al., 1991) (see Figure 3). 
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Figure 3 Central structures involved in the stress response. Appraisal of stress stimulates 
the release of corticotrophin releasing hormone (CRH) from the paraventricular nucleus 
(PVN) (blue) in the hypothalamus, & the release of norepinephrine (NE) from the locus 
coeruleus (LC) (red) in the brain stem. CRH stimulates the release of adrenocorticotrophin 
hormone (ACTH) from the pituitary, and the release of glucocorticoids from the adrenal 
glands, which in turn inhibit the stress response. Solid lines= stimulatory, broken lines= 
inhibitory. Adapted from Kandel, Schwartz & Jesse 11, 1991. 
Activation of both arousal systems provides short term adaptation in the face of 
threat. Prolonged activation of the LC/NE and HP A systems, however, disrupts 
homeostatic balance and increases psychological distress, predisposing susceptible 
individuals to psychiatric pathology (Clark & Kaiyala, 2003; Mizoguchi, Ishige, 
Aburada, & Tabira, 2003). In MDD, arousal is chronically elevated (Chrousos & 
Gold, 1992; Nestler et al., 2002) and with dire consequences, such as diminished 
immune function (Bauer et al., 2003), sleep disturbances (Nofzinger et al., 2000), 
and loss of neuronal function in frontal and limbic brain structures caused by high 
levels of circulating serum cortisol (Drevets, 2000b, 2001, 2003; Eskay, Chautard, 
Torda, Daoud, & Hamlink, 1995; Nofzinger et al., 2000). 
3.6 Cortical anomalies present in depression 
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Structural and functional brain imaging has revealed that MDD is characterised by 
abnormalities in frontal (Harrison, 2002; Mayberg, 2003; Soares & Mann, 1997) and 
limbic brain structures (Drevets, 2003). Specifically, imaging studies have revealed 
volume reductions in the hippocampus (Bremner et al., 2000; Bremner et al., 2002; 
MacQueen et al., 2003; Sheline, Mittler, & Mintun, 2002; Sheline, Sanghavi, 
Mintun, & Gado, 1999) the cingulate (Botteron, Raichle, Drevets, Heath, & Todd, 
2002), and the medial frontal cortical region (Bremner et al., 2002). Post mortem 
studies show decreased glial density and neuronal cell size in deep layers of the 
cortex in subjects with known MDD (Cotter et al., 2002; Drevets, 1999). In addition, 
abnormalities of blood perfusion and glucose metabolism have been found in the 
amygdala, thalamus, and orbital prefrontal cortex (Drevets, 1998, 2000a, 2000b, 
2001, 2003; Nobler, Roose, Prohovnik, & Moeller, 2000), the insula and cingulate 
gyrus (Kimbrell et al., 2002), and also in the basal ganglia, and temporal lobes 
(Brody, Barsom, Bota, & Saxena, 2001) of depressed patients. 
These structural abnormalities help to account for the deficits seen in frontal lobe 
functioning in depression, such as impairments in working memory, sustained 
attention, and other higher order frontal functions (Austin, 1995; Austin et al., 1999; 
Brody et al., 2001; Heller & Nischke, 1997; Henriques & Davidson, 1997; Landro, 
Stiles, & Sletvold, 2001; Shenal, Harrison, & Demaree, 2003). In addition, other 
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studies have revealed hemispheric asymmetries in depression with lower blood 
perfusion (MacHale et al., 2000) and reduced glucose metabolism (Martinat et al., 
1990) in the left prefrontal cortex in comparison to the right. These findings are 
congruent with a large body of EEG research which shows underactivation of the left 
frontal cortex in comparison to the right frontal cortex in depressed individuals 
(Cook & Leuchter, 2001; Davidson, 1992; Davidson, Ekman, Saron, Senulis, & 
Friesen, 1990; Davidson & Henriques, 2000; Davidson & Irwin, 1999; Debener et 
al., 2000; Drevets, 2000b; Gotlib, Ranganath, & Rosenfeld, 1998; Henriques & 
Davidson, 1991; Hinrichs & Machleidt, 1992; Knott, Mahoney, Kennedy, & Evans, 
2001; Matousek, 1991; Nandrino et al., 1994; Pockberger et al., 1985; Wheeler, 
Davidson, & Tomarken, 1993). 
3. 7 EEG in emotion and depression 
Lateralisation of brainwave activity also reflects lateralisation of emotion. Previous 
work in emotion by Silberman and Weingartner ( 1986) found that activation of the 
right frontal cortex was associated with the expression of negative emotion, while 
activation of the left frontal cortex was related to the expression of positive emotions. 
Davidson and colleagues further elucidated these findings and proposed that 
activation of the right frontal cortex is related to withdrawal from aversive stimuli 
and is guided by negative emotions such as disgust, fear and anxiety, while 
activation of the left frontal cortex reflects a propensity to approach a desired goal 
and is driven by positive emotions such as pleasure (Davidson & Henriques, 2000; 
Fox, 1991; Tomarken, Davidson, Wheeler, & Doss, 1992). 
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In depression, approach-withdrawal systems are disrupted because of deficits in 
brain functioning. Typically, the depressed person shows increased alpha activity in 
the left frontal cortex, indicating underactivation, in comparison to the right frontal 
cortex (Gotlib et al., 1998; Henriques & Davidson, 1991). Underactivation of the 
left frontal region robs the person of the experience of positive affect associated with 
seeking and obtaining pleasurable rewards (Davidson & Henriques, 2000). Given 
that the left frontal cortex is responsible for motivating 'approach' type behaviour 
towards desired goals which elicits positive feelings, it is not surprising that the core 
symptoms of MDD include negative affect ( or attenuated positive affect), loss of 
pleasure and interest in activities, and a decrease in motivation to seek social contact 
(American Psychiatric Association, 1995). This finding of left frontal underactivity 
is found so consistently that Davidson proposed that it is a trait-like marker for 
depression which reflects a propensity towards negative affectivity and a diathesis 
for subsequent depression (Davidson, 1998a, 1998b, 2001; Tomarken & Keener, 
1998). 
Anxiety, which is often comorbid with depression, is associated with activation of 
right frontal (Pizzagalli et al., 2002) and right posterior (Davidson & Henriques, 
2000; Heller & Nitschke, 1998; Matousek, 1991; Pozzi, Golimstock, Petracchi, 
Garcia, & Starkstein, 1995) cortical regions. This may contribute to the finding of 
lateral asymmetries of relative right frontal hemispheric activation, especially in 
MDD with comorbid anxiety. High beta rhythms, which are indicative of increased 
cerebral activity, are also associated with arousal and are often present in recurrent 
depression (Matousek, 1991 ; Nystrom, Matousek, & Hallstrom, 1986; Pizzagalli et 
al., 2002), possibly reflecting a chronically dysregulated and overactive HP A and 
sympathetic system. This is consistent with other research which demonstrated a 
positive correlation between cortisol secretion and beta EEG activity (Chapotot, 
Gronfier, J ouny, Muzet, & Brandenberger, 1998). 
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In summary, brain imaging studies attest to the damaging effects of high levels of 
glucocorticoids which are produced during stress responses and are often chronically 
elevated in MDD. Couple this with Davidson's findings of dysfunctional brainwave 
patterns in depression and it is apparent that MDD is characterised by very real 
physical changes which have emotional and behavioural ramifications and may be 
exacerbated and possibly triggered by repeated stress responses (Esch et al., 2002; 
Post, 1992). Brain imaging and EEG findings reflect pathological changes caused by 
chronic hyper-arousal in depression, but they fail to adequately explain the 
underlying mechanisms that contribute to depression and consequently inform 
treatment options. 
3.8 Biological models of depression 
3.8.1 The monoamine hypothesis: Until recently, traditional biological theories of 
depression have failed to acknowledge the role of stress responses in the 
pathogenesis of depression. The most commonly adhered to theory of depression is 
the monoamine hypothesis. The monoamine model purports that depression is 
caused by depletion of serotonin ( 5HT), norepinephrine (NE) (Maes & Meltzer, 
1995), and possibly dopamine (DA) (Di Chiara, Loddo, & Tanda, 1999; Naranjo, 
Tremblay, & Busto, 2001) in the brain. The use of contemporary antidepressants is 
based on this model and aims to increase circulating amines in the brain by blocking 
pre-synaptic re-uptake or by preventing amine degradation, in an effort to increase 
the availability of amines in the synaptic cleft (MIMS, 2000). The mechanisms of 
action, however, are complex and not merely due to increased availability of 
monoamines. For example, it has been shown that simply depleting monoamines 
does not produce dysphoria in non-depressed subjects (Arnulf et al., 2002; Booij et 
al., 2002). While NE and 5HT are necessary in the production of positive mood, 
they are not in themselves sufficient. 
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Further evidence of the inadequacy of the monoamine hypothesis to fully describe 
depression is found in its inability to explain why antidepressant treatment produces 
immediate increases in 5HT and NE, but therapeutic effects can take up to several 
weeks to occur (Nestler, 1998; Nestler et al., 2002). Rather, arousal mechanisms 
appear to be involved as it has been shown that effective antidepressant treatment, 
which increases NE and 5HT levels, subsequently dampens the overactive HP A 
system (Holsboer & Barden, 1996). As a consequence neurogenesis is stimulated 
and previously damaged cortical areas are restored to normal functioning (Duman et 
al., 1997). 
Other research shows that serotonin is involved in arousal pathways (Dinan, 1996) 
and crucial to healthy sleep (Adrien, 2002). This suggests a more complex picture 
than that described by the monamine hypothesis and points to the need to include 
arousal mechanisms in models of depression (Dinan, 1996; Fuller, 1992; Maes & 
Meltzer, 1995; Riedel, Sobczak, Nicolson, & Honig, 2002; Vermetten & Bremner, 
2002). The connection between mood and the monoamines, 5HT and NE, is not 
straightforward and merely increasing the amount of available neurotransmitters 
does not produce immediate short term improvements in mood in depressed 
individuals (Holsboer, 2000a), therefore signifying that other mechanisms must be 
involved. 
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3.8.2 The neurotrophin hypothesis: The discovery that antidepressants increase 
nerve growth factors in the brain via serotonin pathways helped to explain the 
delayed treatment response of antidepressant medications (Altar, 1999). Research 
has shown that by enhancing the availability of serotonin, after some weeks, brain 
derived neurotrophin factor (BDNF) is increased, particularly in areas known to be 
vulnerable to cell damage in depression, such as the prefrontal cortex, the cingulate, 
and the hippocampus (Chen, Dowlasshahi, MacQueen, Wang, & Young, 2001; 
Duman, Malberg, Nakagawa, & D'S a, 2000; Duman, Nakagawa, & Malberg, 2001; 
Shirayama, Chen, Nakagawa, Russell, & Duman, 2002). As a result, neurogenesis 
was restored and a reversal of depression induced atrophy was observed (Nibuya, 
Morinobu, & Duman, 1995; Saarelainen et al., 2003; Shirayama et al., 2002). It was 
assumed, therefore, that neurotrophic factors must also play a role in the 
pathogenesis of depression (Duman et al., 1997). It was also proposed that chronic 
antidepressant treatment played a protective role by preventing further damage and 
cell loss caused by stress responses (Nibuya et al., 1995). While the refined 
neurotrophic model of depression helped to explain the delayed onset of 
antidepressant therapy, it still did not incorporate the hyper-arousal features 
commonly seen in depression. 
3.8.3 The hyper-arousal hypothesis: The hyper-arousal model of depression has 
turned to dysregulation of the HP A and LC/NE systems to account for accumulating 
evidence that depression is characterised by hyper-arousal caused by chronic over 
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stimulation of arousal systems (Arborelius & Owens, 1999; Holsboer, 2001; 
Kasckow, Baker, & Geracioti, 2001; Leonard, 2002; Light et al., 1998; Nestler et al., 
2002). The hyper-arousal hypothesis is a comprehensive model which builds on the 
contributions of both the monoamine and the neurotrophin hypotheses to explain the 
mechanisms underlying depression. 
It is well established that over activation of arousal systems is common in MDD. Up 
to 50% of depressed people show signs of over-arousal and dysregulation of the 
HPA system (Arborelius & Owens, 1999; de Kloet, 2002; Deuschle et al., 1997; 
Holsboer, 2001) with high cortisolaemia (Barden, Reul, & Holsboer, 1995; 
Chrousos, 1998; Galard, Catalan, Castellanos, & Gallart, 2002; Hatzinger, 
Hemmeter, Baumann, Brand, & Holsboer-Trachsler, 2002) and a blunted response to 
dexamethasone (Kasckow et al., 2001) or CRH challenge (Arborelius & Owens, 
1999; Holsboer, 2001). As previously stated, chronically elevated cortisol levels 
damage frontal and limbic brain tissue causing cell loss and atrophy, possibly due to 
the downregulation of BDNF in these regions (Duman et al., 1997). As a result, the 
normal inhibitory feedback functions of the hippocampus are disrupted, and the 
ability of the hippocampus to 'switch off stress responses is attenuated (Calfaa et al., 
2003; Feldman & Weidenfeld, 1993; Mizoguchi et al., 2003). As a consequence, 
cortisol secretion continues unchecked. In addition, chronic activation of stress 
responses in depression repeatedly stimulates the LC/NE system which further 
exacerbates the problem of hyper-arousal with resultant damage to self limiting 
feedback mechanisms in this system also (Leonard, 2002). 
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In support of the hyper-arousal model, it has been shown that antidepressant 
treatment is most effective when normalisation of the HP A system has been achieved 
(Barden et al., 1995; Kasckow et al. , 2001). Poorer treatment outcomes were found 
in those with histories of prolonged and recurrent episodes of depression and 
subsequent increased severity of HPA damage (Hatzinger et al., 2002). Because the 
hippocampus plays a pivotal role in regulation of the HP A system, the damage 
caused by high levels of cortisol prevents the negative feedback necessary to switch 
off the stress response once it has been activated (Duman et al., 1997; Holsboer, 
2000b ). It is proposed that conventional antidepressant therapy normalises the HP A 
system by restoring mineralcorticoid and glucocorticoid receptors in the 
hippocampus to normal functioning (Calfaa et al., 2003). This is made possible by 
increasing the availability of BDNF which in tum stimulates neurogenesis and helps 
to up-regulate these receptors (Bench, Frackowiak, & Dolan, 1995; Drevets et al., 
2002; Holsboer, 2001). 
Firmly based in the hyper-arousal model of depression, new antidepressant 
treatments such as CRH antagonists, aim to re-establish homeostasis by directly 
intervening in the stress response (Ducotteta, Griebelb, & Belzung, 2003). They 
work by antagonising CRH receptor sites in the anterior pituitary, thereby limiting 
the production of ACTH and the subsequent release of glucocorticoids which, if 
chronically elevated, destroys normal feedback mechanisms (Wolkowitz & Reus, 
1999). Early indications are that these medications are safe to use, reduce anxiety 
associated with a chronically stimulated HP A system, and ameliorate dysphoria 
(Zobel et al. , 2000). According to the hyper-arousal hypothesis, therefore, the 
fundamental mechanism underlying depression is dysfunction of inhibitory 
mechanisms necessary for adaptive regulation of the stress response (Chrousos, 
1998; Chrousos & Gold, 1992; Holsboer, 1995, 2000a). 
3.9 Dysregulated HP A and the effects on sleep 
Dysregulated stress responses, which are a core feature of MDD, also disrupt 
homeostatic balance and circadian regulation of sleep (Armitage, Hoffmann, & 
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Rush, 1999; Colwell, 1995; Dinan, 1996; Linkowski et al., 1987; Riemann, Berger, 
& Voderholzer, 2001; Wirz-Justice, 1995). Up to 90% of depressed people complain 
of poor sleep with demonstrable sleep abnormalities at some time during their illness 
(ICSD, 1990; Okuji et al., 2002). Common sleep disturbances in MDD include 
delayed sleep onset, shortened latency to rapid eye movement (REM) sleep, 
decreased slow wave sleep (SWS), disrupted sleep, early morning wakings, and 
diminished sleep efficiency, with reports of feeling tired and un-refreshed after a 
nights sleep (Bardwell, Moore, Ancoli-Israel, & Dimsdale, 2000; Boivin, 2000; 
Buysse et al., 1998; De la Fuente, Bobes, Vizuete, & Mendlewicz, 2001; Kupfer et 
al., 1985). Indicative of the progressive nature of MDD, and the concurrence of 
mood and sleep anomalies (Lustberg & Reynolds, 2000), the severity of sleep 
disturbances increases with recurrent depressive episodes (Jindal et al., 2002; Thase 
et al., 1995; Vitiello, Moe, & Prinz, 2002). Furthermore, chronic sleep deprivation, 
which is a corollary of disrupted sleep, compromises immune system functioning, 
possibly due to the immunosuppressive effects ofhypercortisolaemia in MDD 
(Rogers, Szuba, Staab, Evans, & Dinges, 2001; Savard, Laroche, Simard, Ivers, & 
Morin, 2003), impairs cognitive functioning (Drake et al., 2001; Smulders, 
Kenemans, J onkman, & Kok, 1997), and can double the risk of death in older 
individuals (Dew et al. , 2003). 
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Heightened nocturnal arousal caused by hypercortisolaemia is associated with 
increased severity of sleep disturbance (Madjirova, Tashev, Delchev, & Bakalova, 
1995; Perlis et al., 1997). For example, nocturnal arousal decreases REM latency 
and increases the percentage of REM sleep at the expense of restorative slow wave 
sleep (Somers, Dyken, Mark, & Abboud, 1993; V gontzas et al., 1997). Furthermore, 
it has been shown that the high arousal present in depression is associated with 
increased beta activity, which adds further support to the hyper-arousal hypothesis of 
depression but further compromises sleep quality (Hall et al., 2000; Nofzinger et al., 
2000). In a vicious cycle, increasing severity of depression, which is linked to 
greater dysregulation of arousal systems (Holsboer, 2000a, 2001) also exacerbates 
sleep disturbance (Vitiello et al., 2002) which in turn contributes to further 
dysregulation of arousal mechanisms and increased depressive symptomatology 
(Riemann et al., 2001). Therapies for depression aim to normalise the physiological 
imbalance in arousal and as a consequence, ameliorate the dysphoria and sleep 
disturbance which is prominent in MDD (Adrien, 2002). 
Paradoxically, sleep deprivation is an effective remedy for depression as it has been 
found to exert a short term antidepressant effect, possibly by its ability to produce 
acute increases in serotonin (Adrien, 2002; Challet, Turek, Laute, & Van Reeth, 
2001). Periodic use of sleep deprivation has also been shown to normalise sleep 
EEG with decreased sleep onset, suppression of REM sleep, increased restorative 
slow wave sleep, and a decrease in early morning waking (Clark, Frank, & Brown, 
2001; Grozinger, Kogel, & Raschke, 2002; Hemmeter, Seifritz, Hatzinger, Muller, & 
Holsboer-Trachsler, 1995). These effects, however, are short lived as subjects revert 
to their depressed state following their first night of recovery sleep. Chronic sleep 
deprivation, on the other hand, has the opposite effect and over time increases the 
risk of relapse and heightens the risk of suicide in depression (Dement & Vaughan, 
1999; Holsboer-Trachsler & Seifritz, 2000). 
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Bright light therapy is a non-pharmacological intervention effective in ameliorating 
sleep and mood disturbance in conditions such as seasonal affective disorder, where 
circadian malfunction is prominent (Levitt, Lam, & Levitan, 2002). The ability of 
bright light to shift circadian timing with concomitant behavioural and emotional 
changes is well established (Armitage et al., 1999; Colwell, 1995; Middleton, Stone, 
& Arendt, 2002; Wallace, 1996; Wehr, Aeschback, & Duncan, 2001). For example, 
applying bright light in the early hours of the morning, close to the nadir of cortisol 
secretion, phase advances circadian rhythms, while bright light applied in the 
evening has a phase delaying effect (Boivin, Duffy, Kronauer, & Czeisler, 1994; 
Kubota et al., 2002). Early morning light therapy is the preferred treatment paradigm 
for use in depression as it lifts mood, which is typically low in the morning, possibly 
due to the suppression of melatonin (Badia, Myers, Boecker, & Culpepper, 1991; 
Terman et al., 1989). Given that cortisol has an arousing effect, the ability to delay 
nocturnal cortisol secretion using light therapy, may decrease early morning waking 
which is common in depression. 
Traditional bright light therapy uses high intensities of light ( approximately 10,000 
Lux) but it has been found that even ordinary room light ( approximately 180 Lux) 
can shift circadian rhythms (Boivin & Czeisler, 1998; Boivin, Duffy, Kronauer, & 
Czeisler, 1996). Of interest in this study, is the finding that very low intensity 
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( approximately 8 Lux) short wavelength light can also entrain circadian rhythms 
(Warman, Dijk, Warman, Arendt, & Skene, 2003). This research offers the potential 
that short wavelength low intensity light may be useful for shifting dysregulated 
cortisol rhythms in MDD. There is little evidence, however, that bright light therapy 
is effective in ameliorating sleep and mood disturbances in non-seasonal affective 
disorders despite the finding that cortisol, which is a marker of circadian rhythm, is 
dysregulated (Healy & Waterhouse, 1995; Wirz-Justice, 1995). 
Antidepressant medications, as discussed previously, work partly via their ability to 
reinstate homeostatic regulation and normalise HP A over-activity (Barden et al., 
1995; Bench et al., 1995). In addition to alleviating dysphoria, and exerting direct 
physiological effects on brain tissue, antidepressants have also been shown to 
normalise sleep irregularities (Armitage, 2000; Brunello et al., 2000; Mendlewicz, 
1991 ). Congruent with the hyper-arousal hypothesis of depression, it is proposed 
that they exert their effects by decreasing nocturnal secretion of cortisol and 
stimulating the secretion of melatonin (Wallace, 1996). A common finding with 
effective treatment is the suppression of REM sleep and elongation of REM onset 
(Brunello et al., 2000; Murck et al., 2003; van Bemmel, 1997). Up to 40% of people, 
however, fail to respond to anti-depressant treatment or find the side effects 
intolerable (Montgomery, Baldwin, & Riley, 2002; Spigset & Martensson, 1999). 
Others, for various reasons, simply prefer to seek non-drug treatments for their 
depression and sleep problems. 
While drug therapy may assist by normalising neurotransmitter secretion, and 
consequently improve sleep architecture, antidepressants are not effective in 
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reducing sleep onset, which is often delayed in depression because of increased 
arousal and excessive rumination (Morin, Rodrigue, & Ivers, 2003). Rather, 
cognitive therapies, which include relaxation methods, have been shown to be 
superior to drug therapies in their ability to address sleep initiation problems (Perlis, 
Smith, Cacialli, Nowakowski, & Orff, 2003). Up to 70-80% of people with sleep 
problems who use non-pharmacological interventions, such as biofeedback, 
relaxation training and cognitive and behavioural techniques, find them to be 
effective (Morin, Hauri et al., 1999). 
3.10 The relaxation response and the treatment of mood and sleep disorders 
Relaxation therapy is a proven non-pharmacological treatment for sleep and stress 
related disorders such as depression (Fennell, 1996; Morin, Hauri et al., 1999; Morin, 
Mimeault, & Gagne, 1999; Rosen, Lewin, Goldberg, & Woolfolk, 2000; Viens, De 
Koninck, Mercier, St-Onge, & Lorrain, 2003). Everly and Benson (1989) propose 
that stress responses can be reversed by repeated elicitation of the relaxation 
response, which, over time, can retrain a dysregulated arousal system and help to 
reinstate homeostasis. Relaxation responses have been shown to have calming 
effects on the autonomic nervous system, effectively reducing stress responses and 
increasing positive mood states (Leher, Carr, Sargunaraj, & Woolfolk, 1994). 
According to Benson ( 197 5) the relaxation response is a generalised phenomenon of 
reduced physiological arousal regardless of the technique used. Some studies, 
however, claim that different relaxation methods impact differentially on 
physiological parameters (Leher et al. , 1994; Matsumoto & Smith, 2001), and elicit 
different feeling states (Matsumoto & Smith, 2001; Smith, Amutio, Anderson, & 
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Aria, 1996). For example, progressive muscle relaxation has been shown to have 
more somatic features (Leher et al., 1994) and to elicit feelings of 'disengagement' 
(Matsumoto & Smith, 2001), while deep breathing methods have been shown to 
increase mental awareness (Matsumoto & Smith, 2001; Smith et al., 1996), and 
meditation has been associated with 'prayerfulness', 'joy' and profound reductions in 
arousal (Smith et al., 1996; West, 1980). 
Other studies find little to no differences between methods (Morse et al., 1977; Zeier, 
1985) which supports Benson's (1975) claim that relaxation is a generalised 
reduction in physiological activity. According to Scheufele (2000), any changes 
attributable to various relaxation methods are 'superimposed' on this background of 
decreased physiological arousal. In addition, a common finding is that relaxation 
training, with repeated exposure to the relaxation response and frequent stimulation 
of the parasympathetic system, improves the strength of relaxation responses, 
dampens hyper-arousal mechanisms, and enhances clinical outcomes (Camey et al., 
2000; Carson, Hathaway, Tuohey, & McKay, 1988; Cunningham, Brown, & Kaski, 
2000; Lehrer et al., 2000; Lucini et al., 1997; Matsumoto & Smith, 2001; Orme-
J ohnson, 1973; Rosen et al., 2000; Zeier, 1985). 
In direct contrast to stress responses, which reflect sympathetic and HP A activation, 
relaxation responses are induced by activation of parasympathetic pathways which 
produce reduced physiological arousal. Specifically, relaxation responses produce 
reductions in blood pressure (Agras, Taylor, Kraemer, Allen, & Schneider, 1980; 
Carson et al., 1988), heart rate, skin conductivity, and muscle activity and elicit 
mental quieting (Fried, 1990; Morse, 1993; Morse et al., 1977). Central cortical 
89 
changes include decreases in beta activity, especially in frontal areas, (Jacobs et al. , 
1996), and increases in alpha and theta activity (Arambula et al. , 2001; Jacobs & 
Lubar, 1989; Schacter, 1977) which are evident during relaxation and persist into the 
'awake' state in experienced meditators (Corby, Roth, Zarcone, & Kopell, 1978). 
Furthermore, positive mood states (Ford, Stoebel, Strong, & Szarek, 1982; Morse, 
1993), and improvements in sleep quality (Agras et al., 1980; Rosen et al., 2000) are 
commonly reported by-products of relaxation training. 
Krampen (1999) demonstrated that regular practice of autogenic relaxation could 
significantly enhance the effectiveness of psychotherapy in a group of clinically 
depressed psychiatric outpatients who were able to maintain their depression levels 
below clinical levels for up to 2 years post-treatment (Krampen, 1999). Lazar and 
colleagues (2000) used functional MRI to show that meditation increased cortical 
activity in prefrontal and limbic structures, which are areas of reduced activity in 
MDD. This supports the use of the relaxation response in the treatment of arousal 
disorders and suggests that relaxation therapy may help to restore neuronal damage 
caused by over stimulation of arousal systems. 
Biofeedback training, which induces relaxation responses, has also been shown to 
directly impact on sleep quality. Using operant conditioning methods, Sterman 
(2000) showed that increasing 11-1 SHz activity in the sensory motor strip in the 
awake state stimulated the production of sleep spindles during sleep, thereby 
improving sleep efficiency and stabilising sleep regulation. Hauri et al. (1982) also 
used biofeedback training in the alpha and theta ranges and improved sleep quality in 
a group of anxious insomniacs. In particular, they found that theta training, which is 
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associated with deep relaxation, was most effective for insomniacs with high anxiety 
levels as it helped to reduce night time wakings caused by high arousal. Reducing 
arousal, therefore, appeared to be the key to successful treatment (Hauri, Percy, 
Hellekson, Hartmann, & Russ, 1982). Offering further support for the use of 
relaxation therapies in the treatment of stress-related disorders, relaxation training 
has also been shown to produce permanent changes in autonomic functioning as 
evidenced by decreased cortisol secretion (McKinney, Antoni, Kumar, Tims, & 
McCabe, 1997) and attenuation of stress reactivity in response to stressful stimuli 
(Lucini et al., 1997; Orme-Johnson, 1973). 
Relaxation therapies, particularly breathing techniques, have been shown to restore 
homeostatic balance by acting directly on the autonomic nervous system, further 
supporting their use in hyper-arousal disorders. Respiratory sinus arrhythmia, which 
is a measure of parasympathetic vagal tone, reflects the influence of breathing 
oscillations on heart rate variability (HRV) (Moser et al., 1994). Specifically, each 
inspiration stimulates the sympathetic branch of the vagus nerve and increases heart 
rate, while each expiration activates the parasympathetic branch with a concomitant 
decrease in heart rate (Lehrer et al., 2000; Vaschillo et al., 2002). High HRV reflects 
parasympathetic and sympathetic balance, indicating healthy regulation of the 
autonomic nervous system, which is predictive of adaptive coping in the face of 
stressors (F abes & Eisenberg, 1997). 
In stress related disorders, such as depression and anxiety, which are characterised by 
over stimulation of arousal systems, sympathetic inputs to the heart go unchecked as 
parasympathetic inputs are decreased. As a consequence, heart rate variability 
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decreases as rate increases (Moser et al., 1998), indicating a reduction in the ability 
to regulate autonomic control, which subsequently compromises adaptive processes 
and increases the risk of cardiac incidents in susceptible individuals (Gorman & 
Sloan, 2000). Relaxation therapy has been shown to enhance parasympathetic tone, 
therefore dampening sympathetic over-stimulation and as a consequence, re-
establishing homeostasis (Sakakibara et al., 1994). 
3.11 Photic stimulation in the treatment of mood and sleep disorders 
Relaxation therapy has been shown to enhance both short and long term treatment 
outcomes in MDD (Krampen, 1999) and insomnia (Rosen et al., 2000) when used in 
conjunction with psychotherapy. Photic stimulation is a proven relaxation method 
with reliable anxiolytic effects which make it an appropriate choice for reducing 
arousal in stress related disorders such as MDD with accompanying sleep 
disturbance (Brauchli, 1993; Brauchli et al., 199 5; Morse, 1993, 1994a; Ossebaard, 
2000). Other studies provide direct evidence that photic stimulation is an effective 
treatment for MDD, decreasing dysphoria and enhancing cortical activity 
(Hammond, 2000; Kumano et al., 1996; Takigawa, 1988). As outlined in Chapter 2, 
Study 1 showed that audiovisual stimulation, like relaxation, effectively reduced 
symptoms of depression, anxiety, and psychological distress over time. Given 
previous research and the findings from Study 1, photic stimulation has the potential 
to be an effective adjunct in the treatment of psychiatric disorders such as mood and 
sleep disturbance, with some added advantages over traditional relaxation 
techniques. 
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Brainwave entrainment methods such as photic stimulation promise to be more 
effective than relaxation therapy in the treatment of mood disorders for a number of 
reasons. Firstly, their anxiolytic qualities can be used to address the arousal 
components of depression and help to re-establish homeostasis (Brauchli, 1993; 
Dieter & Weinstein, 1995; Morse, 1993; Ossebaard, 2000). Secondly, the 
phenomenon of photic driving can directly influence cortical neuronal activity and 
help to guide the brain towards normalacy (Jin et al., 1997; Joyce & Siever, 2000; 
Kikuchi et al., 2002; Kumano et al., 1997; Timmermann, Lubar, Rasey, & Frederick, 
1999; Toman, 1941 ). Thirdly, unlike relaxation therapies, which take time and effort 
to master, increasingly popular mind-machines produce states of profound relaxation 
with little effort. Finally, photic stimulation has been shown, even at low levels of 
illumination, to reset circadian and diurnal rhythms, such as sleep-wake cycles, 
which are often dysregulated in major depression (Boivin & Czeisler, 1998; . 
Middleton et al., 2002; Warman et al., 2003). Photic stimulation, therefore, may be 
effective in ameliorating not only mood disorders, but also the sleep disturbance that 
is commonly found in depression. 
3.12 Summary 
In this Chapter, depression has been conceptualised as a stress-related disorder, 
which allowed many of its symptoms to be understood as a function of dysregulated 
arousal systems that are disconnected from normal regulatory control mechanisms. 
It has also provided a rationale for the use of cost effective interventions such as 
photic stimulation and relaxation therapy. The ultimate aim of relaxation therapies 
for the effective treatment of hyper-arousal disorders is to re-train the autonomic 
nervous system and re-establish sympathetic and parasympathetic balance which 
dampens HP A and LC/NE responses to stress. 
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In support of the use of photic stimulation for stress reduction, Study 1 found that 
audiovisual stimulation produced immediate relaxation responses but not long term 
effects to indicate enduring nervous system change. For example, immediate 
reductions in heart rate and skin conductance levels were evident during recording 
sessions, but remained essentially unchanged from baseline to follow-up. In Study 1, 
brainwave entrainment, relaxation, and sitting quietly with eyes closed all reduced 
arousal levels and produced immediate relaxation responses during recording 
sessions. Photic stimulation did show some small additional effects, with different 
frequencies of stimulation affecting mood and arousal in predicted directions. Alpha 
stimulation appeared to enhance positive affect after a number of sessions, while beta 
stimulation decreased positive affect and was accompanied by a small increase in 
skin conductivity, indicating and increase in physiological arousal. A major finding 
in Study 1 was that even in a non-clinical sample, depression, anxiety and 
psychological distress decreased over time, possibly due to the induction of 
relaxation responses in all groups, and contributed to non-specific effects such as the 
building of a therapeutic alliance and positive expectancies. 
Study 1 showed that photic stimulation effectively reduced arousal. Photic 
stimulation, therefore, has the potential to be a useful tool in the treatment of mood 
and sleep disorders that are characterised by overstimulation of arousal systems. In 
addition, photic stimulation has all the necessary components proposed by Benson 
( 197 5) to elicit relaxation responses, plus the added contribution of brainwave 
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entrainment that can be used to shift abnormal brainwave states into more normal 
patterns of functioning. Given recent research on the ability of even low luminance 
light to entrain circadian rhythms, photic stimulation also offers the potential to 
directly impact on the regulation and timing of cortisol and melatonin secretion with 
further benefit to mood and sleep. Photic stimulation, therefore, may be more 
effective than simple relaxation techniques, like autogenic relaxation, in its ability to 
re-train over-stressed nervous systems, and help in the treatment of mood and sleep 
disorders. 
In the next chapter, Study 2 will explore the capacity of photic stimulation to 
ameliorate dysphoria, and improve sleep, in a clinical sample of depressed 
individuals with sleep disturbance. It attempts to address some of the issues that may 
have interfered with the expression of relaxation and mood effects in Study 1 by 
providing participants with portable light devices that can be used at home on a 
regular basis. Consequently, Study 2 endeavours to maximise exposure to relaxation 
responses in order to facilitate training effects that will generalise beyond relaxation 
· practice and beneficially impact on mood and sleep as arousal systems are 
normalised and homeostasis is re-established. 
CHAPTER4 
Study 2: 'Photic stimulation and the treatment of mood and sleep disorders.' 
4.1 Introduction 
Depression has been conceptualised as a stress disorder (Chrousos & Gold, 1992) 
characterised by over-stimulation of the sympathetic noradrenergic system and 
dysregulation of the HP A system, with increased serum cortisol (Madjirova et al., 
1995), mood swings, and often comorbid anxiety (Mineka et al., 1998; Wittchen et 
al., 2001; Yerevanian et al., 2001). These physiological disturbances also disrupt' 
circadian behaviours such as sleep-wake cycles and eating, as normal regulatory 
processes are thrown into disarray (Armitage et al., 1999; Riemann et al., 2001; 
Wirz-Justice, 1995). 
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Recurrent episodes of depression exacerbate the problem as arousal systems become 
increasingly dysregulated and hyper-sensitive, and 'learn' to respond to threat with an 
exaggerated stress response (Everly & Benson, 1989; Post, 1992). Frequent 
elicitation of relaxation responses has been shown to be effective in the treatment of 
stress disorders, as it produces a physiological state which is incongruent with stress 
responses because it decreases arousal, and consequently helps to re-establish normal 
functioning (Benson, 1975, 1985; Everly & Benson, 1989). Photic stimulation 
promises to be an effective adjunctive therapy for use in mood and sleep disturbance 
because of its ability to induce relaxation responses. By the repeated induction of 
relaxation responses, photic stimulation can dampen an over-stimulated sympathetic 
system by enhancing parasympathetic activity, which, via reciprocal innervation, 
reduces HP A activity and over time, helps to reinstate homeostasis. 
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4.2 Review of Study 1 's findings 
Previous research has demonstrated clear entrainment responses to photic stimulation 
(Silberstein, 1995b; Toman, 1941) with beneficial effects on mood (Brauchli et al., 
1995; Glicksohn, 1986; Morse, 1993, 1994a; Ossebaard, 2000) (see Chapter 1). 
Study 1 attempted to demonstrate the differential effects of various frequencies of 
stimulation on mood and cortical activity, but only small to moderate non-significant 
effects were found. As discussed in Chapter 2, entrainment responses were present 
in many participants receiving audiovisual stimulation (A VS), with demonstrated 
increases in EEG amplitude, not only at their frequency of stimulation, but also in the 
other bandwidths of interest. In Study 1, frequency of stimulation influenced mood 
to a small degree. Alpha stimulation increased positive affect, while beta stimulation 
decreased positive affect over experimental trials. Detection of these small effects, 
however, was hampered by low statistical power. The main finding of Study 1, 
which informs the present study, is that photic stimulation was equally as effective as 
autogenic relaxation in its ability to induce relaxation responses, and to reduce 
symptoms of depression and anxiety, over the course of the study, even in a non-
clinical sample. These findings indicate that photic stimulation may be an effective 
adjunctive tool in the treatment of stress-related disorders, like depression, because 
of its ability to reduce arousal, and ameliorate symptoms of depression and anxiety. 
In summary, the findings of Study 1 revealed that 13Hz stimulation tended to 
increase positive affect and subjective feelings of relaxation, while 22Hz A VS 
tended to decrease positive affect and increase physiological arousal. Furthermore, 
photic stimulation was found to be an effective relaxation therapy as 5Hz, 13Hz and 
22Hz A VS produced relaxation effects similar to those induced by autogenic 
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relaxation. In particular, 5Hz A VS appeared to induce the greatest reduction in 
depression and anxiety symptoms indicating that it may have been more effective at 
eliciting relaxation responses than the other frequencies. The small to moderate 
treatment effects observed in Study 1 may have been due to the use of a sample with 
little pathology and, consequently, little room for change within mood and arousal 
parameters. In the present study larger effects sizes are anticipated as a clinical 
sample, who are clearly characterized by dysregulated mood, sleep and arousal, but 
who have more opportunity for improvement, will be used. 
Similar to Study 1, Study 2 also attempts to demonstrate frequency following effects 
to determine if the phenomenon of brainwave entrainment contributes to relaxation 
and mood effects. Previous research has shown that brainwave frequencies are 
positively correlated with arousal and reflect different affective states. Therefore, it 
is hypothesised that by artificially inducing certain brainwave frequencies using 
brainwave entrainment techniques, concomitant arousal and mood effects will be 
induced (see Chapter 1 for a more complete review). For example, theta (5-7Hz) is 
associated with drowsiness (Niedermeyer, 1993; Strijkstra et al., 2003) and found 
during deep relaxation (Arambula et al., 2001; Dierks, Maurer, & Zacher, 1989; 
Jacobs & Lubar, 1989). Alpha rhythms (8-13Hz) also indicate cortical deactivation 
which differs from theta in that they do not accompany drowsiness, but rather a state 
of rest and expectant alertness (Basar et al., 1997; Pfurtscheller et al., 1996). Alpha 
is also associated with positive mood states (Brown, 1970; N owlis & Kamiya, 1970). 
Beta rhythms (>14Hz) reflect cortical desynchronisation which indicates cortical 
activity and is present during task engagement (Micheloyannis et al., 2002; Ray & 
Cole, 1985; Wrobel, 2000). They are also positively related to arousal (Bonnet & 
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Arand, 2001) and anxiety (Wendy. Heller et al., 1997; Pizzagalli et al., 2002), and if 
present during the night, elevated beta compromises sleep efficiency (N of zinger et 
al. , 2000). In order to maximise these mood effects and achieve training effects, 
participants will be exposed to photic stimulation frequencies on a regular basis over 
an extended period, which will also address some of the limitations of previous 
research. 
4.3 Limitations of Study 1 
A criticism of earlier research assessing the effects of audiovisual stimulation on 
mood and relaxation was the use of short exposure times to entraining stimuli 
(Brauchli et al., 1995). To address this problem some studies used repeated 
exposures of short duration (von Gizycki et al., 1998). Other studies more 
thoroughly assessed the therapeutic utility of audiovisual entrainment by using 
longer exposure times over a number of sessions. These studies all attest to the 
ability of audiovisual stimulation to induce immediate relaxation effects (Morse, 
1993, 1994a; Morse et al., 1977), produce reductions in state anxiety (Ossebaard, 
2000), and improve academic performance (Budzynski, Jordy, Budzynski, Tang, & 
Claypoole, 1999; Carter & Russell, 1993; Joyce & Siever, 2000; Patrick, 1996), but 
failed to demonstrate long term changes needed to validate the use of photic 
stimulation in the clinical arena. 
In clinical studies compliance is often a problem (Michalak, Hayes, Wilkinson, 
Hood, & Dowrick, 2002). Researchers rely on participants being motivated to attend 
the A VS sessions, or else they use a 'captive' sample such as a school setting wherein 
participants are easily accessible. Most relaxation techniques require effort, 
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motivation, and an investment of time in order for them to be effective since repeated 
exposure to relaxation responses is necessary to retrain arousal systems to respond in 
a less reactive manner. In clinical settings, relaxation skills are taught and clients are 
then encouraged to practice the skill at home on a daily basis, in order to facilitate 
training effects that generalise beyond the relaxation practice itself so that 
adjustments in sympathetic reactivity can be realised. Aware of the issues of 
compliance and motivation, other studies have supplied participants with light 
devices which could be used at home on a regular basis over an extended period of 
time in order to maximise relaxation and therapeutic effects (Anderson et al., 1997; 
Noton, 1997). 
Generalisation of relaxation responses beyond relaxation practice may have been 
hampered in Study 1 by requiring participants to visit the university for their 
relaxation sessions. While every attempt was made to maximise exposure to 
relaxation by asking participants to attend sessions up to 3-4 times per week, some 
could not do this. While most participants demonstrated immediate relaxation 
responses during relaxation and A VS, there was little evidence to suggest that the 
physiological quieting attained during sessions endured over time. Resting heart 
rate, skin conductance and EEG showed within-session relaxation responses, but 
changed little from session to session. To address this problem, Study 2 provided 
participants with take home light masks in order to encourage regular use and 
maximise exposure to relaxation responses, in order to facilitate training effects 
which would retrain over-stimulated arousal systems and achieve enduring and 
beneficial changes to mood and sleep. 
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4.4 Aims of Study 2 
The main aim of this study was to assess the effectiveness of photic stimulation as an 
adjunctive therapy in the treatment of major depression with associated sleep 
disturbance. Specifically, the study set out to determine if there were differential 
effects of particular photic stimulation frequencies on mood and sleep. The main 
question asked in the study was a clinical one; "Does exposure to particular photic 
stimulation frequencies for up to twenty minutes a day over a period of one month 
have beneficial effects on mood and sleep and if so, what frequencies of stimulation 
are most effective?" By providing clients with their own light mask to use at home it 
was anticipated that relaxation responses would be maximised and the hypothesised 
effects on mood and sleep would become evident. 
4.4.1 Electroencephalography: Another aim of the current study was to determine 
if evidence could be found for the commonly reported phenomenon of frontal alpha 
asymmetry in depression. Davidson and colleagues have provided a large body of 
research showing that depressed subjects display hemispheric asymmetry in the EEG 
with increased alpha in the left midfrontal cortex relative to the right midfrontal 
cortex, indicating deactivation of the left frontal cortex (Davidson, 1992, 1993, 
1998b; Davidson & Henriques, 2000; Davidson et al., 2002; Tomarken & Keener, 
1998). Non-depressed subjects fail to show this asymmetry or display the opposite 
pattern, with increased right midfrontal alpha in comparison to left midfrontal alpha, 
signifying increased activation of the left frontal cortex (Henriques & Davidson, 
1991). These findings are amply supported by brain imaging (Drevets, 2003; 
Mayberg, 2003; Soares & Mann, 1997) and neuropsychological studies (Austin, 
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1995; Austin et al., 1999; Shenal et al., 2003) which show deficits in frontal and 
limbic brain regions. Thus depression is accompanied by a decrease in functioning 
of the left pre-frontal cortex. In the current study, therefore, which used a clinically 
depressed sample, it was anticipated that participants would display an increase in 
left midfrontal alpha (F3) relative to right midfrontal alpha (F4) at baseline, and that 
alpha asymmetry would be positively correlated with depression level and be 
unrelated to group membership. 
In addition, while Henriques and Davidson (1991) found evidence of alpha 
asymmetry in depressed subjects with higher alpha power in left midfrontal regions 
in comparison to the control group, they did not find any difference between 
depressives and controls in absolute alpha power in right midfrontal regions. 
Therefore, it was predicted in the current study that left midfrontal alpha amplitude 
(8-13Hz, at F3) would be higher in comparison to the normative database, while 
right midfrontal alpha amplitude (8-13Hz, at F4), would be similar to the normative 
database. 
Successful treatment of depression is often accompanied by normalisation of cortical 
anomalies (Drevets, 1998; George, Ketter, & Post, 1993). In fact, placebo induced 
remission shows changes in pre frontal areas similar to those found with active 
therapy, with increases in frontal metabolism (Mayberg et al., 2002). Davidson, 
however, found that while cortical asymmetries decrease with remission of 
depression, the pattern of asymmetry persisted even when improvements in mood 
occurred. Thus according to Davidson, the pattern of frontal cerebral asymmetry is a 
trait like marker for depression (Henriques & Davidson, 1990). In the current study, 
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therefore, it was anticipated that cerebral asymmetry would be relatively stable over 
time and independent of treatment outcome. 
4.4.2 Brainwave entrainment: Similarly to Study 1, the current study also aimed 
to demonstrate entrainment effects with increases in EEG amplitude at the 
frequencies of stimulation. In Study 1 it was hoped that evidence of entrainment 
would be found in order to support the presence of a physiological response to A VS. 
Unfortunately, there was very little statistical evidence of frequency following in 
response to A VS, even during stimulus presentation, with only small to moderate 
trends observed. 
To explore this further, EEG amplitude in occipital sites (Mean P3-01 and P4- 02) 
was averaged across the 12 experimental sessions in Study 1 for each A VS group 
(5Hz, 13Hz, and 22Hz) and visually compared to baseline measures (see Figures 4.1, 
4.2, and 4.3). In the 4-6Hz bandwidth (Figure 4.1) it was observed that the beta 
group was the only group to demonstrate an increase in 4-6Hz, not the theta group as 
predicted, while the alpha, relaxation and control groups showed an overall decline 
in 4-6Hz during A VS in comparison to baseline. In the 12-14 Hz bandwidth (Figure 
4.2), all active A VS groups showed a small increase across the twelve experimental 
sessions in comparison to baseline and follow-up, while the relaxation and control 
groups showed the opposite pattern with a decrease in 12-14Hz across the twelve 
sessions. For the 21-23Hz bandwidth (Figure 4.3), only the beta group showed an 
increase in 21- 23Hz EEG amplitude in comparison to baseline, suggesting possible 
entrainment effects were present at higher beta frequencies and not at lower 
frequencies. While these observed effects were small to moderate, and non-
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significant, some interesting patterns did emerge. The beta group consistently 
showed increases in EEG amplitude across the three bandwidths tested, suggesting 
that higher entrainment frequencies affected the EEG in a global way, possibly 
inducing greater cortical relaxation responses as evidenced by increased theta and 
alpha frequencies, and possibly even entrainment effects, as suggested by increased 
amplitude in the 21-22Hz bandwidth for the beta group only. In order to address the 
issue of low power in Study 1, the current study increased experimental power by 
increasing subject numbers in order to more effectively test for evidence of 
entrainment effects. 
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As discussed previously, the lack of evidence for frequency following responses in 
Study 1 may have been due to the frequencies of stimulation used. Frequency 
following is more likely to occur with stimulation frequencies in the 8-12Hz 
bandwidth, which are close to the person's peak alpha frequency. Therefore, the 
second study used a procedure suggested by Pockberger (1985), and participants 
were exposed to a 1 0Hz photic stimulation for 3 minutes while their EEG was 
simultaneously recorded in order to assess frequency following responses across the 
cortex. 
Photic driving responses are most likely to occur in the occipital cortex, but both 
auditory and photic driving responses have been shown to recruit to distant cortical 
areas (Glicksohn, 1986; Kikuchi et al., 2002; Morse, 1993; Mundy-Castle, 1953; 
Neher, 1961 ). If photic driving responses are recruited from occipital to frontal brain 
regions and subsequently change oscillatory neuronal behaviour in these areas in the 
direction of the driving frequency, then it may be possible to use photic stimulation 
in the treatment of frontal lobe disorders such as depression, which are characterised 
by frontal lobe deactivation. Therefore, in the current study, it was hypothesised that 
photic driving responses would be demonstrated with increases in 1 0Hz EEG 
amplitude not only in occipital cortical regions, but also in frontal regions as the 
response is recruited across the cortex. In addition, Pockberger showed that 
entrainment responses are related to depression severity, with attenuation of the 
response with recovery. Thus it was expected that frequency following responses 
would be positively related to level of depression. 
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The small to moderate non-significant entrainment effects present in Study 1 were 
observed at both entrainment frequencies and in distal bandwidths. Therefore, some 
people demonstrated first order and harmonic driving responses at frequencies 
distant from their dominant frequency. For example, those receiving 22Hz A VS 
demonstrated driving responses across all bandwidths of interest. Given this, in the 
current study it would be advantageous to assess entrainment responses to the 
experimental photic stimulation frequencies used in addition to the 1 OHz stimulation 
outlined above. However, in order to maintain the double blind condition this was 
not feasible, as the experimenter conducting the EEG's needed to remain nai:ve to the 
participants' allocated frequencies. There was some concern that the blind would be 
exposed if participants were allowed to use their Lightmask during an EEG session 
as often the frequency of stimulation is apparent in occipital EEG when driving 
responses are being observed. 
Study 1 showed that A VS successfully elicited relaxation responses, possibly due to 
the relaxation features present coupled with entrainment effects. Photic stimulation 
fulfils Benson's requirements for inducing relaxation as it helps to distract the mind 
by providing a repetitive stimulus on which to focus. It also attenuates external 
sensory input by wearing headphones and glasses. In addition, entrainment effects 
help to guide the brain into a relaxed state. As a consequence, muscle tension 
decreases as relaxation responses ensue. In the current study, with enhanced power, 
and regular daily exposure to entrainment stimuli, it was anticipated that brainwave 
entrainment effects would be maximised. If frequency following contributes to 
treatment outcomes, then it was anticipated that regular daily exposure to a specific 
stimulus may, over time, produce demonstrable changes in the EEG as training 
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effects become evident. Thus if entrainment effects are present, it was hypothesised 
that those receiving 5Hz, 13Hz and 22Hz photic stimulation would show increases in 
their eyes closed EEG at 5Hz, 13Hz and 22Hz, respectively. 
4.4.3 Subjective relaxation: Cortical EEG frequencies generally reflect arousal 
levels. Lower theta frequencies are associated with deactivation and drowsiness, 
alpha rhythms with relaxed alertness, and beta frequencies signal an actively engaged 
and aroused mind (Niedermeyer, 1993). In Study 1 there was a general increase in 
subjective relaxation over sessions for all groups after A VS, with a trend towards 
those receiving 13Hz (alpha) A VS to report feeling more relaxed. This trend was in 
expected directions as alpha rhythms are often increased during relaxation and 
usually accompany positive mood states (Basar et al., 1997; Brown, 1970; Morse et 
al., 1977). 
In the current study, however, subjective relaxation ratings were not immediately 
contingent with photic stimulation use. Rather, subjective relaxation ratings were 
obtained when participants attended the hospital for their EEG recordings. It was 
anticipated that regular daily exposure to the different photic stimulation frequencies 
would impact differentially on relaxation responses, with greater relaxation 
anticipated for those receiving theta and alpha stimulation, and lower relaxation 
effects for those receiving beta or continuous light. Therefore, if the different 
experimental frequencies used in Study 2 produce enduring entrainment effects and 
subsequent relaxation responses, then it was anticipated that those receiving photic 
stimulation at 5 and 13Hz would report higher subjective relaxation during the 
experimental phase than those receiving 22Hz photic stimulation, continuous light or 
108 
no therapy. Consequently, it was expected that subjective relaxation would correlate 
positively with theta and alpha bandwidths and negatively with beta EEG. The 
immediate effects of photic stimulation were assessed in the current study by asking 
participants to rate their subjective well-being after each light therapy session, as 
discussed below. 
4.4.4 Mood (PANAS): In the first study, there was an overall decrease in positive 
affect across sessions. There were some trends in predicted directions, however, 
with the alpha group showing a sustained increase in positive affect after session four 
and the beta group showing consistently low positive affect across sessions, but these 
effects did not reach significance. Also, in Study 1, certain items on the PANAS 
were endorsed more than others, with participants endorsing items such as 
'interested', 'enthusiastic', 'inspired', 'proud', 'alert', 'active' and 'determined' on the 
positive affect scale, and 'distressed', 'upset', 'irritable' and 'nervous', on the negative 
affect scale, independent of group membership. 
Previous research shows that relaxation enhances well-being (Benson, 1975; Ford et 
al., 1982; Marshall & Bentler, 1976; Morse, 1993; Morse et al., 1977; Smith et al., 
1996; Stoyva, 1989). In addition, alpha rhythms, which commonly accompany 
relaxation responses, are generally associated with feelings of well-being and 
positive affect (Glicksohn, 1986; Hinrichs & Machleidt, 1992; Plotkin, 1979; 
Rosenfeld, Baehr, Baehr, Gotlib, & Ranganath, 1996; Rosenfeld et al., 1997; Saxby 
& Penniston, 1995; Shimokochi, 1996; Slatter, 1960; Wackermann, P-i.itz, Bi.ichi, 
Strauch, & Lehmann, 2002). Given that photic stimulation reliably produces 
relaxation responses, it was hypothesised that in the current study, photic stimulation 
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would enhance positive affect and decrease negative affect during experimental 
trials. Specifically, it was predicted that those in the active photic stimulation 
groups, 5Hz, 13Hz, and 22Hz, would report higher levels of positive affect and lower 
levels of negative affect than those in wait list (WL) or continuous light (CL) groups. 
As previously stated, in Study 1 those receiving 13Hz (alpha) AVS reported higher 
positive affect after session 4, while those receiving 22Hz (beta) A VS consistently 
reported lower positive affect across sessions, accompanied by greater skin 
conductivity. It appears therefore that alpha stimulation is more pleasurable and less 
arousing than beta stimulation. Therefore, in the current study it was hypothesised 
that those receiving 13Hz photic stimulation would report higher levels of subjective 
well-being immediately after light therapy than those receiving 22Hz photic 
stimulation. 
4.4.5 Depression: Major depression is often a recurrent disorder characterised by 
periods of relapse and remission (Maj et al., 1992). Many people recover from an 
episode of major depression over time, in the absence of therapeutic intervention 
(American Psychiatric Association, 2000; Ross, Quitkin, & Klein, 2002; Solomon et 
al., 1997). In Study 1, which used a non-clinical sample, depression levels decreased 
for all groups, except the alpha group, over the course of the study. As previously 
discussed, the alpha group started the study with depression scores below the norm 
and consequently were affected by floor effects. The decrease in depression 
symptoms had little to do with the particular A VS frequencies participants were 
receiving. Rather, it may have been due to the relaxation responses elicited by A VS 
or simply to changes in mood and depression levels over time. 
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Congruent with the 'hyper-arousal' hypothesis for depression, any intervention that 
reduces arousal by eliciting relaxation responses, has the potential to be beneficial in 
the treatment of arousal disorders such as depression and anxiety. Non-specific 
therapeutic effects and expectancy effects, however, usually play a role in any 
clinical study and contribute to treatment effects (Bench, 2001; Frank, 1982a; Jensen 
& Karoly, 1991 ). In addition, as acknowledged above, depression changes over time 
and improvement may occur regardless of the intervention received. Therefore, in 
the current study it was anticipated that depression would decrease for all groups, 
including the control and wait list groups, over the study period because of the 
variable nature of depression over time and the influence of therapeutic and 
expectancy effects. In Study 1, it was shown that A VS, regardless of frequency, 
elicited relaxation responses. In Study 2, therefore, it was hypothesised that 
depression would decrease more for those in the active photic stimulation groups, 
regardless of the specific frequency of stimulation, than for those in the control or 
continuous light groups. 
4.4.6 Anxiety: Anxiety is often comorbid with depression. In Study 1 anxiety also 
decreased from baseline to follow-up in all groups, except the alpha group. Again, 
the alpha group were affected by floor effects and therefore did not show any change 
in anxiety over time. While greater reductions in anxiety were seen in the theta, beta 
and relaxation groups than in the control group, the observed effects were small and 
not significant; but still suggest that active therapy is more effective than no 
intervention. 
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Therefore, in the current study, using a clinical sample, anxiety was also expected to 
decrease over sessions, firstly because of the relaxing effects of photic stimulation 
and secondly as a function of different photic stimulation frequencies. It was 
hypothesised that photic stimulation at 5Hz would be most effective for participants 
with moderate to high anxiety as it would assist in reducing excess cortical beta 
which often accompanies states ofhyperarousal and anxiety (Chapotot et al., 1998; 
Matousek, 1991 ). Photic stimulation at 22Hz was hypothesised to be effective for 
participants with low anxiety, as it would help to ameliorate frontal lobe 
deactivation, which often accompanies depression, and help to raise cortical activity 
and thus, increase motivation and energy levels. 
4.4.7 Symptom Severity: Symptom severity (global severity index- Symptom 
Checklist 90-R) decreased in all groups in Study 1. The global severity index 
provides an intensity score which reflects the impact of symptoms from all nine 
subscales of the SCL-90-R. Therefore, it is a useful clinical indicator of the impact 
of symptoms regardless of the source. Because of the ability of A VS to elicit 
relaxation responses and consequently reduce symptom severity, it was anticipated 
that global severity index would decrease more for the active photic stimulation 
groups than the WL or CL groups. 
4.4.8 Sleep and photic stimulation: As discussed in Chapter 3, depression is often 
accompanied by sleep disturbance (Brunello et al., 2000; Papadimitriou, Dikeos, 
Daskalopoulou, & Soldatos, 2002; Thase, Simons, & Reynolds, 1996). In this study, 
depression is viewed as a hyperarousal disorder with accompanying physiological 
dysregulation. Techniques which reduce arousal and elicit relaxation responses, 
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therefore, have the potential to be beneficial for mood and sleep disturbance. Study 
2, therefore, also investigated the utility of photic stimulation to ameliorate sleep 
problems which are often exacerbated by high levels of arousal (Nofzinger et al., 
2000). 
Relaxation techniques are frequently used in the treatment of sleep disorder (Dement 
& Vaughan, 1999; Shapiro, Bootzin, Figueredo, Lopez, & Schwartz, 2003; Viens et 
al., 2003). Given that A VS was found to be an effective relaxation tool in the last 
study, regardless of frequency of stimulation, it was hypothesised that photic 
stimulation at 5Hz, 13Hz and 22Hz would be more effective at reducing sleep onset 
latencies and night wakings and improving sleep efficiency than continuous light 
(CL) or no therapy (WL). Consequently, those in the 5Hz, 13Hz and 22Hz groups 
are expected to rate their waking mood higher than those in the WL, or CL groups. 
In addition, if photic driving responses at various frequencies of stimulation were to 
exert differential effects on sleep in this current study, then it was expected that 5Hz 
photic stimulation would be most effective for those people who report difficulty 
falling asleep, as it would assist in decreasing higher cortical activity and help in the 
production of theta frequencies which are required for sleep onset. 
Furthermore, given Sterman's (1981, 2000) work on operant conditioning of the 
'sensory motor rhythm' (SMR 12-15Hz) and its demonstrated ability to improve sleep 
and decrease night wakings, it was expected that photic stimulation at 13Hz would 
be most effective for treating night wakings and therefore improving sleep efficiency 
over the course of the study. Finally, it was hypothesised that photic stimulation at 
22Hz would have less impact on the amelioration of sleep onset latency in 
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comparison to the 5Hz and 13Hz group due to its tendency to increase beta activity, 
which is at odds with sleep onset, but would continue to have more impact than WL 
or CL because of induced relaxation effects. 
4.5 Method 
4.5.1 Participants: The sample consisted of sixty participants drawn from the 
Canberra community. Participation was voluntary with participants responding to 
advertisements in the local newspaper or, alternatively, being referred by health care 
workers who had received information about the study requesting suitable referrals. 
The sample included 22 males and 3 8 females with an age range of 18 to 82 years, 
(M=41.70, SD=14.30). There was an attrition rate of 8% (n=5). Two participants 
moved interstate, one participant left the study after commencement of anti-
depressant medication, the eldest participant, who was in the wait-list group, died 
suddenly from pneumonia, and one participant withdrew because of increased work 
commitments. Two participants withdrew from the waitlist group, two from the 
continuous light group, and one from the 22Hz group. In general, the active light 
therapy groups retained participants suggesting that photic stimulation at least 
sustained people's interest. No participant reported leaving the study because of an 
inability to tolerate the light therapy. 
Handedness was assessed because of previous convention set by Davidson and 
colleagues when investigating cerebral asymmetry and emotion (Davidson et al., 
1990· Davidson & Fox 1989· Henriques & Davidson, 1990, 1991 ; Tomarken, 
' ' ' 
Davidson, & Henriques, 1990). Fifty two participants were right handed, 5 
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participants were left handed and the remaining 3 participants were ambidextrous as 
assessed by the Edinburgh Handedness Inventory (Oldfield, 1971). 
4.5.2 Selection criteria: Participants were admitted to the study if they met the 
DSM-IV criteria for mild to moderate major depression with symptoms of sleep 
disturbance (see Appendix E for Selection Criteria). In order to recruit participants 
with unipolar depression only, respondents were excluded from the study if they had 
a history of bipolar disorder or psychosis. People taking anti-depressant or 
anxiolytic medication were also excluded because of the confounding effects these · 
medications can have on the EEG (Knott, Mahoney, Kennedy, & Evans, 2002). 
Because photic stimulation has been known to induce epileptic seizures in some light 
sensitive epileptics, people with a history of epilepsy were not permitted to enter the 
study. 
While there are studies which report the usefulness of high frequency photic 
stimulation in the treatment of migraine (Anderson, 1989), random allocation of 
participants to groups prohibited control of the particular photic stimulation . 
frequencies participants would receive, therefore, people with a history of migraine 
were excluded from the study. Furthermore, people who reported snoring 'more 
nights than not' were also excluded from the study because of the high likelihood 
they could be suffering from sleep apnoea (Bardwell et al., 2000). Traditionally, 
relaxation therapies have little impact on the amelioration of sleep apnoea (Dement 
& Vaughan, 1999). Approximately 80 respondents were excluded because of failure 
to meet admission criteria. 
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Beck Depression Inventory II (BDI-II) scores ranged from 2 to 46 (M=23.48, 
SD=l 1.04) on admission to the study. Despite intake criteria, 18% of participants 
commenced the study with BDI-II scores in the minimal range (0-13), 22% fell 
within the mild range (14-19), 33% fell within the moderate range (20-28), and 27% 
were in the severe range of depression (29-63). Most participants, 72%, reported a 
depression history of 12 months or longer, (M=102 months, SD=121). 
Symptom Checklist 90-R (SCL-90-R) anxiety T-scores ranged from 37 to 81 (M=64, 
SD=l0.85) on admission. Sixty three percent of participants had SCL-90-R anxiety 
scores greater the 1 SD above the norm. Despite intake criteria, on initial assessment 
1 participant reported no sleep problems. 
At initial assessment, only 18% of participants reported having been hospitalised in 
the last 12 months for minor surgery, cancer treatment, or treatment for cardio-
pulmonary disease. One participant had been hospitalised for a suicide attempt. A 
substantial proportion of participants, 33%, reported living with a chronic illness that 
included ailments such as hypertension, Systemic Lupus Erythematosus, asthma, 
genital herpes, arthritis, breast cancer, or glaucoma. One participant was a Vietnam 
Veteran with a long history of Post Traumatic Stress Disorder who reported being 
stable at the time of entry into the study. In addition, 45% of participants reported 
having been affected by a major life event in the last 3 months, reporting events such 
as relationship break-ups, death or illness of friend or family member, moving house, 
changing jobs or financial stressors. 
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Twenty percent of the sample were smokers, but only 12% of these reporting 
smoking 10 or more cigarettes per day. Only a small proportion, 13% (n=8) reported 
using recreational drugs, with four clients claiming they used marijuana on a regular 
basis ranging from everyday to a few times per week. Some participants disclosed 
they used ecstasy, heroin or cocaine on occasion. No one in the study reported using 
heroin, cocaine or ecstasy on a regular basis. These participants were asked to 
abstain from recreational drug use for 24 hours prior to EEG recordings, while all 
participants were asked to refrain from caffeine intake for 4 hours prior to EEG 
recordings to minimise EEG attenuation associated with caffeine intake (Gilbert, 
Dibb, Plath, & Hiyane, 2000). 
4.6 Design 
A double blind, placebo controlled, 5 by 4 repeated measures mixed design was 
used. Participants were randomly allocated to one of five groups; a wait list control 
group (WL); a continuous light group (CL), who were exposed to photic stimulation 
of 64Hz which is the highest setting on the Lightmask™ and is beyond the flicker 
fusion frequency, or one of three active photic stimulation groups, receiving photic 
stimulation at either a 5Hz, 13Hz, or 22Hz. As can be seen in Figure 4.4, measures 
of EEG, mood, and depression, were collected four times over a 3 month period; at 
baseline, twice during the month of experimental trials, i.e. 2 weeks after using the 
lights and/or keeping a sleep diary, and at the end of the 4 weeks, and finally at 
follow-up 2 months after the completion of light therapy. 
Baseline 
Initial measures 
3 weeks 
QEEG 
PANAS 
BDI-II 
Sleep diary 
(1 week) 
Health Matters 
Questionnaire 
SCL-90-R 
Handedness Inventory 
PS= Photic Stimulation. 
Session 2 
after 2 weeks of 
PS & Sleep diary 
I 
QEEG 
PANAS 
BDI-II 
Sleep diary 
(2 weeks) 
2 weeks 
Light & mood diary 
(2 weeks) 
Session 3 
after 4 weeks of 
PS & Sleep diary 
I 
QEEG 
PANAS 
BDI-II 
Sleep diary 
(2 weeks) 
8 weeks 
Light & mood diary 
(2 weeks) 
Follow-up 
2months 
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post session 3 
I 
QEEG 
PANAS 
BDI-II 
Sleep diary 
(1 week) 
Health Matters 
Questionnaire 
SCL-90-R 
Figure 4.4 Experimental design for study 2 showing measures taken at each session. During the 4 week intervention phase (includes session 2 & 3) participants in the light groups kept 
sleep diaries and a light and mood diary. Participants in the wait-list group kept a sleep diary 
only. 
4. 7 Measures 
On initial interview demographic information, measures of health behaviours, life 
events, mood, and sleep hygiene were presented together in the 'Health Matters 
Questionnaire' (see Appendix F). At all sessions, baseline, session 2, session 3 and 
follow-up, measures of mood, subjective relaxation, depression and EEG were 
obtained. Psychological status was also assessed using the Symptom Checklist 90-R 
at baseline and follow-up only. In addition, participants kept sleep diaries, recording 
sleep hygiene variables, as discussed below, plus light and mood diaries, recording 
time of Lightmask use, and mood before and after Lightmask use, for up to six 
weeks during the study. 
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4.7.1 Subjective relaxation: Subjective relaxation was assessed at each 
measurement session prior to EEG recording. Participants were asked to indicate on 
a 10 point Likert scale, 1 (feeling very relaxed and calm) to 10 (feeling very anxious 
and uptight), how relaxed and calm or anxious and uptight they felt 'right now' (see 
Appendix F, 'Health Matters Questionnaire', p. 4). In order to obtain a measure 
which was reflective of the descriptor 'subjective relaxation', this variable was 
reverse scored so that high scores corresponded with high levels of relaxation and 
low scores with low scores of relaxation. 
4.7.2 Mood (PANAS). Mood was assessed at every session using the Positive and 
Negative Affect Schedule (PANAS) developed by Watson and Clark (1988) (see 
Appendix F, 'Health Matters Questionnaire', p. 4). This is a 20 item scale with 10 
items assessing positive affect and 10 items assessing negative affect. Respondents 
were asked to indicate, on 5 point Likert scale ( 1 = very slightly or not at all, to 5 = 
extremely) "to what extent you have felt this way in the last week". 
4. 7.3 Depression: Depression level was assessed at every session using the Beck 
Depression Inventory II (BDI-II) (Beck, Steer, & Brown, 1996). The BDI-II is a 21 
item self-report instrument used to assess depression severity. It assesses emotional, 
cognitive, somatic and behavioural components of depression. Respondents · are 
required to indicate, on a 4 point Likert scale (0-3) which statement in each group 
best describes them and they way they have been feeling 'during the past two weeks, 
including today'. Summed scores provide a depression severity score within the 
following ranges, 0-13 minimal, 14-19 mild, 20-28 moderate, and 29-63 severe 
depression. 
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The BDI-II boasts high internal consistency reporting alpha coefficients of .92 (Beck 
et al., 1996). This was confirmed in the present study with an alpha reliability of .89 
to .92 across administrations. Test re-test reliability is also reported to be high, at .93 
which makes it a good instrument to use in a repeated measures design (Beck et al., 
1996). An added advantage of the BDI-II is that it has been designed to be 
consistent with the DSM-IV diagnostic criteria for major depression. 
4.7.4 Psychological status: Psychological status was assessed on two occasions, at 
baseline and at follow-up, using the Symptom Checklist 90-R (SCL-90-R). As 
outlined in Chapter 2, the SCL-90-R is a 90 item inventory which has been 
extensively used in both 'normal' and clinical populations. Respondents were asked 
to indicate on a 5 point Likert scale the extent to which they had been distressed or 
bothered by each of the 90 listed problems over the last 7 days. The SCL-90-R 
reports good reliability and validity with alpha coefficients for internal consistency 
reported for the depression scale at 0.90 and for the anxiety scale, 0.88, and high test-
retest reliability, 0.82 (Derogatis & Savitz, 1999). The subscales used in this study 
were anxiety, and the global severity index, and are measured as T-scores with mean 
of 50 and SD of 10. The depression subscale was used to validate the use of the 
Beck Depression Inventory with Pearson's correlation coefficients between the two 
scales of r = .64, p < .01, at baseline, and r = .35, p < .01, at follow-up. According to 
these moderate correlations the SCL-90-R and the BDI-II do not assess the same 
symptoms of depression. Nevertheless, the selection of a clinical sample was 
confirmed with 85% of participants with SCL-90-R depression T-scores of 60 or 
higher at baseline. 
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4.7.5 Sleep hygiene: Sleep hygiene was assessed using a retrospective self-report 
method (see Appendix G). All participants were required to keep sleep diaries for a 
period of six weeks; at baseline for one week after the initial assessment and prior to 
commencing light therapy; during the 4 weeks of experimental trials; and finally, for 
one week prior to follow-up measures. Respondents were asked to fill in their sleep 
diary in the morning on waking and record, the time of 'lights out' the previous night, 
estimation of time to fall asleep (sleep onset latency), estimated 'number of wakings' 
during the night and an estimation of the amount of 'time spent awake' during these 
times, final waking time in the morning, reasons for waking if remembered, and any 
general comments relating to the last nights sleep. From these measures a sleep 
efficiency measure was calculated (ratio of total time asleep to total time in bed, 
expressed as a percentage). Clients were also asked to rate, on a 10 point Likert 
scale, 1 (the worst I have ever felt) to 10 (the best I have ever felt), how they felt on 
waking. 
4. 7.6 Light therapy and mood diary: In addition to keeping sleep diaries, those in 
the light conditions kept a record of the time of day they used their light mask and 
how they felt before and after light mask use, in order to assess if time of day of light 
mask use affected mood or sleep parameters, and also to enable a check on the 
consistency of light mask use (see Appendix H). In addition, to assess if particular 
photic stimulation frequencies had an immediate effect on subjective well-being 
participants were asked to indicate on a 10 point Likert scale, 1 (the worst I have 
ever felt) to 10 (the best I have ever felt) , how they felt before and after light mask 
use. 
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4.7.7 Menstrual cycle: Because of the unusual finding in Study 1 where positive 
affect was found to be positively correlated with week of menstrual cycle, week of 
menstrual cycle was again measured at baseline in an attempt to replicate this 
finding. As outlined in Chapter 2, women were asked to indicate the current week 
(1-4) of their menstrual cycle, with week one corresponding to the onset of menses, 
subsequent weeks 2 and 3, and week 4 indicating the final week of the cycle or 
encompassing the remaining time until the beginning of the next cycle. Correlations 
were performed only on women who indicated a menstrual cycle week, n=23 ( see 
Appendix F, Health Matters Questionnaire, p. 5). 
4.8 Apparatus 
4.8.1 Photic stimulation: During EEG recording photic stimulation at 1 OHz was 
delivered using a portable light and sound machine (XCELR8R II) manufactured by 
'Mind-gear'™. The device has 4 light diodes for each eye; white, green, red and 
blue, arranged in a circular array that delivers a low intensity ( approximately 10 Lux) 
synchronised pulsed ( on/off) light stimulus through closed eyelids. 
4.8.2 Lightmask: Participants in the light conditions were each given a 
commercially available 'Lightmask'™ and a recharging unit to take home and use 
(see Appendix I for description). Each light mask was preprogrammed at the 
designated frequency for each group by an independent person so the experimenter 
would remain blind to group allocation. The Lightmask TM is a fully programmable 
easy to use portable photic stimulation device that delivers a synchronised pulsed 
( on/off) light stimulus of a set frequency via two red diodes ( one for each eye), 
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through closed eyelids. Light intensity was set low to medium ( approximately 10-15 
Lux) in order to find a level which could be tolerated by most people. 
In order to control for possible variation in photic driving responses in the EEG due 
to time of day effects, participants were asked to use their light mask in the evening, 
and preferably, just prior to retiring and optimally, at the same time each day. On 
average, participants tended to use their light mask between 9 and 1 0pm. In order to 
maintain the double blind condition, as discussed above, EEG was not assessed 
during 5Hz, 13Hz or 22Hz photic stimulation with the Light mask. 
4.8.3 Electroencephalography: EEG was data was recorded using a 16 channel 
'Minset'™ data acquisition device and stored on hard disk for further analysis. The 
Mindset used in this study was tested and calibrated by the manufacture prior to 
study commencement. Calibration was checked using a 50µ V signal during and also 
at study completion. Some signal attenuation was found at 4Hz and below with 
approximately 10-20% signal attenuation in the 3-4Hz bandwidth, however, there 
was accurate signal detection for the remaininglHz bins (5-22Hz) used in the study. 
Data was sampled at 256Hz, with band pass filters set between 3 and 30Hz. An 
Electro-Cap TM was fitted according to instructions using 'Electro-Cap Gel'™ and an 
abrasive agent, 'Nu-Prep'™, in order to reduce impedance levels to 5Kohms or below. 
On occasion this was not possible, and impedance levels were kept below 1 0Kohms 
prior to EEG recording (Andreassi, 1995; Kaiser, 2000; Niedermeyer & Lopes Da 
Silva, 1993 ). Referential EEG measures were recorded from sixteen sites (Fp 1, Fp2, 
F3, F4, F7, F8, C3, C4, T3, T4, TS, T6, P3, P4, 01, and 02) across the scalp in 
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accordance with the International 10/20 System (Homan, Herman, & Purdy, 1987; 
Jasper, 1958) using a linked ear reference montage (Davidson, 1988; Kaiser, 2000). 
Participants were seated comfortably in an upright chair approximately 1 metre from 
the Mindset and out of view of the video monitor display. 
Raw EEG data were processed using SKILTM software version 2. 05 (Sterman & 
Kaiser, 2000). SKILTM provides an automated artifact removal algorithm that 
removes variation from Fp 1 caused by eye blink and movement. In addition, all raw 
EEG files were visually inspected to detect and remove movement artifacts present 
in other leads. Digitised EEG data were then subject to Fast Fourier Transform and 
decomposed into individual lHz frequency bins. Data was then exported for further 
statistical analysis. To ensure consistency in manual artifact removal a subset of raw 
EEG files were assessed and inspected for artifacts by an independent psychologist 
working in the EEG field. Pearson's correlation coefficient was used to compare 
time lengths of EEG files after artifact removal. Using this method inter-rater 
reliability was .87. 
SKILTM also provides a normative database. This database is comprised of repeated 
EEG measures from 135 people ranging in age from 18-55years, 80% percent male 
and 20% female. Subjects were recruited from the wider community and included 
students, laboratory personnel, and U. S Air Force personnel. Handedness was 
assessed using the Edinburgh Handedness Inventory (Oldfield, 1971), and subjects 
were screened for medical history, recent life events, and drug use. Time of day 
corrections are provided for use with the eyes closed and eyes open conditions. The 
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normative database also allows for comparison with eyes closed, eyes open, and two 
active task conditions such as reading and arithmetic. 
4.9 Procedure 
4.9.1 Recruitment: Subjects were recruited over a 12 month period from July 2001 
to July 2002. Participants were either self-referred, responding to advertisements 
placed in a local newspaper or to information in pamphlets left at doctors' and 
psychologists' offices, or directly referred by health practitioners. Preliminary 
screening was conducted over the telephone to ascertain eligibility for entry into the 
study. Using a tick list of depression and sleep disorder symptoms, participants were 
admitted to the study if they met minimal requirements for mild to moderate major 
depression and also reported some symptoms of sleep disturbance as defined by 
DSM-IV (see Appendix E for Selection Criteria). 
All sessions were conducted in a clinical room in the Psychology Department at The 
Canberra Hospital. During the initial interview, participants were told that the study 
was investigating the effects of photic stimulation or light flicker on mood and sleep 
disturbance. In order to keep expectancy and placebo effects constant, participants 
were informed that photic stimulation had been reported to have beneficial effects on 
mood and sleep but that there was little controlled research regarding its clinical 
usefulness, and that the present study was attempting to address this issue. 
Participants were informed that it was a double blind study, and they would not 
know what frequency of photic stimulation they were receiving, nor the intended 
effects of the stimulation until the end of their participation, nor would the 
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experimenter recording their EEG know the particular light frequency they were 
receiving. Participants were shown the Lightmask ™ that would be used in the study. 
Next they were informed that some frequencies would be very high and some very 
low and that the perception of 'light flicker' was not always possible; but 
nevertheless, photic stimulation had been shown to affect brainwave functioning. 
Research regarding the most beneficial frequencies for the treatment of mood 
disorders and the frequencies used in the current study were not discussed. Random 
allocation to groups and the waitlist condition were explained. Experimental 
procedures were outlined in detail prior to written consent being obtained. 
Next, participants completed the 'Health Matters Questionnaire', the Beck Depression 
Inventory-II (Beck et al., 1996), the Edinburgh Handedness Inventory (Oldfield, 
1971), and the Symptom Checklist 90-R (Derogatis, 1977). 
Following this, EEG measures were obtained as previously outlined. Because of 
'time of day' effects on the EEG, sessions were scheduled as much as possible at the 
same time each day (Cummings et al., 2000; Lafrance & Dumont, 2000; Lafrance et 
al., 2002; Sterman, 1998). Before baseline recording commenced, participants were 
asked to sit quietly for a number of minutes with their eyes closed in an attempt to 
induce a habituation response and minimise artifact. When participants indicated 
they were feeling quite relaxed a series of three minute recordings were done; eyes 
closed, eyes open, and 1 0Hz photic stimulation. Prior to the eyes closed and photic 
stimulation recordings, participants were instructed to sit quietly with their eyes 
closed and to try to minimise the amount of eye movement. Prior to the eyes open 
condition participants were instructed to fix a 'comfortable gaze' on the picture in 
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front of them. In an attempt to maintain a relaxed gaze without undue strain on the 
eyes, participants were told they could blink if necessary, but to avoid unnecessary 
eye movement or blinking. A small A4 size nature picture (a rainforest scene, a lake 
scene or a snow scene) was placed approximately 2 metres in front of the client 
slightly below eye level to help fix the gaze and avoid unnecessary eye movement. 
Up to 30 seconds was allowed after the initiation of a new task before recording 
commenced to allow for state changes and to minimise artifact in the EEG. If 
artifact contamination appeared excessive, the initial eyes closed condition was 
repeated at the end of recording, thus allowing for comparison with the first eyes 
closed and ensuring reliable baseline measures had been obtained. 
Eyes open EEG was recorded in the absence of specific hypotheses in order to assess 
the normal functioning of the EEG. It is usual to observe attenuation of occipital 
alpha on eyes open and with task engagement (Hammond, 2002; Niedermeyer & 
Lopes Da Silva, 1993; Sterman, 1996). It also enabled comparison of the eyes open 
condition with the normative database provided with the SK.IL™ software which 
facilitated meaningful feedback to clients at the end of the study. 
Finally, participants were shown how to fill in their baseline sleep diary, and random 
allocation to group was done. If participants were in a light therapy group, an 
appointment for collection of their lightmask was made for the following week. In 
order to maintain the double blind condition the lightmasks were programmed by a 
colleague privy to the allocated photic stimulation frequencies. At the end of this 
process participants were given the opportunity to ask any further questions. All 
participants received an information pack to take away containing information about 
the study, the researchers, sleep diaries, light and mood diaries, and diary keeping 
instructions (see Appendix J, for 'Participant Information Sheet'). 
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During sessions 2 and 3, participants completed the PANAS and gave a subjective 
relaxation rating prior to EEG measures. At follow-up, all measures were re-done, 
and a final EEG obtained. Participants were debriefed by the second experimenter 
regarding the particular photic stimulation frequency they had received and the 
intended effects on mood and sleep. At the end of the study, participants were given 
material to take away, which included information about managing depression, 
guidelines for good sleep, and a list of references for obtaining information about 
photic stimulation and treatment of mood and sleep disturbance. 
4.10 Results 
Assumptions of linearity, normal distribution and homogeneous variance, were 
checked graphically by means of residual plots. Data was also screened for outliers 
using visual inspection of box plots and Mahalanobis' s distance. Data analysis was 
done using the SPSS V.10 statistical package and repeated-measures multivariate 
analyses of variance (MANOVA) was used to test hypotheses using a .05 alpha 
level. Effect sizes are reported using partial eta squared (17 2). Means and standard 
deviations for variables used in hypotheses testing are located in Appendix K. 
4.10.1 Electroencephalography: Processed EEG data was assessed for alpha 
attenuation in the occipital cortex on eyes open to ensure a 'normal' 
desynchronisation response was present. All participants demonstrated alpha 
attenuation to varying degrees. Untransformed mean magnitude (µ V /Hz) EEG data 
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tended to be positively skewed. Natural log transformation remedied this and is the 
recommended transform for mean EEG (µV/Hz) data (Kaiser, 2000). Mean log EEG 
magnitude (µ V /Hz) was used in all EEG analysis except alpha asymmetry which 
used a power measure. Broadband EEG variables, as recommended by Kaiser 
(2000), were used in some statistical analysis; theta (mean 5-7Hz), alpha (mean 8-
13Hz) and beta (mean 14-20Hz). Because of increased EEG amplitude from frontal 
to posterior sites, correlational analyses used frontal (mean Fpl, Fp2, F3, F4, F7 & 
F8), midline (mean T3, T4, C3 & C4), or posterior (mean P3, P4, TS, T6, 01, & 02) 
broadband measures, or global theta, alpha or beta measures (means of all 16 sites). 
Prior to using EEG data in hypotheses testing, mean log EEG magnitude for eyes 
closed was assessed for expected patterns of response using a four way MANOVA 
with group (WL, CL, 5Hz, 13Hz, and 22Hz) as the between groups variable, and 
session (1-4), site (Fpl, Fp2, F3, F4, C3, C4, P3, P4, 01, 02), and band (theta 5-7Hz, 
alpha 8-13Hz, and beta 14-20Hz) as the within groups variables. There was a main 
effect for site, F(9,38) = 42.42, p < .05, 17 2 = .90, revealing an increase in EEG 
amplitude moving from the front to the back of the cortex which is in accordance 
with expected patterns. There was also a main effect for band, F(2,45) = 148, p < 
.05, 17 2 = .86, with the greatest amount of amplitude in the alpha band, followed by 
the theta band and finally, the beta band, as expected. In addition, there was a 
significant site by band interaction, F(l 8,29) = 85.50, p < .05, 11 2 = .98, with the 
largest amplitudes occurring in the alpha band at the posterior sites, showing the well 
known phenomenon of occipital alpha peak frequency (Berger, 1976 reprint of 1934; 
Kaiser, 2000; Niedermeyer & Lopes Da Silva, 1993). There was no main effect for 
group. 
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4.10.2 EEG alpha asymmetry: Alpha asymmetry was assessed using the 
broadband alpha EEG variable, 8Hz to 13Hz, transformed into log power (µV 2/Hz), 
in accordance with that used by Henriques & Davidson (1991). Based on previous 
work by Davidson and colleagues, it was hypothesised that left midfrontal alpha 
would be greater than right midfrontal alpha in this depressed sample. This 
hypothesis was tested using a three way MANOV A with group (WL, CL, 5Hz, 
13Hz, and 22Hz) as the between groups variable, and site (F3 & F4) and session (1 
to 4) as the within groups variables. 
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Figure 4.5 Mean log alpha power (µV 2/Hz) at F3 and F4 across sessions, showing 
higher left midfrontal alpha in comparison to right midfrontal alpha (n=51 ). 
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As can be seen in Figure 4.5 a main effect for site was revealed with mean log alpha 
power at F3 significantly higher than mean log alpha power at F4, F(l,46) =16.34, p 
< .05, 11 2 = .26. While alpha power increased across sessions this was not significant 
suggesting that alpha asymmetry was relatively stable across time, F(3,44) =2.31, p > 
.05, 11 2= .14. Group membership did not influence alpha asymmetry as predicted, 
F ( 4, 46) = 1. 1, p > . 0 5, 11 2 = . 09, and there were no interaction effects. Thus this 
sample of depressed clients showed left midfrontal deactivation relative to right 
midfrontal activation which persisted across sessions, indicating a trait like character 
as proposed by Davidson. 
4.10.3 Comparison to Normative Database: Comparison of alpha (8-13Hz) EEG 
magnitude (µ V /Hz) to the SKIL normative database showed that participants did not 
have higher left midfrontal alpha in comparison to the norm, with a mean standard 
deviation for the sample of -1.40 (SD= .57) at F3 accompanied by low right 
midfrontal alpha (F4) with a mean standard deviation of -1.43 (SD= .56). Overall 
the sample was situated within 2SD of the normative database in the alpha 
bandwidth across all 16 scalp sites. Further exploration found mean EEG magnitude 
to be lower than the normative database in all frequency bands across the scalp with 
the most prominent finding that of low frontal theta. 
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Figure 4.6 Topographical brain map eyes closed EEG in lHz frequency bins 
showing low frontal theta (5-7Hz) in comparison to the normative database (standard 
deviations) in a 56year old female. 
Figure 4.6, is a topographical brain map of lHz frequency bins showing the typical 
pattern of low frontal theta across 5-7Hz found in this sample. Approximately 45-
50% of participants demonstrated low frontal theta at Fpl, Fp2, F3 and F4 of less 
than 2SD or more below the norm. The sample also displayed low frontal beta, with 
approximately 30-35% of participants showing beta magnitudes of 2 or more 
standard deviations below the norm at Fp 1, Fp2, F3, and F4. 
4.10.4 Brainwave entrainment: It was anticipated that participants would 
demonstrate photic driving in response to a 1 0Hz photic stimulus, not only in 
occipital regions, but also in frontal regions with recruitment of the response across 
the cortex. This was tested using a four way MANOV A, with group (WL, CL, 5Hz, 
13Hz, and 22Hz) as the between groups variable, and site (Fpl, Fp2, F3, F4, C3, C4, 
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P3, P4, 01, and 02), condition ( eyes closed vs. 1 0Hz photic stimulation), and 
session (1 to 4) as the within groups variables, using mean log l0Hz EEG (µV/Hz). 
There was a main effect for condition with photic stimulation demonstrating higher 
EEG amplitude across all sites in comparison to eyes closed, F(l,46) = 45.26, p < 
.05, 17 2 = .50. This effect was uncomplicated by session or group membership 
suggesting that it was somewhat stable across time and unaffected by light therapy, 
but was dependent on site, with larger driving responses noted in the occipital cortex 
at P3, P4, 01 and 02, F(9,38) = 2.66, p < .05, 172 = .39. There was also a main effect 
for site, with a significant linear effect showing increased EEG amplitude moving 
from frontal to occipital sites as previously noted, F(9,38) = 69.34, p < .05, 17 2 = .94. 
There was no main effect for group, F( 4,46) = 1.94, p > .05, 17 2 = .14. 
Photic stimulation responses were varied with some participants showing no 
entrainment while others showed marked entrainment. Figure 4. 7 a shows baseline 
eyes closed EEG in a 22 year old female participant with a BDI-II score of 41. Her 
response to 1 0Hz photic stimulation is clearly visible in Figure 4. 7b with maximal 
response evident in posterior leads. Many participants also showed clear harmonic 
responses to 1 0Hz photic stimulation. Figure 4. 8a shows a spectral plot of eyes 
closed baseline EEG for the same 22year old female with 1 lHz dominant alpha 
frequency clearly visible at O 1, 02, P3 and P4. Her response to 1 0Hz photic 
stimulation is very evident in Figure 4.8b with increased amplitude in the l0Hz 
frequency bandwidth across the cortex, and clear 20Hz harmonic responses visible, 
not only in occipital leads, but recruiting into frontal leads. 
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Figure 4.7b Eyes closed EEG showing 1 OHz photic stimulation response particularly 
in occipital leads, and across the cortex in the same 22 year old female. 
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Figure 4.8a. Spectral plot of eyes closed EEG (µ V) across 16 scalp sites (markers at 
0, 10, & 20Hz) showing dominant occipital alpha frequency (l lHz) in 22year old, 
right handed, depressed female, BDI-II=41. 
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Figure 4.8b. Spectral plot showing 1 OHz photic stimulation in eyes closed EEG (µ V) 
across 16 scalp sites, with a 20Hz harmonic visible across the scalp, in the same 22yr 
old female. 
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Pockberger (1985) suggested that frequency following responses increase with 
increasing severity of depression and attenuate on recovery from depression. 
Pearson's correlation coefficients between depression level and frequency following 
response showed little to no relationship at baseline, r = .05, p > .05; at session 2, r = 
-.12, p > .05; session 3, r = .03 , p > .05; or at follow-up r =-.03, p > .05. 
Similar to Study 1 there was no evidence of entrainment to the three experimental 
photic stimulation frequencies (5Hz, 13Hz, and 22Hz). Unlike Study 1, however, the 
current study did not record EEG while participants were exposed to these 
frequencies, rather, it was reliant on finding evidence of 'a training effect' in eyes 
closed EEG after regular daily exposure to experimental photic stimulation 
frequencies. Separate three way MANOV A's, with group (WL, CL, 5Hz, 13Hz, and 
22Hz) as the between groups variable, session (1 to 4), and site (F3, F4, C3, C4, P3, 
P4, 01, and 02), as the within groups variables, were computed for each bandwidth, 
5Hz, 13Hz, and 22Hz. It was anticipated that exposure to a particular photic 
stimulation frequency may increase EEG amplitude in that frequency band during 
the experimental phase and possibly also at follow-up, but not at baseline, therefore, 
only session by group interactions were of interest. 
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Figure 4.9 Mean log magnitude 13Hz in eyes closed EEG averaged across F3, F4, 
C3, C4, P3, P4, 01 and 02, for wait list (WL), continuous light (CL), 5Hz, 13Hz, 
and 22Hz groups . 
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Figure 4.1 0 Mean log magnitude in 22Hz eyes closed EEG averaged across F3, F 4, 
C3, C4, P3, P4, 01 and 02, for wait list (WL), continuous light (CL), 5Hz, 13Hz, 
and 22Hz groups. 
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As can be seen in Figures 4.9 and 4.10 there was little evidence of increased EEG 
magnitude for the 13 Hz or 22Hz groups with a small drop in 22Hz magnitude for the 
22Hz group after 2 weeks of light therapy and a gradual return to baseline at the end 
of the experimental phase. There was no change across sessions for the 13 Hz group 
at their entrainment frequency . 
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Figure 4.11 Mean log magnitude in 5Hz eyes closed EEG averaged across F3, F4, 
C3, C4, P3, P4, 01 and 02, for wait list (WL), continuous light (CL), 5Hz, 13Hz, 
and 22Hz groups. 
The 5Hz group (see Figure 4.11) showed a slight increase in 5Hz magnitude after 2 
weeks of light therapy, only to return to baseline levels by the end of the month. On . 
analysis, session by group interaction effects were very small and non-significant for 
all experimental frequencies, 5Hz, F(12,138) = 1.12, p > .05, ri2= .09; 13Hz, 
F(12,138) = .66, p > .05, 11 2 = .05; and 22Hz, F(12,138) = 1.23, p > .05, 11 2 = .10. In 
addition, there were no main effects for group or session. Thus there was no 
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evidence of increased EEG amplitude in these bandwidths that could be attributable 
to experimental manipulation. 
Due to previous findings of increased positive affect with alpha A VS and decreased 
positive affect with beta AVS in Study 1, it was predicted that those receiving 13Hz 
photic stimulation would report higher levels of well-being than those receiving 
22Hz photic stimulation immediately after light mask use. Figure 4.12 shows that all 
the active photic stimulation groups reported higher well-being after light therapy in 
comparison to the sham or continuous light group. This pattern was repeated with 
rated well-being prior to light therapy with no distinction evident between the three 
active photic stimulation frequencies. Contrary to predictions, the 22Hz group report 
higher well-being after photic stimulation than the 13Hz group. 
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Figure 4.12 Mean well-being rating immediately after Lightmask™ use for photic 
stimulation groups; continuous light (CL), 22Hz, 5Hz, and 13Hz. 
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Omnibus three way MANOVA with group (WL, CL, 5Hz, 13Hz, and 22Hz) as the 
between groups variable, and time (before and after) and session (1 to 4) as the 
within groups variables revealed a main effect for time, F(l ,36) = 20.60, p < .05, 172 = 
.36, with participants reporting enhanced well-being after light therapy, and a main 
effect for session, F(3,34) = 3.90, p < .05, 17 2= .25, indicating an increase in reported 
well-being across sessions. To test the hypothesis a time by group interaction was 
expected. This was not found, F(3,36) = .88, p > .05, 112 = .07. There was no main 
effect for group, F(3,36) =1.20, p > .05, 11 2 = .09, suggesting that the observed 
differences between the active experimental photic stimulation conditions and the CL 
condition were not significant. 
Time of day of light mask use was also recorded to assess its effect on mood and 
sleep parameters. As previously reported, most participants used their light masks 
between 9 and 10 pm (range 2pm to 12pm) before retiring for the night. There was a 
consistent negative correlation between time of light mask use and well-being after 
using the light mask, r =-.13, p > .05, for week 1; r =-.25, p > .05, for week2; r =-.50, 
p < .05, for week3; and r =-.25, p > .05, for week 4, possibly indicating a decrease in 
rated well-being with increasing tiredness with later light mask use. 
Time of light mask use had little impact on depression levels, r = .12, p > .05, at 
week 2, and r = .25, p > .05, at week 4. Similarly, time of light mask use was 
unrelated to positive affect, r = .08, p > .05, at week 2, and r = -.28, p > .05 at week 
4; and negative affect, r = -.07, p > .05, at week 2, and r = .11, p > .05, at week 4. 
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Later light mask use was associated with decreased sleep onset latency, r = -.24, p > 
.05, for week 1, r = -.30, p < .05, for week 2, r = -.15, p > .05, for week 3, and r = 
.04, p > .05, for week 4; but had no impact on night wakings, r = .19, p > .05, for 
week 1 r = -.03, p > .05, for week 2; r = .08, p= .05, for week 3; and r = .09, p > .05, 
for week 4; or sleep efficiency, r = .13, p > .05, for week 1, r = .18, p > .05, for week 
2, r = .08, p > .05, for week 3, and r = .03, p > .05, for week 4. 
There was little variation in the time of day light masks were used with most 
participants adhering to study instructions and using their light masks in the evening. 
Consequently, there was little correlation between time of day of light mask use and 
sleep and mood parameters. In addition, it is difficult to tease out the impact of 
increasing fatigue, which invariably exerts its effects on mood and sleep parameters, 
such as sleep onset, as the day progresses. 
4.10.5 Subjective relaxation: It was predicted that those receiving 5Hz and 13Hz 
photic stimulation would report higher subjective relaxation during the experimental 
phase than those in the 22Hz, CL or WL groups. This hypothesis was tested using a 
two way MANOVA with group (WL, CL, 5Hz, 13Hz, and 22Hz) as the between 
groups variable and session (1-4) as the within groups variable. As can be seen in 
Figure 4.13 the hypothesis was only partially supported with the 5Hz group showing 
the highest subjective relaxation across sessions, and the 22Hz group reporting the 
lowest subjective relaxation ratings. This observed trend was not supported 
statistically with no session by group interaction present, F(12, 141) = 0.81, p > .05, 
r/= .06. It can also be seen that subjective relaxation was variable for all groups 
with no clear trends observed across sessions. This was indicated by a very small 
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non-significant session effect, F(3,45) =. 73, p > .05, 11 2= .06. Finally, there was no 
main effect for group, F(4,47) = 1.23, p > .05, 11 2= .09. 
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Figure 4.13 Mean subjective relaxation across sessions. 
In addition, it was expected that subjective relaxation would correlate positively with 
theta and alpha, and negatively with beta frequencies across sessions. Contrary to 
expectations small to moderate inverse correlations were found between subjective 
relaxation and theta at different sites, r = -.12 to -20, p > .05, and alpha, r =-.39, p < 
.05, to -.25, p > .05 at baseline. A trend in predicted directions was found between 
subjective relaxation and beta amplitude with small inverse correlations revealed, r = 
-.25 to -.13, p > .05. This pattern of relationship between beta and subjective 
relaxation was not repeated at session 2, with near zero correlations revealed for all 
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bandwidths across the scalp, but was repeated again at session 3, r = -.14 to -.11, p > 
.05, and was accompanied by near zero correlations between theta and alpha across 
the scalp. At follow-up, higher subjective relaxation was associated with decreased 
beta amplitude across frontal sites, r = -.31, p < .05, midline, r = -.34, p < .05, and 
posteriorally, r = -.14, p > .05, but no relationship between subjective relaxation and 
alpha or theta. Thus subjective relaxation tended to be associated with a decrease in 
beta amplitude rather than increases in theta or alpha, particularly in frontal and 
midline regions rather than posterior regions. 
4.10.6 Mood (PANAS): As discussed in Chapter 2, positive and negative affect are 
purported to be orthogonal constructs (Diener & Emmons, 1985; Watson, Clark, & 
Tellegen, 1988). Prior to use in the current study, the factor structure of the PANAS 
was assessed using visual observation of the scree plots and factor analysis. The 
orthogonal structure was supported at some administrations, but not at others, with 
two strong main factors generally present, but at times a possible weaker third factor 
also present. 
Specifically, factor analysis of PANAS items revealed a strong positive affect factor 
and a less robust negative affect factor on all administrations except at session two. 
On the second administration of the PANAS positive affect was less robust with 
three items, 'excited', 'proud', and 'alert' loading on the negative affect factor. Despite 
this, Pearson's correlation coefficients between positive affect and negative affect at 
session two were small and non-significant, r = .14, p > .05). Consistent with the 
independence hypothesis for these two constructs, there was no relationship between 
positive affect and negative at session 1, r = .04, p > .05; session 3, r =-.09, p > .05; 
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nor at follow-up, r =-.24, P > .05. These findings were similar to Study 1. The alpha 
reliability coefficients for the two scales in the current study ranged from .87 to .92 
for positive affect and .86 to .89 for negative affect across administrations, therefore 
all items were retained for analysis. 
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Figure 4.14 Mean positive affect (PANAS) across sessions. 
It was hypothesised that active photic stimulation would induce a relaxation response 
and produce greater positive affect and lower negative affect in the 5Hz, 13Hz, and 
22Hz groups in comparison to the WL or CL. This was tested using three way 
MANOVA's with group (WL, CL, 5Hz, 13Hz, and 22Hz) as the between groups 
variable, and session (1 to 4) and items (1-10) as the within groups variables for both 
positive and negative affect. Unlike Study 1, positive affect increased for all groups 
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over sessions with a significant main effect for session, F(3,44) = 3.91, p,.05, 17 2 = 
.21 revealed (see Figure 4.14). This effect, however, was independent of group 
membership, F(l2,138) = .93, p > .05, 17 2 = .07. Particular adjectives, such as 
'interested' and 'alert' were endorsed more than other positive affect adjectives with a 
main effect for items revealed, F(9,38) = 20.18, p < .05, 172 = .83, but this was not 
dependent of group membership, F(36,164) = .99, p > .05, 172 = .18. In addition, 
there was no main effect for group, F( 4, 46) = .63, p > .05, 17 2 = .05. The expected 
pattern of results was not found, the active photic stimulation groups did not report 
higher positive affect than the WL or CL groups as evidenced by a non-significant 
small session by group interaction effect, F(12,138) = .93, p > .05, 112 = .07. 
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Figure 4.15 Mean negative affect (PANAS) across sessions. 
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As can be seen in Figure 4.15 negative affect declined over sessions for all 
participants. This was supported with a moderately strong main effect for session, 
F(3,46) =10.66, p < .05, ri 2 = .41. Further exploration of this effect revealed that 
negative affect was significantly lower than baseline measures at every subsequent 
session. The expected pattern of effects with the 5Hz, 13Hz, and the 22Hz groups 
showing greater reductions in negative affect than the WL or CL groups was not 
found as evidenced by a very small non significant session by group interaction 
effect, F(12,144) = .56, p > .05, ri 2 = .04. In addition, there was no main effect for 
group, F(4,48) = 1.31, p > .05, ri 2 = .09. Commensurate with Study 1, there was a 
main effect for items with participants endorsing adjectives such as 'irritable', 'upset', 
and 'distressed', more than other adjectives, but this was not dependent on group 
membership, F(36,172) = 1.16, p > .05, ri 2 = .19. 
4.10.7 Depression: Because of the relaxing effects of photic stimulation coupled 
with expectancy effects for all participants, it was anticipated that depression levels 
would decrease for all groups, with the greatest amount of decrease observed in those 
receiving active light therapy (5Hz, 13Hz or 22Hz). This prediction was tested using 
a two way MANOV A with group (WL, CL, 5Hz, 13Hz, and 22Hz) as the between 
groups variable, and session (1 to 4) as the within groups variable. There were no 
differences between the groups at baseline. As can been seen in Figure 4.16, 
depression levels decreased for all groups across sessions as predicted. This was 
supported with a strong main effect for session, F(3,45) =36, p < .05, ri 2= .70, with 
significant decreases in depression scores observed at every session in comparison to 
baseline. However, contrary to predictions, there was no difference between the 
active photic stimulation groups and the wait list and control groups during the 
intervention phase, as evidenced by a non significant session by group interaction, 
F(l2, 141) =1.44, P > .05, 112 = .11. There was no main effect for group, F(4,47) = 
.34, p > .05, 17 2 = .03. 
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Figure 4.16 l\11ean depression level (BDI-II) across sessions. 
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4.10.8 Anxiety: It was also hypothesised that anxiety levels would decrease over 
sessions as relaxation responses becan1e realised. In particular it was predicted that 
5Hz photic stimulation would most benefit those with high anxiety levels as it would 
assist in reducing possible high beta which can be associated with high anxiety, and 
help to reduce hyper arousal. Whereas, photic stimulation at 22Hz was expected to 
benefit those with low anxiety as it would assist in increasing motivation and 
alertness with the generation of higher cortical activity. There were no differences 
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between groups in anxiety level at baseline. Omnibus MANOV A with group (WL, 
CL, 5Hz, 13Hz, and 22Hz) as the between groups variable, and session (1 to 2) as the 
within groups variable revealed a moderate main effect for session, F(l,49) = 39.62, 
17 2 = .46, but no session by group interaction, F( 4,49) = 1.12, 17 2 = .08. There was no 
main effect for group, F( 4,49) = 1. 50, 17 2 = .12. 
Table 4.1 Mean SCL-90-R anxiety T-Scores at baseline and follow-up for low(< 
64) and high(> 64) anxiety participants. 
Group 
WL 
CL 
22Hz 
5Hz 
13Hz 
Baseline 
low 
Mean (SD) 
49.67 (6.98) 
(n=6) 
58.33 (1.15) 
(n=3) 
54.75 (11.98) 
(n=4) 
55.67 (6.51) 
(n=3) 
56.14 (5.40) 
(n=7) 
high 
Mean (SD) 
68.25 (5.44) 
(n=4) 
71.71 (6.63) 
(n=7) 
72.17 (5.64) 
(n=6) 
72.44 (6.84) 
(n=9) 
70.80 (6.42) 
(n=5) 
WL= wait list, CL = continuous light. 
low 
Follow-up 
high 
Mean (SD) 
45.50 (6.12) 
45.67 (7.77) 
47.75 (9.18) 
53.67 (8.96) 
50.14 (10.99) 
Mean (SD) 
61.25 (8.77) 
61.71 (7.25) 
68.67 (10.37) 
64.11 (8.96) 
67.40 (13.67) 
To assess this hypothesis more fully, separate two way MANOV A's with group 
(WL, CL, 5Hz, 13Hz, and 22Hz) as the between groups variable, and session (1 to 2) 
as the within groups variable were computed for high anxiety and low anxiety 
participants using a median split for anxiety. Effectively this split the sample at a T-
score of 64 dividing the sample into low and high anxiety. This was a convenient 
split as a T-score of 63 or higher signifies a person 'at risk' of pathology according to 
Derogatis, (1977). There was a main effect for session for both low and high anxiety 
participants, F(l,18) =14.48, p < .05, 17 2= .45, and F(l,26) =19.10, p < .05, 17 2= .42, 
respectively, but no predicted session by group interactions for low anxiety, F( 4, 18) 
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= .90, p > .05, 11 2 = .17, or for high anxiety, F( 4,26) = .86, p > .05, 17 2 = .12 (see Table 
4.1 for means). 
4.10.9 Symptom severity: Symptom severity (Global Severity Index SCL-90-R) 
was predicted to decrease more for the active photic stimulation groups in 
comparison to WL or CL across sessions, because of the arousal reducing ability of 
photic stimulation. This hypothesis was tested using a two way MANOV A with 
group (WL, CL, 5Hz, 13Hz, and 22Hz) as the between groups variable, and session 
(1 to 2) as the within groups variable. As can be seen in Table 4.2, global severity 
index T-scores decreased significantly for all groups across sessions as evidenced by 
a main effect for session, F(l,49) = 48.97, p < .05, 17 2 = .50. However, the hypothesis 
was not supported, with the WL and CL groups demonstrating similar decreases in 
symptom severity to the active photic stimulation groups at follow-up with a non-
significant session by group interaction revealed, F( 4,49) = .48, p > .05, 172 = .04. 
There was no main effect for group F( 4,49) = .65, p > .05, 172 = .05. 
Table 4.2 Mean SCL-90-R global severity index T-Scores at baseline & follow-up 
WL 
(n=6) 
CL 
(n=3) 
22Hz 
(n=4) 
5Hz 
(n=3) 
13Hz 
(n=7) 
Baseline Follow-up 
Mean (SD) Mean (SD) 
64.30 (9.26) 59.40 (9.47) 
69.90 (10.04) 
68.50 (10.26) 
70.33 (7.24) 
67.17 (6.78) 
62. 70 (13 .30) 
61.90 (14.52) 
64.83 (8 .13) 
58.67 (12.44) 
WL= wait list, CL = continuous light. 
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Contrary to reports, there was little to no correlation between anxiety and EEG 
measures across sessions for either local broadband EEG measures or global 
measures, r =.01, p > .05, for global theta; r = -.19 to -.11, p > .05 for global alpha; 
and r = -.08 to -.14, p > .05 for global beta. Thus the hypothesised trend, that higher 
anxiety levels would be associated with higher beta amplitudes was not found. 
Rather, correlations between anxiety and localised broadband EEG measures for 
each of the sixteen sites, tended to be small and inverse (r'"'-'-.20, p > .05), suggesting 
that anxiety was associated with a decrease in amplitude across all bandwidths. 
Likewise for depression, there was little to no correlation between depression and 
either local broadband or global EEG measures across sessions, with a tendency for 
EEG amplitude in all bandwidths to decrease as depression level increased, r = .02 to 
-.19, p > .05, for global theta; r =-.19 to .05, p > .05, for global alpha, and r = -.13 to 
.05, p > .05, for global beta. 
Depression and anxiety correlated moderately together both at baseline, r = .51, p < 
.01, and follow-up, r = .66, p < .01. Consistent with Watson and Clark (1988), 
depression was moderately negatively correlated with positive affect, r =-.59, to -.34, 
p < .01, across the four sessions, and positively correlated with negative affect, r = 
.41 to .61, p < .01, indicating that depression comprised negative affect with an 
absence of positive affect. Anxiety, on the other hand, was unrelated to positive 
affect, r = -.22 to -.14, p > .05, and strongly related to negative affect, r = .58 to .69, 
p < .01, across sessions. In addition, symptom severity correlated strongly with both 
depression, r = .78 to .80, p < .05, and anxiety, r = .70 to .80, p < .05. 
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4.10.10 Sleep and photic stimulation: At baseline, 62% of participants reported 
initial difficulty falling asleep, 72% reported difficulty falling asleep after waking 
during the night, and 58% reported waking during the night and lying awake 
worrying. Only 30% of participants reported night sweats and nightmares, which are 
symptoms consistent with high anxiety states. Most participants, 88%, reported 
waking feeling tired and 65% said they never quite got enough sleep. The majority 
of participants, 73%, reported sleep problems most nights while 20% reported 
experiencing sleep problems 'every other night'. 
It was predicted that photic stimulation at 5Hz, 13Hz, or 22Hz would improve sleep 
parameters over and above no therapy or continuous light. In particular, it was 
proposed that photic stimulation at 5Hz would be most effective for reducing sleep 
onset latency, while photic stimulation at 13Hz was expected to offer the best 
treatment for night wakings. Separate MANOV A's were computed with group (WL, 
CL, 5Hz, 13Hz, and 22Hz) as the between groups variable, and time (week 1 to 6) as 
the within groups variable for sleep onset, night wakings, sleep efficiency and 
waking mood. 
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Figure 4.17 Mean 'sleep onset latency' across six weeks of sleep diary. 
As can be seen in Figure 4.17, the WL and 13Hz groups displayed lower sleep onset 
latencies than the CL, 5Hz, and 22Hz groups at baseline, however these differences 
were not statistically significant. While sleep onset latency appears to decrease to a 
small extent over sessions, regardless of group membership, this effect was not 
significant, indicating that sleep onset latency remained relatively unchanged over 
the study period, F(5,43) = 1.74, p > .05, 112 = .17. Consistent with predictions, the 
22Hz group experienced higher sleep onset latencies than the 5Hz and 13Hz groups, 
but not lower sleep onset latencies than the WL or CL groups. These effects were 
small and non-significant, as evidenced by a non-significant session by group 
interaction, F(20,184) = .98, p > .05, 112 = .09. There was no main effect for group, 
F( 4,47) = .63, p > .05, 112 = .05. 
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Figure 4.18 Mean number of 'night wakings' across six weeks of sleep diary. 
Figure 4.18 shows that the average number of night wakings decreased for all groups 
in the first few weeks of the study with the WL group showing an increase in night 
wakings during weeks 3 and 4. This trend was supported with a significant main 
effect for time, F(5,42) = 2.55, p < .05, 112 = .23. Further exploration of this effect 
found that the mean number of night wakings was significantly less at every week 
except week 2 in comparison to baseline. This decrease in night wakings over time 
was not dependent on group membership as proposed, with 13Hz photic stimulation 
being just as effective as photic stimulation at other frequencies as revealed by a non- . 
significant session by group interaction, F(20, 180) = .68, p > .05, 112 = .07. There 
was no main effect for group, F( 4,46) = .32, p > .05, 112 = .03. 
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It was also hypothesised that photic stimulation at 5Hz, 13 Hz and 22Hz would be 
more effective at improving sleep efficiency in comparison to WL or CL. As can be 
seen in Figure 4.19 there was a general trend of improvement in sleep efficiency for 
all groups over the course of the study. This was supported with a main effect for 
time, F(5,43) = 3.21, p < .05, 112 = .27, with significant increases in sleep efficiency 
at every week post baseline. The expected pattern of effects, with the 5Hz, 13Hz and 
22Hz groups showing greater improvement in sleep efficiency during the 
experimental phase, was not supported with a small non-significant time by group 
interaction effect revealed, F(20, 184) = .93, p > .05, 112 = .09. There was no main 
effect for group, F( 4,47) = 1.12, p > .05, 112 = .09. 
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Figure 4.19 Mean sleep efficiency across six weeks of sleep diary. 
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It was predicted that those in the 5Hz, 13 Hz, and 22Hz groups would report higher 
waking mood than those in the WL, or CL groups because of expected reductions in 
sleep onset latencies and night wakings for these groups. As can be seen in Figure 
4.20, there were no differences between groups in waking mood at baseline with an 
increase in waking mood for all groups over the six weeks of sleep diary 
maintenance. This was supported with a significant main effect for time, F(S,43) = 
5.70, p < .05, 11 2 = .40, and characterised by significant increases in waking mood for 
every time period in comparison to baseline. The hypothesised pattern of effects was 
only partially supported, with all active photic stimulation groups reporting higher 
waking mood than those in the WL or CL groups. This effect was not significant, 
however, as evidenced by a non-significant time by group interaction effect, 
F(20, 184) = .54, p > .05, 112 = .06. 
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Figure 4.20 Mean waking mood across six weeks of sleep diary. 
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4.10.11 Sleep, EEG and mood inter-relationships: Correlations between sleep 
variables and EEG were small to moderate across sessions ( see Appendix L, for 
correlation matrix). Sleep onset latency failed to correlate with global theta r = -.08 
to -.01, p > .05; global alpha, r =-.15 to -.02, p > .05 ; or global beta, r =-.09 to .13, p 
< .05. Similarly, there was little to no relationship between sleep efficiency and 
global EEG, r = -.07 to .07, p > .05, for global theta; r = -.13 to -.01, p > .05, for 
global alpha; and r = -.20 to -.06, p < .05, for global beta. Number of 'night 
wakings', however, was positively correlated with global EEG measures, r = .12 to 
.26, p > .05, for global theta; r = .16, p > .05, to .31, p < .05, for global alpha; and r = 
.15, p > .05, to .30, p < .05, for global beta, indicating that number of night wakings 
was associated with increased EEG amplitude in the alpha and beta bandwidths. 
Table: 4.3 Ranges for Pearson's Correlation Coefficients for frontal, midline and 
posterior broadband EEG and sleep variables across sessions. 
1. sleep onset 
2. sleep efficiency 
3. night wakings 
4. frontal theta 
5. frontal alpha 
6. frontal beta 
7. midline theta 
8. midline alpha 
9. midline beta 
10. posterior theta 
11. posterior alpha 
12. posterior beta 
Sleep onset Sleep efficiency 
1.0 
[-.85**,-.78**] 
[-.21, -.05] 
[-.05,.06] 
[-.11,.03] 
[-.05, .14] 
[-.08, .01] 
[-.13, .10] 
[-.10, .13] 
[-.15, -.08] 
[-.17, .25] 
[-.08 , .12] 
1.0 
[-.10,.06] 
[-.10,.09] 
[-.15,.01] 
[-.19, -.08] 
[-.09, .06] 
[-.17, -.02] 
[-.19, -.04] 
[-.06, .07] 
[-.06, .02] 
[-.20, -.05] 
*significance LE .05 **significance LE .01 
Night wakings 
1.0 
[.03,.18] 
[.11,.26*] 
[-.34**,.20] 
[.10, .43**] 
[.10, .26*] 
[.10, .28*] 
[.15, .34**] 
[.22, .37**] 
[.17, .34**] 
On closer inspection, see Table 4.3, it was found that number of night wakings 
tended to correlate more strongly with mean posterior broadband EEG than with 
frontal or midline broadband EEG, suggesting that participants reported more night 
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wakings with increased posterior theta, alpha and beta amplitudes than with 
increased frontal or midline EEG amplitude. For example, at baseline, night wakings 
were significantly correlated with posterior theta, r = .33, p < .05, but not with 
frontal, r = .12, p > .05, or midline theta, r = .27, p > .05 with a similar pattern 
observed across sessions. 
Sleep variables showed only small to moderate correlations with psychological 
variables across sessions. Depression was associated with increased sleep onset with 
positive correlations between sleep onset latency and depression level at baseline, r = 
.25, p > .05, session 3, r = .32, p < .05, and follow-up, r = .22, p > .05, but not at 
session 2, r = -.10, p > .05. Thus, overall, the expected trend of disrupted sleep onset 
with increasing depression levels was found. Congruent with this finding, sleep 
onset latency correlated negatively with positive affect at session 2, r = -.31, p < .05; 
session 3, r = -.29, p < .05; and somewhat at follow-up, r = -.16, p > .05, but not at 
baseline, r = . 02, p > . 05. 
Contrary to expectations, sleep onset was unrelated to anxiety levels, r = .13 to .1 7, p 
> .05, across sessions. Interestingly, sleep onset was related to photic stimulation 
response, at session 2, r = .34, p < .01, but not at other sessions and with alpha 
asymmetry at session 3, r = .29, p < .05, but not at other sessions. Thus sporadically, 
enhanced photic driving responses and increased alpha asymmetry were associated 
with disrupted sleep onset. 
Sleep efficiency was generally unrelated to depression with small non-significant 
correlations across sessions, r = -21 to .16, p > .05. Likewise for anxiety, small non-
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significant inverse correlations were found across sessions, r = -.11 to -.07, p > .05. 
Sleep efficiency correlated with positive affect during the active photic stimulation 
period only, r = .26, p < .05, at session 2, and r = .29, p < .05, at session 3, with small 
non-significant positive correlations at baseline and follow-up. However, there was 
no relationship between sleep efficiency and negative affect, r = -.12 to .13, p > 0.5, 
across sessions. A consistent negative correlation was found between sleep 
efficiency and photic stimulation response and alpha asymmetry across sessions, 
with a significant correlation with photic stimulation response, r -.30, p < .05, and 
alpha asymmetry, r = -.29, p < .05, at session 3, but not at other sessions. 
Contrary to expectations, depression was associated with a lower number of night 
wakings at baseline as evidenced by a significant inverse correlation, r = -.28, p < 
.05. This pattern was not consistent, with near zero correlations revealed at other 
sessions. Similarly, number of night wakings was inversely related to anxiety levels 
at baseline, r = -.34, p < .05, but a near zero correlation at follow-up. Night wakings 
were unrelated to positive affect, r = .04 to .22, p > .05, and negative affect, r = -.11 
to .15, p > .05, across all sessions. 
4.10.12 Menstrual cycle and EEG: Week of menstrual cycle was ascertained at 
baseline because of the unusual positive correlation between week of menstrual cycle 
and positive affect in Study 1, suggesting increased positive affect as the luteal phase 
of the menstrual cycle progressed. The positive correlation between positive affect 
and week of menstrual cycle was not replicated in the current study, r = .08, p > .05. 
Week of menstrual cycle was also unrelated to negative affect, r = -.01, p > .05, 
depression, r = -.17, p > .05, and anxiety, r = -.17, p > .05. Unlike Study 1, week of 
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menstrual cycle was also unrelated to EEG, r = .1 0, p > .05, for global theta; r = .28, 
p > .05, for global alpha, and, r = .17, p > .05, for global beta. 
4.11 Discussion 
The main aim of this study was to assess the therapeutic utility of photic stimulation 
in the treatment of mood and sleep disturbance. As outlined in Chapter 3, depression 
can be viewed as a stress-related disorder characterised by over-stimulation of 
arousal systems and dysregulated feedback mechanisms, with dire consequences for 
the regulation of mood and sleep (Chrousos & Gold, 1992). Based on the premise 
that frequent elicitation of relaxation responses 're-trains' over-taxed arousal systems 
and helps to restore homeostasis (Benson, 1975, 1985), this study sought to test the 
ability of photic stimulation to decrease arousal and ameliorate dysphoria and sleep 
disturbance in a clinically depressed group. 
This study attempted to mimic the therapeutic setting where the therapist teaches 
relaxation skills and encourages regular home practice, in order to facilitate training 
effects which generalise beyond the practice period, because of frequent elicitation of 
relaxation responses, which then become over-learned and almost automatic (Agras 
et al., 1980; Everly & Benson, 1989). This was achieved by, providing participants 
with light masks, to take home and use on a daily basis, for a period of one month. It 
was anticipated that with practice, over-stimulated arousal systems would adapt and 
become less reactive to threat and challenge. As arousal systems normalised, it was 
hypothesised that mood, depression, anxiety, and sleep would improve over the 
course of the study, with concomitant changes in EEG functioning and decreased 
responsivity to light flicker. 
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4.11.1 EEG findings: This study supported Henriques and Davidson's (1991) 
robust finding of alpha asymmetry in depression. Participants showed greater left 
midfrontal alpha relative to right midfrontal alpha, indicating left frontal cortical 
deactivation relative to the right. Alpha asymmetry was found to be relatively stable 
over time despite improvements in mood. This was also reflected in the finding that 
alpha asymmetry was unrelated to depression level, with small, non-significant 
positive correlations found. Increasing alpha asymmetry, however, was associated 
with negative affect with significant positive correlations. Given that alpha 
asymmetry was due to an increase in left midfrontal alpha in the current study, this 
finding supports Davidson's proposal that deactivation of the left frontal cortex 
diminishes the ability to experience positive emotions and results in a preponderance 
of negative emotions. Alpha asymmetry, therefore, is a trait marker for depression 
which influences affective style and increases the risk of subsequent depressive 
episodes (Davidson, 1998b, 2001; Tomarken & Keener, 1998). In previous work, 
Davidson and colleagues found that depressives had increased left frontal alpha in 
comparison to controls, but right frontal alpha was within normal limits. In the 
current study this was not supported, with both left and right alpha magnitude 
approximately 1.5 standard deviations below the norm at baseline. 
Another characteristic of the current sample was the finding of low frontal theta and 
beta, with approximately 45 to 50% of participants showing low frontal theta, and 
30-35% displaying low frontal beta, two standard deviations or more below the 
normative database. Previous research has also found low frontal theta in depressed 
subjects accompanied by high frontal and posterior beta (Ohashi, 1994). Ohashi's 
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findings are congruent with the arousal model of depression as high beta indicates 
cortical arousal and is associated with anxiety, and low theta possibly indicating a 
diminished ability to 'switch off and relax. In the current sample, however, the 
finding of low frontal theta was not accompanied by high beta. The findings in this 
study only partially support the hyper arousal hypothesis of depression, with low 
frontal theta possibly reflecting difficulties initiating relaxation responses that in tum 
prolong sleep onset. It is possible that the sample used in the current study were not 
as 'stressed' or hyperaroused as that used by Ohashi, which would account for the 
absence of elevated beta. The presence of low frontal theta, however, is possibly a 
characteristic of the depressed and sleep disturbed sample used in this study, as 
suggested by Ohashi (1994). 
4.11.2 Brainwave entrainment: The current study showed strong evidence for 
photic driving in response to 1 0Hz photic stimulation with 72% of participants 
displaying increased amplitude in the 1 0Hz bandwidth and recruitment of the 
response across the cortex into frontal areas. Of those who did respond, 79% 
demonstrated a 50°/o or more increase in cortical alpha in response to photic 
stimulation. Given that strong entrainment responses were not found with 5Hz, 
l 3Hz or 22Hz A VS in Study 1, this supports the claim that entrainment effects are 
more likely to be found at frequencies close to occipital peak alpha frequencies 
(Niedermeyer, 1997; Silberstein, 1995b; Toman, 1941). 
In addition to entrainment responses many participants also showed clear harmonic 
responses. Forty two percent of participants showed a 50% or more increase in the 
20Hz bandwidth in response to 1 0Hz photic stimulation in occipital leads, and in 
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some people also in central and frontal leads (see Figure 4. 7b ). This is consistent 
with other research which showed harmonic effects in beta bandwidths in response to 
1 0Hz photic stimulation (Rosenfeld et al., 1997). Larger harmonic responses are 
more likely to be found when using photic frequencies close to the individual's peak 
alpha frequency (Lazarev et al., 2001), but have also been noted with 5Hz and 20Hz 
photic stimulation (Kikuchi et al., 2002). 
The presence of harmonic responses with photic stimulation complicates the use 
brainwave entrainment tools for therapeutic purposes. Entrainment at a particular 
frequency may be producing cortical changes at harmonics of the first, second, third, 
fourth and possibly higher orders (Kikuchi et al., 2002; Rosenfeld et al., 1997). For 
example, using a light flicker of 1 0Hz, with the intention of enhancing alpha rhythms 
and eliciting concomitant relaxation effects, may be offset with enhancement of beta 
rhythms within the 20Hz, 30Hz or even 40Hz bandwidths caused by harmonic 
responses which can be accompanied by increased alertness, agitation, or even 
anxiety (Walter, 1953; Walter & Walter, 1949). Prior to using brainwave 
entrainment tools, it may be necessary to assess individual responsivity to the driving 
stimulus and the extent of harmonic effects. 
While there was strong evidence for entrainment to 1 0Hz photic stimulation, 
entrainment responses to experimental frequencies were not directly assessed. 
Rather, evidence of entrainment was sought by assessing if regular daily light mask 
use produced 'carry-over effects' evidenced by increases in EEG magnitude at 
entrainment frequencies in the eyes closed EEG. There was little evidence of 
entrainment 'carry-over' effects in the data, with very small non-significant effects 
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revealed. Possible EEG training effects were present in the 5Hz group who showed 
a sharp increase in EEG magnitude in the 5Hz bandwidth after 2 weeks of light 
therapy. This effect did not persist, however, with a return to baseline levels by the 
end of 4 weeks of light therapy. All remaining groups, l 3Hz, 22Hz, CL, and 
including the WL group, who received no light therapy, also showed very small non-
significant increases in the 5Hz bandwidth across sessions. It is possible that 
participants in the photic stimulation groups showed increases in 5Hz EEG 
magnitude because of harmonic responses. Given that the control group also 
displayed increases in 5Hz EEG magnitude, however, this is not likely. 
The most likely explanation for the small increase in 5Hz EEG activity seen across 
groups is the presence of general relaxation responses or an increase in sleepiness 
both of which are associated with increased theta activity (Banquet, 1973; Corby et 
al., 1978; Dierks et al., 1989; Jacobs et al., 1996; Jacobs & Lubar, 1989; Saxby & 
Penniston, 1995; Strijkstra et al., 2003). Over the course of time as participants 
became familiarised with the EEG procedure it is quite likely they exhibited greater 
relaxation responses during recording sessions. This is further supported by reports 
by some participants of increased fatigue during the recording session, despite efforts 
to ensure that participants did not fall asleep during EEG recordings. Given that 
theta is associated with cortical deactivation and drowsiness this would also account 
for these small increases in theta EEG (Fried, 1993; Jacobs & Lubar, 1989; Sterman, 
1996). To assess if Lightmask frequencies produced photic driving responses in this 
study it would be necessary to record changes in EEG magnitude while participants 
were exposed to their Lightmask frequency, however, in order to maintain the double 
blind condition, this was not done. 
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To address this issue, at the end the study, frequency following responses to 5Hz, 
13Hz and 22Hz photic stimulation were assessed in a 15year old unmedicated female 
with mild pathology (SCL-90-R depression T-score=71, anxiety T-score=67, and 
general severity index T-score=71) and responsive to I OHz photic stimulation, in 
order to ascertain if entrainment to I OHz photic stimulation was also accompanied by 
entrainment at other frequencies, or limited to frequencies close to the peak alpha 
frequency. Using the same procedures and equipment as described above, photic 
stimulation of 5Hz, I OHz, 13Hz, and 22Hz was delivered using the Mind-Gear light 
and sound machine and EEG recorded for three minutes. 
As can be seen in Figure 4.21, the client had a dominant alpha frequency of 
approximately I OHz. Figure 4.22 shows clear entrainment responses to I OHz photic 
stimulation with an increase in EEG amplitude in the I OHz bandwidth and a clear 
harmonic response noted at 20Hz both occipitally and extending into frontal regions. 
Photic stimulation at 5Hz (Figure 4.23) shows no entrainment response in the 4-6Hz 
bandwidth, but marked harmonic responses can be seen in the I OHz and 20Hz 
bandwidths. Figure 4.24 shows clear frequency following to 13Hz photic 
stimulation with entrainment evident in the 12-14Hz bandwidth. Interestingly, 
photic stimulation at 13Hz resulted in attenuation of EEG amplitude at the sub-
harmonic level of 6.5Hz. No first order entrainment effects were seen with photic 
stimulation at 22Hz with little to no increase in EEG amplitude in the 22Hz 
bandwidth. Sub-harmonic responses were noted, however, with a small increase in 
EEG amplitude within the 9-1 IHz bandwidth in occipital leads only. 
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Figure 4.21 Spectral plot of 'eyes closed' EEG across 16 scalp sites (0-23Hz 
bandwidth with markers at 0, 10 and 20Hz) showing a lOHz dominant alpha 
frequency in a 15year old, mild to moderately depressed female, with anxiety 
symptoms. 
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Figure 4.22 Response to lOHz photic stimulation in the same 15yr old female 
showing a notable increase in 1 OHz dominant alpha frequency and clear 20Hz 
harmonic effects extending across the cortex. 
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Figure 4.23 Response to 5Hz photic stimulation in the same 15yr old female 
showing little evidence of entrainment at 5Hz, but harmonics visible at 1 OHz and 
20Hz. 
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Figure 4.24 Response to 13hz photic stimulation in the same 15yr old female 
showing entrainment in the 13-l 4Hz bandwidth, a decrease in dominant 1 OHz alpha, 
and a decrease in 6.5Hz. 
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Figure 4.25 Response to 22Hz photic stimulation in the same 15 yr old female 
showing no entrainment in the 22Hz band, but a sub-harmonic response at 1 lHz 
visible in occipital leads. 
Therefore, in a sample of one it was shown that photic driving responses occur not 
only at the dominant alpha frequency, but also at entrainment frequencies quite 
distant from the peak alpha rhythm, and with evidence of harmonic responses at 
frequencies distal from the peak alpha frequency. This is consistent with previous 
research which shows photic driving across a wide range of frequencies with 
recruitment of harmonic responses across the cortex (Mundy-Castle, 1953; Wada et 
al., 1994; Walter & Walter, 1949). Thus it is plausible in the current study that 
participants who demonstrated photic driving to 1 OHz stimulation, were also 
experiencing frequency following when using their light mask at home. Evidence 
for entrainment 'carry-over' effects following regular daily light mask use were not 
found when assessing eyes closed EEG, therefore showing that while entrainment 
) 
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effects may have been occurring during light mask use at home, they did not have an 
enduring influence on the EEG. 
Some caution needs to be exercised before generalising these findings. The data 
were collected from a 15year old mild to moderately depressed client with reported 
sleep disturbance. The age difference between this client and the sample used in the 
current study may prohibit direct comparisons as photic driving is higher in children 
and adolescents than in adults (Takahashi, 1993). In addition, while entrainment 
responses were found using the 'Mind Gear' light and sound machine in one client, it 
is possible that photic driving responses using the Lightmask may not be equivalent. 
This needs to be addressed in future research. 
Failure to find clear evidence of entrainment to Lightmask frequencies in the current 
study, may have been contributed to by harmonic effects which could have masked 
intended EEG changes at entrainment frequencies by increasing power in opposing 
EEG frequencies. Consequently, mood and relaxation effects usually associated with 
particular cortical EEG frequencies, may have been offset by enhancing EEG 
frequencies and mood effects antithetical to the desired outcome (Rosenfeld et al., 
1997). 
Evidence for the effectiveness of photic stimulation to produce immediate relaxation 
responses, however, can be found in participants' rated subjective well-being 
immediately after light mask use. Those receiving 5Hz, 13Hz, or 22Hz photic 
stimulation tended to report higher well-being than participants exposed to 
continuous light, but this effect was small and not significant. The most plausible 
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explanation for this small effect is the greater relaxation responses elicited by active 
photic stimulation in comparison to continuous light. Continuous light lacks one of 
Benson's main components for producing relaxation responses, 'a repetitive stimulus 
on which to focus'. It is plausible that participants habituated more readily to 
continuous light than to perceptible light flicker, which may hold attention and 
suspend mental activity for longer with greater opportunity to elicit relaxation 
responses before habituation occurs. These findings are consistent with previous 
research which showed that photic stimulation produces immediate relaxation 
effects, but does not have enduring long term effects on psychological state 
(Ossebaard, 2000). 
4.11.3 Mood and sleep: Mood improved significantly across sessions for all groups 
with strong placebo and non-specific effects contributing to results. In the current 
study it was anticipated that improvements in mood would be evident firstly because 
of the influence of expectancy effects, which were manipulated to produce positive 
expectancies, and secondly, as a function of the different photic stimulation 
frequencies used. Positive affect, negative affect, depression, anxiety and symptom 
severity all changed in predicted directions, but largely independently of the photic 
stimulation frequencies used. Specifically, positive affect increased for all groups 
over the course of the study, including the waitlist group who received no 
intervention. Correspondingly, negative affect decreased for all groups over the 
study period. The observed effects of increased positive affect and decreased 
negative affect with l 3Hz stimulation over and above the other frequencies of 
stimulation, which was found in Study 1, was not repeated. Similarly, the 
hypothesised greater increases in positive affect and decreases in negative affect, 
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attributable to active photic stimulation in comparison to WL and CL, was not found 
as all groups performed in a similar manner. In addition, it was anticipated that 
depression and symptom severity would decrease over the course of the study for all 
groups, with greater improvement in participants using active photic stimulation. 
While all groups showed improvement in depression and symptom severity over the 
study period, photic stimulation contributed little to these effects. 
Likewise, for anxiety, all groups showed significant decreases in anxiety from 
baseline to follow-up. It was anticipated that 5Hz photic stimulation would benefit 
high anxiety participants, while 22Hz photic stimulation would benefit those with 
low anxiety. In the current study, however, different frequencies of photic 
stimulation did not preferentially influence high or low anxiety levels as predicted. 
Therefore entrainment effects were not responsible for the decrease in anxiety levels 
observed, rather, relaxation responses coupled with strong placebo and non-specific 
effects appear to have played a significant role. 
These findings are consistent with previous research which found placebo to be as 
effective as active treatment using mind-machines in its ability to induce relaxation 
responses (Walach, 1998). In Walach's study, the use of a sophisticated mind 
machine may have been sufficient to elicit strong placebo responses from users, 
despite no active treatment. Similarly in the current study, the use of the light mask 
may have induced placebo effects. Contrary to this, however, is the finding that even · 
the waitlist group improved over time with similar enhancements in mood and 
decreases in depression and anxiety as the active and placebo groups. This suggests, 
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therefore, that while light mask use may have elicited beneficial placebo effects and 
possibly some subtle relaxation effects, other non-specific effects were also present. 
A similar picture emerged for sleep. Sleep improved over the course of the study 
with a decrease in number of night wakings, improved sleep efficiency and waking 
mood, but no change in sleep onset latency for all groups. These changes however, 
were largely independent of group membership, with those in the WL and CL groups 
reporting improvements in sleep similar to the active photic stimulation groups. 
There were some patterns of response with regard to sleep that could potentially be 
related to entrainment effects. For example, 5Hz photic stimulation decreased sleep 
onset latency from 46 minutes at baseline, to below 3 0 minutes for the entire 
intervention phase, which is under that recommended for clinical significance (Epsie, 
2002), with a return to baseline measures by follow-up. Unexpectedly, CL also 
reduced time to sleep onset to below clinical levels after one week of use with a 
persistence of the effect to follow-up. It is possible that the latter response was due 
to entrainment effects caused by sub-harmonic responses to 64hz stimulation that 
impacted on the EEG at lower frequencies and, in tum, reduced sleep onset in a 
manner similar to 5Hz stimulation. This assertion is difficult to sustain, however, 
with the finding that waking mood was higher in the active photic stimulation groups 
in comparison to WL or CL, possibly due to photic driving responses influencing 
aspects of sleep quality that were not directly assessed in this study, but that 
nevertheless impacted on waking mood. The finding of a marked decrease in sleep 
onset latency with 5Hz photic stimulation with little to no change afforded by 13Hz 
or 22Hz stimulation further supports the view that frequency following may be 
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involved, as increasing theta activity ( 5Hz photic stimulation) is conducive to sleep 
initiation. 
An alternative explanation, however, is that both CL and active photic stimulation 
produce relaxation and entrainment effects, with active photic stimulation producing 
greater relaxation effects than CL which consequently impacts to a greater degree on 
waking mood. Entrainment initiated by 13Hz or 22Hz photic stimulation would 
produce relaxation effects as demonstrated in Study 1, but would also act to increase 
cortical arousal, and drive the cortex away from slow theta oscillations which are 
necessary for sleep initiation; and therefore work in opposition to relaxation effects 
and have little impact on sleep onset. While these conclusions offer some support 
for the presence of relaxation and entrainment effects with photic stimulation, they 
were drawn from non-significant trends, based on inferences within the data and 
without direct evidence of entrainment with Lightmask use. 
Confounding the interpretation of results is the finding that even the WL group 
demonstrated improvement in mood, depression, anxiety and sleep similar to that 
seen in the other groups. This points to the presence of other non-specific effects. 
For example, all participants visited a psychologist in the psychology department at 
the local hospital four times over the course of 3 months, with at least 6 hours of 
contact time with a professional. Since 48% of the sample reported, at initial 
interview, that they were currently seeing a health professional for their depression, it · 
can not be ruled out that the building of a therapeutic alliance with a health 
professional over the course of the study may have contributed to the improvements 
noted (Ilardi & Craighead, 1994; Mayberg et al., 2002). Further to this point, there 
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was no difference between groups for professional help seeking behaviour, therefore 
the effect observed in the wait-list group cannot be attributed to initial lower health 
professional contact which may have been ameliorated by study participation. 
In addition, all participants were required to maintain sleep diaries for six weeks over 
a 3 month period, and completed mood questionnaires four times over this period, 
thus highlighting to participants the extent of their sleep and mood problems. Some 
participants reported that merely noting sleep patterns and becoming aware of their 
daily mood, was sufficient to motivate behaviour change and improve lifestyle 
factors related to mood and sleep hygiene. These ad hoc reports suggest that diary 
keeping was sufficient to motivate some people to change aspects of depressive 
behaviour which consequently impacted on mood and sleep. Within a stress and 
coping model, diary keeping can be viewed as a problem focussed coping strategy 
providing participants with a course of action which enables them to better cope and 
adapt with the stress of depression (Lazarus & Folkman, 1984). Successful 
adaptation also increases self-efficacy and enhances positive expectancies which 
foster hope that 'things will get better' (Bandura & Adams, 1977; Lazarus, 1991a). 
Requiring participants to attend a health setting for the experiment can also elicit 
positive expectancies and generate hope that help is being sought and recovery will 
ensue (Frank, 1973, 1982b; Ilardi & Craighead, 1994). Expectancy and placebo 
effects are well noted in clinical research and have been shown to induce therapeutic 
effects in psychological and physiological parameters and even produce responses 
similar to those induced by active pharmacological treatment (Leuchter, Cook, Witte, 
Morgan, & Abrams, 2002; Mayberg et al., 2002; Schatzberg & Kraemer, 2000). 
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4.11.4 Photic stimulation, EEG, mood and sleep inter-relationships 
As previously noted, photic driving response to 1 OHz photic stimulation was found 
in a substantial proportion of the sample, but contrary to previous research, it was 
found to be independent of depression level. Frequency following responses did not 
decrease over the course of the study as purported by Pockberger (1985). Instead, 
they behaved in a more stable manner across time possibly reflecting a trait like 
aspect of depression. Other research has reported higher frequency fallowing 
responses with alpha stimulation in individuals with low alpha power and attenuated 
responses in those with high alpha power (Rosenfeld et al., 1997). This is somewhat 
congruent with early work by Shagass (1955) who found high anxiety, depressed 
females, possibly with low alpha power, had higher photic driving responses in 
comparison to low anxiety depressed females, most likely with higher alpha power. 
Similarly, Kumano (1997) found that physiologically and emotionally reactive 
subjects, indicating heightened arousal, also showed higher photic driving responses 
in comparison to more stable subjects. In the current study, however, there was no 
correlation between heightened arousal, as indicated by anxiety, and photic 
stimulation response, nor photic stimulation and alpha power (see Appendix L). In 
contrast, however, photic stimulation was inversely related to sleep and subjective 
relaxation. Those with higher photic stimulation responsivity reported feeling less 
relaxed, had higher sleep onset latencies, and poorer sleep efficiency suggesting that 
some form of physiological arousal was involved and related to photic driving 
responsivity as indicated by previous research. 
Previous research has found a relationship between anxiety and psychological 
distress and increased cortical activity such as beta rhythms which reflect increased 
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arousal (Matousek, 1991; Nofzinger et al. , 2000; Nystrom et al., 1986). In the 
current study, however, increasing pathology, such as depression, anxiety and 
symptom severity tended to be associated with a decrease in amplitude across all 
bandwidths, with a decrease in theta, alpha and beta amplitude for depression and 
symptom severity, and attenuated alpha and beta amplitude for anxiety, as evidenced 
by small non-significant correlations. This decrease in EEG amplitude with 
increasing pathology reflects the findings ofNandrino (1994) who found that 
depressive individuals have less complexity in their EEG in comparison to their 
never depressed counterparts, with increasing stability or loss of variation with 
increasing number of depressive episodes. N andrino argues that a healthy cortical 
system is chaotic and complex in nature and therefore able to adapt when required, 
whereas the increased stability found in the EEG of depressives reflects underlying 
pathology and is associated with maladaptive behaviours such as ruminative thinking 
and psychomotor retardation (Nandrino et al., 1994; Pezard & Nandrino, 2001). 
Significant correlations between depression and sleep were found. Increasing 
severity of depression was associated with delays in sleep onset as expected. 
Unexpectedly, the number of night wakings decreased as depression deteriorated, yet 
sleep efficiency remained compromised as evidenced by small inverse correlations 
between sleep efficiency and depression. Therefore this small decline in sleep 
efficiency was not due to an increase in nigh time waking, but rather related to 
difficulties with sleep onset or early morning waking. These findings are consistent 
with the hyper-arousal hypothesis of depression wherein increased physiological and 
cognitive arousal leads to disrupted sleep wake cycles and delays in sleep onset. A 
further symptom of dysregulated arousal in depression is the advance in the timing of 
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nocturnal cortisol secretion that leads to early morning waking and difficulties 
returning to sleep after waking, contributing to sleep loss and further compromising 
sleep efficiency (Wallace, 1996). In the current study, a significant positive 
correlation was found between night time waking and global alpha and beta. This 
adds further support to the hypothesis that arousal mechanisms play a role in sleep 
disruption in depressed individuals, as those with higher alpha and beta amplitude 
reported increased night time waking, which contributes to disruption of sleep 
continuity. 
Study 1 revealed the unexpected finding of increased positive affect as menstrual 
cycle progressed. In the current study, however, menstrual cycle was unrelated to 
positive affect and all experimental variables. This finding is not surprising given 
the small number of subjects used to calculate these statistics (n=23), coupled with a 
limited range of variability due to the use of a depressed sample. A small, almost 
significant positive correlation was found between menstrual cycle and alpha, 
indicating an increase in alpha activity, or increased cortical deactivation as the luteal 
phase of the menstrual cycle approached. 
4.12 Limitations of the study 
A limitation of the current study was the inability to assess if the CL group, receiving 
64Hz continuous light, were in fact a placebo control and unaffected by light flicker, 
or conversely, experiencing photic driving induced by lower order harmonics at 
3 2Hz 16Hz or even 8Hz stimulation. While 64 Hz is beyond the flicker fusion 
' ' 
point, some studies report EEG responses to higher frequencies caused by sub-
harmonics (Takahashi, 1993). For example, some light sensitive epileptics are much 
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more likely to show paroxysmal EEG spikes to a 50Hz video monitor than a 1 00Hz 
video monitor because of the 25Hz harmonic produced by the 50Hz monitor 
(Badinand-Hubert et al., 1998; Harding, Fylan, & Edson, 1997). Fluorescent 
lighting, which flickers at ,.., 50Hz, has also been shown to impact on the EEG by 
attenuating alpha rhythms and found to increase arousal and decrease performance in 
some individuals (Kuller & Laike, 1998). Future research needs to assess the impact 
of lower order harmonics, not only on the EEG, but also on mood and sleep 
parameters. It is possible in this study that some of the effects associated with CL 
can be attributed to harmonic effects. 
A further limitation of the current study was the inability to directly assess 
entrainment responses to the take home Lightmasks participants used. As outlined 
above, in order to maintain the double blind condition, the experimenter doing the 
EEG was not able to assess frequency following responses to the Lightmask without 
risking exposing the frequency allocations. To my knowledge there is no published 
data assessing photic driving responses in the EEG in response to Lightmask 
stimulation. Previous research, however, has shown that greater entrainment 
responses are found with red light (Carterette & Symmes, 1952; Takahashi, 
Tsukahara, & Kaneda, 1981) and can be induced with light intensities as low as 10 
Lux (Kumano et al., 1997). Given that in this study, using a sample of one, that clear 
first order and harmonic photic driving responses were demonstrated in response to 
experimental frequencies, then it is highly probable that the light masks used in this 
study exerted entrainment effects. This in tum helps to explain some of the subtle 
differences that were found in the active photic stimulation groups in comparison to 
CL orWL. 
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4.13 Conclusions 
This study explored the effectiveness of photic stimulation in the treatment of mood 
and sleep disorder. The results revealed significant decreases in depression, anxiety, 
and symptom severity accompanied by improvements in sleep efficiency and 
decreased number of night wakings for all groups over the course of the study. 
These significant clinical improvements, however, cannot be attributed to re-training 
of arousal systems induced by frequent elicitation of relaxation responses as 
hypothesised, as symptom reduction occurred in all groups. Contrary to 
expectations, the placebo and wait list groups did as well as the active experimental 
groups with very limited evidence to indicate that photic stimulation contributed to 
these improvements over and above relaxation responses, positive expectancies and 
other non-specific effects. 
These findings are consistent with many studies which demonstrate the potency of 
placebo effects to produce changes in emotional and physical processes (Butler & 
Steptoe, 1986; Leuchter et al., 2002; Mayberg et al., 2002). In addition, placebo 
responses in clinical studies for depression are quite high, with up to 65-80% of 
treatment effects obtained with active antidepressant medication able to be 
reproduced using placebo (Kirsch, 2000). Typically, up to 30-40% of depressed 
subjects show clinical improvement in response to placebo alone (Brown, Dornseif, 
& Wernicke, 1988), with placebo capable of maintaining clinical remission for up to 
2years (Kirsch, 2000). Other research has shown that effective placebo treatment 
produces demonstrable changes in brain functioning similar to that obtained with 
active treatment (Leuchter et al. , 2002; Mayberg et al., 2002). The warmth and 
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enthusiasm of the therapist can also contribute to placebo effects, and has been 
shown to greatly enhance relaxation responses in study participants (Bench, 2001 ). 
Furthermore, stronger placebo responses are usually found in less severely depressed 
subjects without long term chronicity, not unlike the sample used in the current study 
(Rush, 2000). 
Clinical studies inherently contain many non-specific elements, pertaining to the 
participant, the experimenter, and the therapeutic setting, which impact on treatment 
outcomes (Orne, 1962). According to Frank (1973, 1982, 1982b) psychotherapy and 
clinical research include common features that help to ameliorate the psychological 
suffering of the client. They provide a therapeutic setting conducive to healing; a 
supportive therapist equipped with 'expert knowledge'; a very convincing rationale 
regarding the efficacy of treatment and expected outcomes; and a set procedure 
through which to operate. Frank asserts, that these factors function to facilitate 
treatment outcomes by enhancing client self-efficacy, instilling hope for successful 
treatment, and eliciting positive expectancies, and thereby maximising the impact of 
placebo responses. This is congruent with the current study, which provided a 
"healing setting", a trained clinician, a set procedure, a convincing rationale, the 
manipulation of positive expectancies, and the building of a therapeutic alliance over 
a three month period. 
In the current study, it was anticipated that the various frequencies of stimulation 
would exert differential effects on mood and sleep that would be evident over and 
above positive expectancies and placebo responses. This was not found. The only 
evidence to indicate that photic stimulation may have been more effective than wait-
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list or placebo (CL), were some small non-significant trends in predicted directions. 
In summary, photic stimulation at 5Hz, 13Hz, or 22Hz enhanced well-being and 
improved waking mood to a small degree over and above exposure to continuous 
light. Furthermore, 5Hz photic stimulation appeared to reduce arousal, decreasing 
sleep onset latency, depression and increasing positive affect more than other 
frequencies to a small degree. 
This naturalistic study attempted to reproduce the therapeutic setting by providing 
participants with a take home light mask in order to maximise treatment effects and 
enhance compliance. When imitating the 'real life' situation, however, it is difficult 
to control the interplay of multiple factors that contribute to treatment outcomes, 
even when controlling for placebo and expectancy effects. There was little evidence 
in this study of enduring entrainment effects that could be attributed to Lightmask 
use as hypothesised. Rather, it appears that relaxation effects, coupled with strong 
positive expectancy effects, and non-specific factors, such as demand characteristics 
and the development of a therapeutic alliance, contributed to recovery, possibly by 
increasing self-efficacy and enhancing problem-focused coping (Bandura, 1977; 
Frank, 1982a; Lazarus, DeLongis, Folkman, & Gruen, 1985). In general, the 
findings of this study highlight the need for clinicians and researchers to be aware of 
the powerful impact of placebo and non-specific therapeutic effects and their ability 
to change behaviour and produce clinical recovery, and that they can be utilised in 
therapy to maximise treatment outcomes (Frank, 1982a, 1982b; Walach & 
Sadaghiani, 2002). 
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CHAPTERS 
'Conclusions and future directions' 
5.1 Introduction 
Stress is pervasive and can not be avoided in day to day life (Selye, 1976). Under 
normal circumstances it is not the amount of stress that we face that impairs coping 
capacity, but rather it is our appraisal of the degree of threat and challenge that is 
present which leads to stress responses (Lazarus et al., 1985; Morin et al., 2003). In 
healthy organisms, adaptation occurs when perceived stress is successfully managed, 
by summoning and using available resources, so that the perceived threat to the self 
is removed or reduced, and physiological stress responses abate (Lazarus, 1991 b, 
1993; Lazarus et al., 1985). 
In stress related disorders, such as Major Depressive Disorder (MDD), however, 
which are defined by dysphoria and a negative thinking style (Bisno, 1985; 
McDermut, Haaga, & Bilek 1997), there is a greater tendency to appraise daily 
stressors and hassles as threatening (Lazarus, 1991 b ), which results in more :frequent 
stimulation of arousal systems and leads to an escalating cycle of dysregulation 
(Chrousos & Gold, 1992; Gold et al., 1988; Post, 1992). As a consequence, 
circulating stress hormones become chronically elevated. This disrupts normal 
homeostatic regulation, and has deleterious effects on mood, cognition, behaviour, 
circadian and diurnal regulation of sleep-wake cycles, and appetitive functions, 
which can culminate in severe impairment of daily functioning. 
As discussed in Chapter 3, depression is the biggest contributor to loss of 
productivity and personal suffering in the developing world, and is predicted to 
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increase to epidemic proportions by 2020, with huge costs to society (Brunello et al., 
2000; Murray & Lopez, 1997; Murray & Lopez, 1996b ). Depression exacts further 
costs to society as it increases the risk of early death and is a major risk factor in the 
development of cardiovascular disease (Wulsin, Vaillant, & Wells, 1999). Sleep 
disturbance is commonly co-morbid with depressive disorders, reflecting the degree 
of dysregulated arousal, and further contributes to personal suffering (McCrae et al., 
2003; Okuji et al., 2002), and increases the risk of mortality for older individuals 
(Dew et al., 2003). There is an urgent need, therefore, for health initiatives to curtail 
this global rise in depression in order to lessen the burden of disease. 
Contemporary models of depression consistently highlight the involvement of 
arousal systems and their role in maintaining depressive symptomatology (Chrousos 
& Gold, 1992; Everly & Benson, 1989). In support of the arousal hypothesis, 
successful antidepressant treatment has been shown to exert its effects by 
normalising arousal systems and restoring sleep quality (Barden et al., 1995; 
Kasckow et al., 2001; Riemann et al., 2001 ). Newer antidepressant treatments 
directly target arousal systems and act to dampen stress responses in order to achieve 
their antidepressant effects (Wolkowitz & Reus, 1999; Zobel et al., 2000). Some 
people, however, find antidepressant treatment intolerable because of unwanted side 
effects, or are unable to take antidepressants because of pregnancy or medical illness, 
and turn to alternative treatments. Relaxation therapy is a widely accepted treatment 
for stress-related disorders and has been shown to improve long term treatment 
outcomes when combined with behaviour therapy and problem focussed 
psychotherapy in the treatment of depression (Krampen, 1999). 
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Relaxation responses are antithetical to stress reactions as they produce physiological 
responses that are in direct opposition to stress responses. As outlined in Chapter 3, 
stress appraisals activate both the hypothalamic-pituitary-adrenal axis (HP A) and the 
release of norepinephrine from the locus ceoruleus (LC/NE) in the brainstem, in 
order to mobilise adaptive behaviours necessary to cope with the perceived stress. 
Specifically, activation of the HP A system leads to the release of corticotrophin 
releasing hormone ( CRH) from the para ventricular nucleus (PVN) in the thalamus, 
which in tum stimulates the release of adrenocorticotrophin hormone (ACTH) from 
the adenohypophysis. Adrenocorticotrophin hormone targets the adrenal cortex and 
stimulates the release of stress hormones, such as glucocorticoids or cortisol, into 
general circulation. Simultaneously, an immediate alarm reaction is triggered as 
norepinephrine is released into the bloodstream. As a result, heart rate increases, 
respiratory rate quickens and breathing becomes shallow, oxygen consumption and 
metabolic rate increase, and blood flow is redirected to skeletal muscles in readiness 
for 'fight or flight' (Selye, 1976). Accompanying these physiological changes are 
feelings of anxiety, apprehension and worry, and increased mental vigilance. 
Frequent elicitation of relaxation responses has been shown to readjust over-reactive 
stress responses by favouring activation of inhibitory parasympathetic inputs and 
dampening HPA activity (Everly & Benson, 1989; Lehrer et al., 2000; Vaschillo et 
al., 2002). 
Relaxation responses can be induced by various methods, such as progressive muscle • 
relaxation (Matsumoto & Smith, 2001; Scheufele, 2000), mental quieting (Benson, 
197 5), photic stimulation (Brauchli, 1993; Morse, 1993 ), or voluntary control of 
breathing, which directly impacts on parasympathetic activity (Vaschillo et al., 
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2002). Benson (1975) defined the necessary criteria common to all relaxation 
methods: the creation of a 'quiet space' free from interruption, the taking up a 
comfortable position which is conducive to the release of muscle tension, the use of a 
repetitive word, phrase, or stimulus, designed to focus the mind and distract it from 
internal dialogue, and above all, the adoption of a 'passive attitude' in order to 
achieve mental quieting. In contrast to stress responses, relaxation responses 
decrease heart rate, blood pressure, respiratory rate, and oxygen consumption, cause 
peripheral vasodilation, promote the redirection of blood flow for digestive and 
sexual functions, and are usually accompanied by increased well-being and feelings 
of 'warmth', and 'peacefulness' (Ford et al., 1982; Smith et al., 1996). Frequent 
elicitation of relaxation responses has been shown to create 'training effects' which 
blunt reactivity to stressful stimuli (Lucini et al., 1997) and permanently alter mood 
and physiological functioning, to produce a generalised decrease in arousal (Agras et 
al., 1980; Ford et al., 1982; Krampen, 1999; Matsumoto & Smith, 2001; Rosen et al., 
2000). 
Photic stimulation has been shown in this research, and in previous studies (Brauchli 
et al., 1995; Morse, 1993; Ossebaard, 2000), to reliably induce relaxation responses 
quickly and effortlessly. Photic stimulation satisfies all of Benson's criteria for 
inducing relaxation responses. For example, repetitive light flicker provides a 
stimulus to distract and focus the mind. The wearing of goggles, and headphones if 
using audiovisual stimulation, act to create a personal space, and reduce 
environmental influences. In addition to traditional relaxation techniques, photic 
stimulation utilises specific frequencies of stimulation designed to 'lull' the brain into 
states conducive to deep relaxation. As a consequence, muscle tension decreases as 
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relaxation responses are quickly and easily induced, while novel and repetitive light 
stimuli help to maintain the relaxed state. Photic stimulation also creates altered 
states of consciousness typically associated with states of deep relaxation (Mundy-
Castle, 1953; Walach, 1998). Unlike most relaxation therapies, however, photic 
stimulation is a passive therapy, is easy to use, and requires no prior learning in order 
to be effective. For these reasons, photic stimulation was predicted to be more 
effective than traditional relaxation therapies for a group of depressed individuals, in 
whom difficulties with motivation and compliance are common. 
This thesis draws upon a strong foundation of research which shows that photic 
stimulation produces photic driving responses in the cortex and can be used to alter 
cortical activity (Silberstein, 1995b; Toman, 1941; Walter & Walter, 1949). It also 
rests on a large body of EEG research providing evidence that different EEG 
rhythms reflect different levels of cortical activity, and are often related to specific 
mood states (Basar et al., 1997; Brown, 1970; Hinrichs & Machleidt, 1992; Steriade 
et al., 1990; Sterman, 1996). The underlying assumption in this thesis is that 
different frequencies of photic stimulation could be used to create specific EEG 
patterns that in tum, produce related mood and physiological changes. It was 
anticipated that frequent, long term exposure to entraining stimuli would produce 
EEG training effects which would be evident as increases in EEG power at 
entrainment frequencies, with enduring and beneficial effects on mood and sleep. 
This research explored the use of brainwave entrainment techniques, and their 
capacity to influence mood and reduce stress. It adds to previous research as it 
explored the clinical utility of brainwave entrainment, not just its immediate impact 
on arousal and mood, which has been extensively explored (Brauchli et al., 1995; 
Dieter & Weinstein, 1995; Morse, 1993; Mundy-Castle, 1953). Using a clinical 
paradigm, two studies tested the effects of regular exposure to auditory and photic 
stimulation, over an extended period of time, on emotional and physiological 
regulation. 
5.2 Study 1 
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Study 1 addressed the preliminary question, 'whether brainwave entrainment is 
superior to well established relaxation therapy'. It also explored the effects of 
particular frequencies of audiovisual stimulation (A VS) on mood and arousal in a 
non-clinical sample. Consistent with previous research, A VS quickly produced 
decreases in physiological arousal (Morse, 1994b; Morse & Chow, 1993; Ossebaard, 
2000), and was found to be equally as effective as autogenic relaxation at inducing 
relaxation responses. In this study, however, even the placebo group demonstrated 
relaxation responses. Therefore, sitting quietly for 20 minutes, with eyes closed, and 
wearing eye glasses and headphones, but with no stimulation, induced relaxation 
responses, possibly because they provided most of the necessary requirements for 
relaxation outlined by Benson (1975). Photic and auditory driving responses were 
found, and evidenced by moderate effect sizes, however, their detection was 
hampered because of low statistical power. 
These moderate entrainment effects showed that audiovisual stimulation at 5Hz 
tended to increase EEG magnitude within the 12-14 Hz bandwidth, while stimulation 
at 22Hz tended to increase energy within the 4-6Hz bandwidth, most likely due to 
harmonic and sub-harmonic responses. Published research using this data and 
186 
applying a non-linear dynamic model, also found entrainment like responses with 
22Hz stimulation, but not at the other frequencies (5 & l 3Hz) (Gregson & Leahan, 
2003). Gregson and Leahan (2003) found that 22Hz A VS intermittently captured the 
EEG, possibly because of the presence of sub harmonic influences operating closer 
to the dominant frequency. In addition, Study 1 found that autogenic relaxation 
tended to decrease theta activity across sessions, possibly due to the increased 
cortical activity necessary to process the taped instructions. 
Mood effects were also present, with trends in predicted directions. Audiovisual 
stimulation at 13Hz tended to increase subjective relaxation, and enhance positive 
affect, after a number of sessions, while stimulation at 22Hz tended to increase 
physiological arousal, and decrease positive affect. As anticipated, negative affect 
was positively associated with indices of arousal and beta activity, thus supporting 
earlier work (Bonnet & Arand, 2001; Lim et al., 1996; Nofzinger et al., 2000). Of 
interest in this non-clinical sample, however, were the findings of significant 
reductions in depression and anxiety symptoms over the course of the study, thus 
indicating that brainwave entrainment had the potential to be an effective treatment 
for depression and arousal disorders. In Study 2 it was anticipated that using a 
clinically depressed sample, with predicted hyper-arousal and accompanying 
dysphoria, would reveal stronger treatment responses, as the group had more to gain, 
and much greater room for improvement. 
5.3 Study 2 
Study 2, extended the findings of study 1, by using a clinically depressed sample, 
who were hypothesised to be hyper-aroused with disturbed autonomic regulation, 
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which was reflected in the presence of comorbid sleep disturbance. It also improved 
on previous research by including a control group, plus a sham condition, the use of 
a double blind procedure, and random allocation of participants to experimental 
conditions. Study 2 differed from the first study, in that it attempted to mimic the 
therapeutic setting, by providing participants with a Lightmask to use at home, for 20 
minutes a day, for a period of one month. It was anticipated that this would 
maximise exposure to entrainment frequencies and relaxation responses, and 
therefore, facilitate training effects that would be evident as enduring changes in 
mood and EEG. 
Study 2 supported Davidson's model of frontal cerebral asymmetry and emotion, 
with the finding of increased left midfrontal alpha, relative to the right, in a 
depressed sample. Davidson postulated that frontal cerebral asymmetry is a diathesis 
for negative affect and cognitive style, and a trait marker for depression (Davidson, 
1998a). Specifically, he proposed that the left frontal cortex is involved in pleasure-
seeking or approach type behaviours, while the right frontal cortex is involved in 
withdrawal behaviours and associated with emotions of fear, anxiety, and disgust 
(Davidson & Henriques, 2000; Tomarken et al., 1992). Increased left frontal alpha 
activity indicates deactivation in this area, and therefore, a diminished ability to 
experience positive emotions, and a predisposition towards negativity (Davidson & 
Henriques, 2000; Henriques & Davidson, 1990, 1991 ). 
Study 2 also showed that photic stimulation contributed to improvements in sleep, 
and possibly mood, to a small degree, but unfortunately these effects were 
indistinguishable from a background of significant treatment effects elicited by non-
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specific factors such as demand characteristics, therapeutic effects, and placebo 
responses. As discussed in Chapter 4, depression research is plagued by the presence 
of significant placebo responses, especially when mild to moderately depressed 
samples are used, as was the case in this study (Brown, 1994; Keck, Welge, 
McElroy, Arnold, & Strakowski, 2000; Kirsch, 2000). Research assessing the 
effectiveness of psychotherapy for depression shows that a large proportion of 
treatment responses are obtained in the first few weeks of therapy, before the crucial 
elements of the therapy have been presented (Ilardi & Craighead, 1994, 1999). 
Clearly, placebo and non-specific factors contribute to treatment outcomes, with 
'early responders' able to maintain treatment gains over time (Haas, Hill, Lambert, & 
Morrell, 2002). The current study is consistent with these findings, with a substantial 
drop in depression levels after only 2 weeks of photic stimulation and sleep diary 
maintenance, which was sustained until follow-up some 10 weeks later. 
In summary, both studies showed that brainwave entrainment reliably produced 
immediate relaxation responses contingent on stimulus presentation. The finding of 
additional training responses, with enduring effects on EEG and mood, which would 
be necessary to validate the use of brainwave entrainment in clinical therapy, were 
not found. These studies are consistent with previous research which found · 
brainwave entrainment to be an effective short term anxiolytic, but unable to produce 
long term changes in physiological arousal, and emotion regulation (Ossebaard, 
2000; Walach, 1998). 
Both studies elicited strong placebo responses. As outlined in Chapter 4, Frank 
(1973, 1982a, b) proposes that clinical therapy fosters placebo responses by 
189 
providing a caring therapist, a 'healing setting', a convincing treatment rationale, and 
a 'ritual' or set of predictable procedures. Both studies provided these features, 
which, plausibly, contributed to treatment outcomes. In addition, photic stimulation 
and EEG recording, both of which use sophisticated equipment, may also elicit 
potent demand characteristics and contribute to placebo responses (Ho et al., 1988). 
Other research shows that therapeutic touch effectively produces relaxation 
responses (Gordon, Merenstein, D'Amico, & Hudgens, 1998; Meehan, 1998; 
Wilkinson et al., 2002). Other studies, however, found no additional effects 
contributable to therapeutic touch (Engle & Graney, 2000; Shiflett, N ayak, Bid, 
Miles, & Agostinelli, 2002). Given that both studies included EEG measures, which 
involved considerable touching of the scalp, this may have contributed to placebo 
responses. Furthermore, in study 2, which demonstrated stronger placebo responses 
than study 1, participants were required to keep sleep diaries for up to 6 weeks. For 
some participants, diary keeping made depressive and sleep symptoms more salient 
and led to changes in behaviour, which impacted on treatment recovery. According 
to Ilardi and Craighead (1994) homework can help to increase self-efficacy, which in 
tum contributes to clinical recovery. 
5.4 Using placebo to treat depression 
An obvious conclusion from this research is that placebo responses are potent 
treatment tools. Most clinical research such as this attempts to disentangle placebo 
and treatment effects, by anticipating that treatment responses will be detectable over 
and above placebo effects. Small to moderate treatment effects are difficult to detect 
when placebo effects are large, which often occurs in studies assessing therapies for 
depression, and particularly if studies lack statistical power, as was the case in this 
research (Schatzberg & Kraemer, 2000). It has been suggested, however, that 
placebos are active agents that can be used in the therapeutic setting to maximise 
treatment outcomes and should not be discarded as peripheral an unimportant 
(Bench, 2001; Brown, 1994; Frank, 1982a; Goldberg, Weller, & Blittner, 1982; 
Walach & Sadaghiani, 2002). In study 1, however, the entrainment responses that 
were present, emerged alongside placebo responses, despite a methodology which 
acted to conceal them. 
5.5 Limitations of the research 
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Study 1 may have been limited in its ability to detect entrainment responses, because 
of the montage used. Sequential or bipolar montages are superior for filtering out 
interference, such as environmental noise, which impacts simultaneously across 
active electrodes and is rejected from the EEG recording because of common mode 
rejection (Kaiser, 2000; Niedermeyer, 1993; Rosenfeld, 2000). If auditory and 
photic driving occurred in Study 1, with recruitment of responses across the cortex, it 
would increase synchrony across sites, thus affecting the cortex in a more global 
manner. As a consequence, there would be an increase in common activity between 
active electrode sites, and because of common mode rejection, much of the response 
would be cancelled out. Despite this, there was evidence of entrainment occurring in 
Study 1, with moderate non-significant interaction effects showing enhanced activity 
in the 22Hz and 13 Hz bands in response to 22Hz A VS. The fact that entrainment 
effects were present at all is testimony that A VS did indeed produce entrainment 
effects in Study 1, which were possibly higher than the data suggest in order for them 
to be detected at all. 
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Study 2 addressed these issues and maximised the potential to detect entrainment 
responses by using a referential montage with a linked ears reference, which more 
accurately reflects activity at individual electrode sites (Davidson, 1998b; Kaiser, 
2000). As a result, very clear photic driving responses were noted, often with 
harmonic effects, in response to 1 0Hz stimulation. This study did not support 
Pockberger's (1985) assertion that photic driving responses are positively related to 
depression severity, and attenuate on recovery. Rather, photic driving response was 
unrelated to depression level and negative affect, but appeared to be related to some 
aspects of physiological arousal. For example, enhanced photic driving response 
was associated with difficulties with sleep initiation, and decreased sleep efficiency, 
both of which are accompanied by hyper-arousal. 
A limitation of Study 2 was the inability to directly assess physiological arousal. It is 
possible that the sample chosen was not as hyper-aroused_ as predicted, despite the 
presence of sleep disturbance, which is often comorbid with depression because of 
increased nocturnal cortisol secretion (Nofzinger et al., 2000). This was supported 
by the finding of low amplitude beta in many participants, but not supported by the 
high level of comorbid anxiety, which suggests that substantial levels of arousal were 
indeed present. 
Further to this point, in Study 2, photic stimulation enhanced waking mood to a small 
degree over and above continuous light, thus indicating that photic stimulation 
affected some aspect of sleep that was not directly assessed in the study. It is 
possible that photic stimulation induced superior relaxation effects and decreased 
nocturnal arousal, which impacted on waking mood. In addition, there was a trend 
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for 5Hz stimulation to decrease sleep onset to a greater degree than other 
frequencies, which adds further support to this arousal reduction hypothesis. 
Assessment of salivary cortisol would have shed more light on this issue by 
providing an objective measure of arousal system functioning. Future research may 
also consider using polysomnography to see if photic stimulation exerts its effects on 
waking mood, possibly by reducing nocturnal arousal, and thereby normalising sleep 
architecture. 
Another explanation for the small effects observed on sleep parameters in study 2, 
particularly sleep onset, is that late evening light tends to decrease melatonin, at a 
time when it is required for sleep initiation. Most participants reported using their 
Lightmask before retiring. Reductions in melatonin have been demonstrated 
following stimulation with low luminance opaque white light (Shealy et al., 1990), 
however, given that low luminance red light was used in study 2, it is likely that this 
effect was quite small. Nevertheless, pulsed evening white light tends to phase delay 
human circadian functioning, which may have a beneficial effect in depression. 
Depressed individuals often experience shortened latency to REM sleep and 
decreased slow wave sleep, due to elevated and early secretion of nocturnal cortisol, 
which greatly undermines sleep quality (N ofzinger et al., 2000). Delaying nocturnal 
cortisol secretion would assist by increasing the latency to REM sleep, and delaying 
wake time, therefore improving overall sleep efficiency. Recent research has shown 
that low luminance (8 Lux) short wavelength light (blue or violet) can influence 
circadian rhythm function, and offset nocturnal cortisol secretion (Warman et al. , 
2003). An alternative model for the treatment of depression, therefore, may be to use 
short wavelength, low luminance light, presented as a light flicker, to combine the 
193 
effects of brainwave entrainment, early in the evening, in an attempt to phase delay 
night time cortisol release, with the effect of increasing the period of slow wave 
sleep, and thereby improve sleep quality. Regular practice, for a period of longer 
than 4-5 weeks, would be advised, in order to maximise training effects, as recent 
research has shown that relaxation responses are greatly augmented if practised for 
longer than 4-5 weeks (Matsumoto & Smith, 2001). This model may prove to be 
more beneficial for depressed, hyper-aroused, sleep disturbed individuals. 
5.6 Future directions 
Traditional methods of EEG recording use filters in an attempt to remove unwanted 
noise and extraneous input from muscle and physiological activity, but in the process 
can remove potentially relevant information about brain function (Gregson, 2003; 
Watters, 1999). In addition, Fast Fourier Transformation techniques are applied 
across numerous data points, in order to derive a mean for a particular bandwidth. 
Linear methods of statistical analysis, using grouped data, further reduce data 
variance and can preclude the presence of internal complexities (Gregson, 2003, in 
press). Non-linear dynamical methods of analysis have the ability to assess the 
richness and complexity of EEG data which can be lost with traditional linear 
techniques (Gregson, 2002; Watters, 1999). As discussed in Chapter 4, healthy 
biological systems are characterised by a wide range of variance and complexity, 
reflecting their adaptability (Pool, 1989; Winfree, 1987). Reductions in complexity, 
such as occurs in MDD (Nandrino et al., 1994), with increased frontal lobe alpha, or 
excessive chaotic behaviour, as is the case in epilepsy (Wright & Liley, 1996), signal 
diminished adaptive ability and are indicators of disease. 
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In the current research, photic stimulation influenced the EEG in a complex manner, 
with harmonic and sub-harmonic responses found. The linear statistical methods 
used, however, possibly precluded the ability to show the full extent of this 
complexity over time, which may be remedied using additional non-linear analysis. 
This research also highlights the problems inherent in assuming that cortical 
stimulation using a particular frequency will only affect bandwidths at those 
frequencies. As was shown in this research, and other studies, harmonic and sub-
harmonic effects produce complex patterns of EEG response, which in tum can have 
a range of influences on mood and behaviour (Rosenfeld et al., 1997; Walter & 
Walter, 1949). 
5. 7 Conclusion 
Ample evidence was provided in this thesis to show that depression can be defined as 
a stress-related disorder, characterised by over stimulation of arousal systems, with 
accompanying dysphoria and sleep disturbance (Arborelius & Owens, 1999; 
N ofzinger et al., 2000). Depression is a serious health issue in developing countries, 
contributing substantially to loss of productivity, and personal suffering, with 
forecasts of increasing burden and social cost in the future (Murray & Lopez, 1997). 
There is urgent need, therefore, for effective and easy to use health interventions to 
help curb this trend. 
In response to this need, this project investigated the use of a non-pharmacological 
treatment, photic stimulation, as an adjunctive therapy in the treatment of MDD. 
This research replicated earlier work and showed that photic stimulation produces 
immediate relaxation effects, effortlessly, and without prior training (Brauchli et al., 
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1995; Morse, 1993, 1994b; Ossebaard, 2000), but anticipated long term training 
effects on mood and EEG, as a result of regular, long term use, were not found. This 
research demonstrated clear frequency following responses in the cortex, with some 
enhancement to mood and small improvements to sleep quality. 
The short term anxiolytic qualities of photic stimulation were demonstrated and 
remain effective therapeutic tools, possibly more suited for acute pain, or acute stress 
responses which demand immediate intervention. Arousal models of depression 
argue that repeated stress responses in depression, act to sensitise arousal systems 
and increase stress responsivity. As a consequence, each depressive episode leads to 
an escalating cycle of increasing vulnerability with subsequent depressive episodes 
becoming more severe and protracted, and less amenable to treatment. To prevent 
this cycle, it is proposed that stress responses need to be ameliorated quickly and 
effectively (Everly & Benson, 1989; Post, 1992). Photic stimulation, therefore, is a 
potent treatment tool for immediate stress management, particularly at a time when 
coping resources, and motivation, are at their lowest. As a consequence, photic 
stimulation may work to limit the severity of depressive episodes and help to inhibit 
the vicious cycle of sensitisation of arousal systems. Photic stimulation may yet help 
to play a role in ameliorating the burden of disease in depression, and its effects may 
only be evident over many years, as the severity of depressive episodes is 
diminished. 
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Study 1 'Thoughts Emotions & Health Questionnaire'. 
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Thoughts, Emotions, & Health Questionnaire (p.1). 
Name································ ············•• ••• •••.• Sub']·ect ID 
····· ·······. ········· . ······ •••• ••••••• ••••• •• • •• • ••••••• ••••••••• • 
Address: 
... ···························· ··· ··· ·· ·· ··· ·· .. .... ···············. ········· ·· ········· .. ·········· .. ··········· ..... ....... ........ . 
Occupation ................................. .. .. ....... ............. ....... ... ........... .......... ... .. . Date: .......................... . 
Contact numbers: home............... ... work 
........... ·············· ....... . ................................................. . 
Sex: 
Marital Status 
Male 
Single 
Female 
Divorced/ Separated 
Number of children ...................... .......... ... .. .. ...... . 
Age ..... ....... ..... . 
Married 
De facto 
Thank you for volunteering to participate in this research. The foil owing questions ask 
about your general health, health behaviours, thoughts and feelings. Please read the 
questions carefully and answer to the best of your ability. 
FEELINGS & EMOTIONS 
This scale consists of a number of words that describe different feelings and emotions. Read 
each ite1n and then circle the appropriate answer next to the word. Indicate to what extent 
you have felt this way in the last WEEK, that is, how you feel on the average. Use the 
following scale to record your answers. 
1 
very slightly 
or not at all 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
2 
a little 
interested 
distressed 
excited 
upset 
strong 
guilty 
scared 
hostile 
enthusiastic 
proud 
3 
moderately 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
12345 
4 
quite a bit 
irritable 
alert 
ashamed 
inspired 
nervous 
determined 
attentive 
jittery 
active 
afraid 
5 
extremely 
22 7 
THOUGHTS (p.2) 
Listed below are a variety of thoughts that pop into people's heads. Please read each thought 
a~d ~ndicate how frequently, if at all, the thought occurred to you over the last WEEK by 
c1rchng one response. Please read each item carefully and fill in the appropriate answer by 
using the following scale: 
1 2 3 4 5 
not at all sometimes moderately often all the time 
Response Thoughts Response Thoughts 
1 2 3 4 5 I feel like I'm up against the 1 2 3 4 5 I enjoy a challenge. 
world. 1 2 3 4 5 I can't get things together. 
1 2 3 4 5 I'm no good. 1 2 3 4 5 I hate myself. 
1 2 3 4 5 I am respected by my peers. 1 2 3 4 5 My social life is terrific. 
1 2 3 4 5 I have a good sense of humour. 1 2 3 4 5 There's nothing to worry 
1 2 3 4 5 Why can't I ever succeed. about. 
1 2 3 4 5 No one understands me. 1 2 3 4 5 I'm worthless. 
1 2 3 4 5 My future is bright. 1 2 3 4 5 Wish I could just disappear. 
1 2 3 4 5 I will be successful. 1 2 3 4 5 I'm so relaxed. 
1 2 3 4 5 I've let people down. 1 2 3 4 5 My life is running smoothly. 
1 2 3 4 5 I am fun to be with. 1 2 3 4 5 What's the matter with me? 
1 2 3 4 5 I am in a great mood. 1 2 3 4 5 I'm a loser. 
1 2 3 4 5 I don't think I can go on. 1 2 3 4 5 I'm happy with the way I look. 
1 2 3 4 5 I wish I were a better person. 1 2 3 4 5 I take good care of myself. 
1 2 3 4 5 There are many people who 1 2 3 4 5 My life is a mess. 
care about me. 1 2 3 4 5 I'm a failure. 
1 2 3 4 5 I'm proud of my 1 2 3 4 5 I deserve the best in life. 
accomplishments. 1 2 3 4 5 Bad days are rare. 
1 2 3 4 5 I'm so weak. 1 2 3 4 5 I'll never make it. 
1 2 3 4 5 My life's not going the way I 1 2 3 4 5 I feel so helpless. 
want it to. 1 2 3 4 5 I have many useful qualities. 
1 2 3 4 5 I will finish what I start. 1 2 3 4 5 There is no problem that is 
1 2 3 4 5 I have n1any good qualities. hopeless. 
1 2 3 4 5 I'm so disappointed in myself. 1 2 3 4 5 Something has to change. 
1 2 3 4 5 Nothing feels good anymore. 1 2 3 4 5 There must be something 
1 2 3 4 5 I am comfortable with life. wrong with me. 
1 2 3 4 5 I have a good way with others. 1 2 3 4 5 I won't give up. 
1 2 3 4 5 I can't stand this anymore. 1 2 3 4 5 I state my opinions with 
1 2 3 4 5 I can't get started. confidence. 
1 2 3 4 5 I am a lucky person. 1 2 3 4 5 My future is bleak. 
1 2 3 4 5 I have friends who support me. 1 2 3 4 5 It's just not worth it. 
1 2 3 4 5 What's wrong with me? 1 2 3 4 5 I can't finish anything. 
1 2 3 4 5 I wish I were somewhere else. 1 2 3 4 5 My life keeps getting better. 
1 2 3 4 5 Life is exciting. 1 2 3 4 5 Today I've accomplished a lot. 
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HASSLES (p.3) 
This next part of the questionnaire lists areas in your life which may or 1nay not be a problem 
or a hassle for you. A HASSLE is an irritant which annoys or bothers you; they can make you 
upset or angry, they can be minor irritants or fairly major pressures. Please indicate if any of 
these following AREAS is currently a HASSLE for you by circling the appropriate response. 
0 1 2 3 
None or not Somewhat Quite a bit A great deal 
Applicable 
0 1 2 3 Illness of a family member. 0 1 2 3 Concerns about weight. 
0 1 2 3 Your partner.. 0 1 2 3 Preparing meals. 
0 1 2 3 The weather 0 1 2 3 Too many things to do. 
0 1 2 3 Fertility issues. 0 1 2 3 Job dissatisfaction. 
0 1 2 3 Your friends. 0 1 2 3 Legal matters. 
0 1 2 3 Your children. 0 1 2 3 Problems with divorce or 
0 1 2 3 Your parents. separation. 
0 1 2 3 Work or study colleagues. 0 1 2 3 Concerns about inner 
0 1 2 3 Concerns about money. 0 1 2 3 Conflicts. 
0 1 2 3 Use of drugs or alcohol. 0 1 2 3 Sex. 
0 1 2 3 Care for pet. 0 1 2 3 Concerns about getting 
0 1 2 3 Trouble making decisions. ahead. 
0 1 2 3 Home maintenance. 0 1 2 3 Employment. 
0 1 2 3 Being lonely. 0 1 2 3 Not enough time. 
0 1 2 3 Concerns about medical 0 1 2 3 Transportation problems. 
treatment. 0 1 2 3 Crime. 
0 1 2 3 Physical appearance. 0 1 2 3 Political or social issues. 
0 1 2 3 Concerns about health in general. 0 1 2 3 Other, please specify 
0 1 2 3 Your environment (noise, space, ......................................... 
greenery etc.) 
HEALTH MATTERS. 
Please respond to the following questions by placing a tick in the appropriate box 
In the past year have you suffered from a medical condition which has resulted in you being 
hospitalised? Yes No 
If yes, what was the nature of this condition? .............................................................................. . 
In the last 3 months has there being any event which has had a major impact on you~ life? 
Yes No 
If yes, would you please describe the event? ........................ •• .................. ••••••• ............................ . 
HEAL TH BEHAVIOURS 
ALCOHOL AND DRUGS 
How often do you normally drink ALCOHOL? everyday or most days 
2-3 times per week 
less than 2 times per week 
never 
How much do you normally drink in any one session? 1-2 drinks 
Do you smoke TOBACCO? 
If yes, 
3-6 drinks 
more than 6 drinks 
Yes No 
On average, how many cigarettes per day do you smoke? ...................................... . 
Are you currently taking any PRESCRIBED MEDICATION? Yes No 
If yes, please indicate below the type of medication you are taking and the dosage: 
Drug Dosage 
Do you use RECREATIONAL DRUGS Yes No 
(for example; marijuana, speed, crack, heroin, etc.) 
If yes, 
What do You Use? ....... .............................................................. . . ................................ . 
How often would you use this/these drug(s)? everyday or most days 
1-2 times per week 
less than once per week 
less than once per month 
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(p.4) 
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How DO YOU FEEL RIGHT NOW? (p.5) 
On a scale of l(feeling very relaxed and calm) to 10 (feeling very anxious and uptight), please 
indicate, by circling one number only, how relaxed and calm or anxious and uptight you feel 
right now. 
1 
very relaxed 
& calm 
2 
For Women Only: 
3 4 5 6 7 8 9 10 
very uptight 
& anxious 
Because feelings and emotions are affected by different stages of the menstrual cycle would 
you please indicate what stage of your cycle you are at: 
First week (menstruation) ........................ . Day 1-7 
Second week ............................................. Day 8-14 
Third week ............................................... . Day 15-21 
Fourth week ............................................. . Day 2 2 to end of cycle 
No longer have periods 
What is the average length (in days) of your menstrual cycle? ............. . 
If you have any questions, please don't hesitate to ask. 
THANK YOU FOR YOUR COOPERATION AND PARTICIPATION. 
NOTES: .......................................................................................................................................... . 
=-..;__::.....;:...__.c.. 
······················································································································································ 
..................................................................... ................................................................................. 
............................................................................................................................................. ........ . 
.............................................................................................. ...................................................... .. 
...................................................................................... ..................... .. .............. ··············.· ........... . 
........... ························································ .................................................................................. . 
................................. ........................................... ...... ....... .. ... ............. ...... ....... ........ ......... ....... ...... . 
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APPENDIXB 
Study 1 autogenic relaxation script. 
STUDY 1 RELAXATION SCRIPT. 
En~u~e that you are comfortable. Scan your body from your head to your toes 
not~c1ng areas of cal~ and relaxation (4) .... and areas of tension and pressure (8). 
Ad Just your body letting go of tension and ensuring that you are comfortable and 
relaxed. 
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Take your focus to your breath .... Notice the air as it passes in and out of your 
nostrils. Feel the coolness of the air as you breath in .... and the warmth of the air as 
you breath out. .... (16) As you breath in, notice where your breath goes in your 
chest; is it shallow? ... Or is it deeper into the abdomen? ... Spend some moments 
observing your breath. (16). 
If your mind wanders, and you are distracted by thoughts, quietly guide your 
awareness back to your breath and let whatever thoughts arise waft past you, as if 
you can observe them from afar. 
Gently and effortlessly, start to slow down your breathing. Take your breath lower 
into your abdomen. As you breath in let your abdomen fill and expand ... ( 4) and as 
you breath out, let the abdo1nen fall. Allow the breath to be easy and effortless. 
Breath in to the count of 4, ... hold the breath for 2 counts, ... breath out to the count 
of 4. Do this for several breaths (16). Gently let go of counting and allow the 
breath to be easy and effortless. 
Take your awareness to your head and neck. Notice any areas of tension, and areas 
of quiet and calm. Now focus on the muscles around your eyes. Notice where there 
is tension, where there is calm. Let go of any tension and allow the eyes to become 
soft in their sockets (8). Next become aware of your forehead and your scalp, ... 
notice where there is tightness and where there is quiet and calm ( 4). Let go of any 
tightness and allow the muscles to soften and relax (8). Now become aware of your 
face, jaw, and throat. .. Allow the muscles to soften, letting go of tightness and 
tension ( 4). Feel the whole head as heavy, warm and relaxed. Say to yourself, 
several times, "my head, neck and throat are calm and relaxed" Rx3 (16). 
Allow the heaviness of relaxation to spread to your shoulders. Become aware of the 
muscles in your shoulders letting go of any tightness and allowing your shoulders to 
drop and relax .... Say to yourself 'my sl;ioulders are heavy and relaxed' Rx3 (4). 
In1agine this feeling of calm and relaxation spreading down your arms. Imagine any 
areas of tension softening and relaxing as your arms become warm and heavy. 
Allow the feeling of relaxation to move down your arms, from your shoulders to 
your elbows, down into your wrists, your hands and to your fingers. Relax your 
hands and fingers feeling the warmth and heaviness spreading to the tips of your 
fingers. Say slowly to yourself; several times "my hands are warmer and warmer" · 
(16). 
Feel your whole head, ... your shoulders, ... arms ... hands ... and fingers as relaxed, 
warm and heavy. (8) 
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Take your awareness to your chest and abdomen. Notice first the muscles in your 
chest, if there is any tension and tightness, where there are quiet calm areas (8). 
Then focus on the muscles of your stomach and abdomen. Notice tension and 
tightness, notice quiet calm areas. Gently let the edges of any tension or tightness 
soften now, soften gradually more and more, thinking to yourself: "the 1nuscles of 
my chest and stomach are quiet and calm" R x3 (16). 
Become aware of your pelvis and hips. Notice any areas of tension or discon1fort. 
Imagine that you can breathe into these areas of tightness and discomfort ... letting 
go with each out breath. With each breath you become more relaxed, ... more 
calm, ... your whole abdomen and pelvis feels warm, comfortable, and relaxed (4). 
Say to yourself over and over, "the muscles of my chest, abdomen and pelvis are 
calmer and calmer" (16). 
Allow this feeling of warmth and calm to flow down to your thighs. Allow the 
muscles of your thighs to become loose, and relaxed. . .. Let go of any areas of 
tension. Allow the feeling of warmth and relaxation to filter down from your thighs, 
into your knees, and on down into your calves and shins, down to your ankles, down 
to your feet and into the tips of your toes. Both your legs feel heavy, warm, and 
comfortable. Think to yourself; "the muscles of my legs and feet are relaxed and 
calm" (16). 
Scan your whole body from your toes to your head (8). Gently let go of any 
remaining tension. Let the outbreath help you to relax, and allow the feeling of 
relaxed warmth to fill your entire body (8) . 
. . . say to yourself 'my whole body is relaxed and warm' Rx3. 
Take your awareness back to your breath. Notice the breath in your chest. Is it 
shallow or deep? ( 4). Observe the rate of your breathing, it is slow and rhythmic or 
fast and shallow? (8). As you breathe in, observe the coolness of the air in your 
nostrils ... and the warmth of the air as you breath out. (16). 
Gently now begin to bring you awareness back to the room and be aware of your 
body in contact with the chair. (4). Be aware of the noises you can hear in the room. 
(4) Take several minutes and gently bring yourself back fully to the room feeling 
your body supported by the chair you are resting on. 
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APPENDIXC 
Means and standard deviations for Study 1 variables. 
Appendix C: Means and standard deviations (SD) for Study 1 variables; heart rate, skin conductance, subjective relaxation, positive affect, negative 
affect, and EEG amplitude in the 4-6hz, 12-14Hz, and 21-23Hz bandwidths. 
Mean heart rate and (SD) {1 trol.. relaxation .. theta .. aloh d bet (n=30) 
session 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
control 64.8 67.9 69.1 67.1 70.7 69.4 65.9 67.2 67.8 68.3 70.7 68.6 68.5 66.8 
(6.4) (10.5) (14.5) (6.9) (9.3) (14.4) (7.4) (9.1) (7.0) (7.0) (10.8) (11.1) (10.6) (11.2) 
relaxation 69.0 70.9 72.5 73.5 68.7 74.8 70 75.9 73.1 70 70.1 74 76 68 
(12.6) (11.0) (12.8) (11.2) (10) (15.3) (10) (14.8) (11. 1) (12.8) (11.3) (10.8) (16.8) (8.6) 
theta 64.2 73.4 71.8 68.2 69.9 68.3 73.6 71.1 73.7 69.5 69.9 68.5 72 72 
(8.5) (16.4) (10) (13 .6) (11.6) (12.9) (15.7) (14.3) (9.4) (12) (8.2) (5.2) (6.5) (9.9) 
alpha 60.9 65.8 68.4 62.2 70 70.3 69.9 67 68.2 67.9 62.6 67.8 65. 8 63.7 
(11.2) (6.9) (10.6) (6.1) (8.8) (10.9) (6.8) (6.5) (7.3) (6.2) (6.8) (4.9) (4.1) (5.9) 
beta 62.2 72.5 67 65.9 65 71.2 66.1 64 63.4 64.3 66.9 61.7 63.3 63.9 
(9.2) (12.1) (13 .7) (9.0) (9.0) (9.7) (5.1) (9.0) (5.3) (9.7) (9.6) (7.6) (9 .5) (6 .6) 
M 
session 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
control 8.9 10.7 10.8 8.7 7.7 9.4 8.6 7.5 7.8 10.3 11.3 9.2 6.9 10.4 
(4.8) (8.8) (3.5) (5.1) (3.3) 96.9) (3.9) (4.4) (4.4) (3.3) (12) (1.3) (3 .6) (5.5) 
relaxation 9.6 8.0 6.3 9.8 9.2 9.3 10.2 10.7 7.8 12.1 6.4 7.9 7.3 10.4 
(3.1) (5.1) (4.4) (5.4) (6.0) (7.0) (3.8) (4.8) (2.5) (3.1) (2.9) (2.7) (3 .2) (7.6) 
theta 10 13 .2 3.3 8.6 12 12.1 13.6 9.0 8.2 8.0 8.5 12.1 8.4 6.5 
(6.10 (9.3) (1.1) (5.6) (9.70 (12.4) (13.1) (5.5) (4.8) (7.5) (4.0) (11.8) (7.4) (2 .6) 
alpha 6.8 9.4 6.5 5.2 1.08 13.4 7.5 9.9 10.1 6.7 5.4 5.9 10.6 9.0 
(4.4) (6.8) (2.1) (1.3) (6.5) (10.5) (12.1) (7 .5) (11.1) (3.1) (2.9) (3.8) (8.7) (6.3) 
beta 13.8 19.3 16.1 15.1 13.6 16.6 14.1 14.7 11.3 13.3 16.5 11.7 11.0 19.1 
(7.10 _(13) (8.5) (13.7 (7.4) (9.1) (7.3) (5.2) (4.8) (6.9) (8.5) (5.5) (4.5) (5.8) 
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Appendix C continued. 
M biecf laxaf d (SD} f1 trot relaxation .. theta .. aloh d bet (n=30) 
. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 session 
control 7.3 7.8 8.0 8.3 8.2 7.8 8.3 7.7 7.3 7.8 8.2 7.7 7.5 7.7 
(1.2) (2.4) (1.4) (1.0) (1.0) (1.3) (1.4) (1.5) (1.8) (2.5) (1.5) (1.0) (2.5) (1.9) 
relaxation 5.3 6.7 7.5 7.7 7.5 7.5 8.0 8.2 8.0 7.3 8.3 8.0 7.7 7.0 
(0.8) (2.2) (1.6) (1.9) (1.5) (1.5) (1.4) (1.2) (1.5) (1.9) (1.2) (1.7) (1.5) (2.2) 
theta 7.3 6.8 6.7 7.2 7.8 7.5 7.7 8.1 7.7 7.7 8.0 8.2 8.3 8.2 
(1.6) (1.7) (1.9) (1.8) (2.0) (2.9) (2.5) (1.0) (1.9) (2.3) (1.5) (1.7) (1.4) (1.0) 
alpha 8.3 9.2 9.3 9.3 9.3 9.5 9.5 9.3 8.8 9.7 9.7 9.3 9.3 9.0 
(0.5) (0.7) (1.6) (0.5) (0.5) (0.8) (0.5) (0.8) (1.0) (0.5) (0.8) (0.5) (1.2) (0.6) 
beta 7.0 8.0 7.8 8.5 7.8 7.0 8.2 8.0 7.8 7.5 8.2 7.8 7.8 7.8 
(2.4) (1.5) (1.9) (0.5) (1.2) (2.0) (1.6) (0.9) (1.5) (1.5) (1.5) (1.2) (1.2) (1.0) 
M 'tive affect and (SD) f1 trol.. relaxation .. theta .. aloha and bet 
- - ,.., 
- - - - •- - (n=30) 
session 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
control 38 32 28.3 31.8 28.3 27.2 26.3 26.6 29 28.3 23.7 28.0 26.7 29.5 
(2.9) (7.4) (5.5) (10.8) (10) (5.4) (3.3) (7.5) (5.9) (4.6) (7.8) (7.5) (6.2) (7.9) 
relaxation 35 34.6 29.5 31.3 29.2 26.5 27 28.3 31 28.3 30.2 26.7 27.0 30.7 
(7.6) (9.3) (8.7) (11.3) (10.7) (12.3) (10.7) (13.1) (14.2) (11.5) (12.8) (13.0) (10.8) (12.9) 
theta 39 32.3 31.8 28.5 26.2 24.8 26 29.3 27.8 29.6 28.3 28.7 28.3 32.8 
(7.0) (9.0) (11.4) (8.7) (9.5) (10.4) (8.8) (10.4) (8.0) (8.4) (9.6) (10.1) (11.3) (13 .0) 
alpha 39 35.6 32.5 32.5 36.3 37.5 37.2 36.3 35 35.5 36.0 33.8 30.3 33.8 
(7.0) (9.4) (5.7) (7.9) (8 .1) (10.5) (10.6) (11.2) (10.4) (11.0) (10.1) (12.0) (13.2) (11.2) 
beta 28.8 25.8 22.8 20.2 20 22.3 19.8 19.6 21 20.5 22.5 23.7 21.7 24.5 
(7.4) (10.6) (8.3) (9.7) (11) (9.9) (9.4) (10.1) (11.2) (10.4) (12.9) (13.1) (9.2) (12.1) 
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Appendix C continued. 
M tive affect and (SD) f1 trol.. relaxation .. theta .. aloh d bet 
-
(n_ 30) 
session 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
control 16.7 20.0 16.5 17.0 17.2 13.2 13.8 15.7 15.8 12.8 15.7 13.7 13.7 13.3 
(3.9) (8.6) (7.3) (4.8) (6.2) (3.1) (2.1) (5.1) (4.8) (3.8) (5.6) (3.3) (3.5) (3.6) 
relaxation 19.5 17.3 15.8 13.7 13.3 11.8 11.8 12.0 12.7 13.7 12.5 11.2 12.7 13.8 
(6.6) (5.0) (4.0) (3.2) (3.1) (1.3) (2.6) (2.4) (3.1) (4.5) (2.7) (1.6) (1.9) (2.0) 
theta 19.3 12.5 13.0 14.8 14.0 17.8 13.2 16.0 15.2 13.5 14.7 13.3 12.0 16.2 
(5.8) (2.0) (4.4) (3.2) (4.0) (8.0) (3.5) (5.4) (6.1) (3.6) (3.4) (4.0) (3.6) (9.0) 
alpha 13.8 16.8 13.0 15.3 13.7 12.3 12.7 16.7 14.5 13.7 12.2 12.3 14.7 15.5 
(3.9) (6.3) (3.7) (4.1) (3.1) (3.4) (3.3) (4.4) (4.2) (3.3) (2.9) (3.2) (5.4) (3.6) 
beta 20.0 18.7 14.3 15.8 14.0 15.0 15.3 16.8 14.7 16.8 17.0 14.7 13.5 16.8 
(5.7) (8.1) (5.2) (6.3) (9.4) (8.0) (5.9) (9.3) (5.0) (8.4) (10.2) (3.9) (3.0) (6.6) 
M 
. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 session 
control 2.7 2.2 2.1 1.6 2.2 2.3 2.7 2.0 2.3 2.3 2.2 2.5 2.0 2.3 
(1.0) (1. 1) (1.1) (0.6) (0.8) (1.0) (1.1) (1.0) (0.8) (0.9) (0.4) (1.2) (0.6) (1. 1) 
relaxation 1.8 1.4 1.1 1.2 1.5 1.1 0.9 0.8 1.2 1.3 1.2 1.2 1.2 1.9 
(0.8) (1.0) (1.2) (0.8) (0.8) (0.5) (1.0) (0.4) . 90.7) (0.7) (0.8) (0.6) (0.5) (0.8) 
theta 2.1 2.1 2.0 2.0 1.6 1.5 2.2 2.4 2.3 2.3 2.3 2.3 2.5 2.9 
(0.8) (0.5) (0.6) (0.6) (0.9) (0.5) (0.8) (0.7) (0.7) (0.8) (0.7) (0.6) (0.9) (1.3) 
alpha 2.1 1.2 1.7 1.7 1.3 1.3 1.8 1.3 1.7 1.7 1.9 2.1 2.0 1.9 
(1.0) (0.6) (0.9) (0.8) (0.6) (0.9) (0.6) (0.5) (1.1) (0.7) (0.8) (0.6) (1.0) (0.5) 
beta 1.6 1.5 1.5 2.2 2.1 2.4 2.5 1.5 2.0 1.7 1.5 1.5 1.6 1.5 
(0.4) (0.7) (0.4) (1.6) (1.2) (2.2) (2.3) (0.4) (1.3) (0.3) (0.4) (0.3) (0.5) (0.3) 
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Appendix C continued. 
M ean occipital 12-14Hz (µV) and 1 SD) for control, relaxation, theta, alpha and beta groups (n=30) 
session 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
control 1.6 1.3 1.4 1.0 1.5 1.6 1.6 1.5 1.5 1.4 1.4 1.5 1.4 1.5 
(0.5) (0.3) (0.5) (0.4) (0.7) (0.7) (0.7) (0.7) (0.3) (0.2) (0.2) (0.6) (0.2) (0.2) 
relaxation 1.4 1.4 1.1 1.1 1.2 1.0 0.7 0.8 1.1 1.2 1.2 0.9 1.2 1.5 
(0.6) (1.0) (1.2) (0.8) (0.6) (0.7) (0.9) (0.5) (0.7) (0.7) (0.8) (0.6) (0.6) (0.8) 
theta 1.8 2.1 1.9 1.8 1.9 1.5 1.9 2.3 1.9 2.0 1.8 1.7 2.0 1.7 
(0.8) (0.9) (1.3) (1.0) (1.4) (0.9) (1. 1) (1.2) (0.9) (1.0) (0.7) (0.6) (0.8) (0.4) 
alpha 1.2 1.0 1.4 1.4 1.4 1.1 1.6 1.1 1.3 1.3 1.6 1.7 1.8 1.2 
(0.3) (0.7) (0.9) (0.8) (1.0) (0.6) (0.8) (0.4) (0.6) (0.3) (0.8) (0.6) (0.6) (0.2) 
beta 1.2 1.1 1.2 1.5 1.3 1.7 1.8 1.1 1.2 1.3 1.1 1.1 1.2 1.0 
(0.4) (0.4) (0.5) (0.9) (0.6) (1.3) (1.3) (0.3) (0.5) (0.3) (0.4) (0.3) (0.4) (0.2) 
M ean occipital 21-23Hz (µV) and 1 SD) for control, relaxation, theta, alpha and beta groups (n=30) 
session 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
control 0.7 0.6 0.7 0.5 0.7 0.7 0.7 0.6 0.7 0.7 0.6 0.7 0.6 0.7 
(0.2) (0.2) (0.2) (0.2) (0.4) (0.2) (0.1) (0.2) (0.2) (0.2) (0.1) (0.2) (0.1) (0.1) 
relaxation 0.8 0.7 0.5 0.4 0.7 0.6 0.4 0.4 0.8 0.8 0.7 0.6 0.7 0.7 
(0.2) (0.3) (0.3) (0.2) (0.3) (0.3) (0.3) (0.2) . (0.6) (0.4) (0.6) (0.3) (0.6) (0.1) 
theta 0.8 0.8 0.7 0.6 0.6 0.5 0.8 0.8 0.7 0.7 0.7 0.7 0.9 0.8 
(0.3) (0.4) (0.3) (0.2) (0.4) (0.2) (0.5) (0.3) (0.3) (0.3) (0.3) (0.2) (0.3) (0.3) 
alpha 0.6 0.4 0.6 0.6 0.5 0.5 0.7 0.5 0.5 0.6 0.7 0.7 0.8 0.7 
(0.2) (0.1) (0.4) (0.4) (0.4) (0.3) (0.3) (0.1) (0.1) (0.2) (0.3) (0.2) (0.4) (0.3) 
beta 0.5 0.5 0.5 0.6 0.6 0.7 0.8 0.5 0.6 0.5 0.5 0.5 0.5 0.5 
(0.1) (0.2) (0.1) (0.3) (0.3) (0.4) (0.5) (0.1) (0.2) (0.1) (0.1) (0.1) (0.2) (0.1) 
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APPENDIXD 
Ranges of Pearson's correlation coefficients for Study 1 variables. 
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Appendix D: Ranges for Pearson's correlation coefficients for study 1 variables across 14 sessions. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 global theta 1.0 
2 global alpha [.50, .85**J 1.0 
3 global beta [.20, .80**J [.48**,.81 **J 1.0 
4 heart rate [.07 ,-.40*J [- .02, .38*J [Ol,50*J 1.0 
5 skin conductance I [-.20,.58**J [- .03 ,.43*J [-.Ol ,46*J [-.04,.52*J 1.0 
6 subjective relaxation [- .Ol ,.40*J [- .Ol, .43*J [- .03,.38*J [-.35,-.04J [-.30,-.03J 1.0 
7 depression [.04, .05J [.06,.09J [.12, .14J [-.03, .lOJ [-.01,.01] [-.06,-.30J 1.0 
8 anxiety [.06, .15J [-.03 ,. 1 OJ [-.05, .20J [- .07, .16J [.10,.30J [- .45* ,.42*J [.60*, .70**J 1.0 
9 global severity index I [- .07 ,.08J [.02,.03J [- .07,. 13J [.03, .17J [- .09, .23J [- .38*,-.13J [.78** ,.80**J [.70** ,.80**J 1.0 
10 positive affect [-.40*,.0lJ [- .38*,-.0 lJ [-.02, .32J [-.25,.24J [-.21, .25J [.07,.25J [-.43*,- .30J [-.33,-.20J [- .44*,-.41 *J 1.0 
11 negative affect [.Ol,.13J [-.30,.30J [- .33,.42*J [-.20,.37*J [-. l 7,.39*J [-.49*,-.07J [.16, .65**J [.40*,.72**J [.02,.69**J [.03,-.57**J 1.0 
12 positive thoughts [15,30J [- .27,lOJ [.14,. l 9J [-.03,-.0lJ [.Ol ,.05J [.16,.2 1J [.05,-.36*J [.02,-.25J [-.40* ,-. lOJ [.70**, .80**J [-.33,.12J 1.0 
13 negative thoughts I [.13,.17J [- .05, .1 lJ [-.02,.1 OJ [-.26, .14J [-.03, .0lJ [-.20, .35J [ .50* ,. 70**J [.25,.52**J [.40*,.60**J [-.50**,-.05J [- .20, .60**J [- . l 3, .06J 1.0 
14 daily hassles I [- .20,-.03J [- .28,27J [.07,.35J [.08, .42*J [-.Ol ,.29J [-.62*,0lJ [46* ,57*J [30,39*J [.35, .53*J [-. l 2, .28J [.30, .56*J [- .05, . l 7J [.22 ,.70 **J 1.0 
15 menstrual cycle [- .50**,-.02J [-.46* ,. 12J [-.32, .16J [.O l ,.30J [- .30,. l 8J [-.30,.27J [-.30,-.27J [- .18,-.17J [-.32,-.31J [.07,.55**J [- .41 *,.26J [- .Ol, .14J [- .22,-.17J [-.3 1,-.07J 
* significance LE .05 ** significance LE .01 
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APPENDIXE 
Study 2 Selection Criteria. 
SELECTION CRITERIA: 
THE USE OF PHOTIC STilvfULATION TO TREAT MOOD AND SLEEP PROBLEMS 
Participants will be eligible to enter the study if they have mild or moderate 
depression and sleep disturbance. Please use the following criteria to guide your 
selection. 
People will not be admitted to the study if they: 
• Have a history of bipolar disorder or are psychotic. 
• Have a history of epilepsy or migraine. 
• Are currently taking anti-depressant, or anxiolytic medication. 
• Report snoring most nights or 'more nights than not'. 
1. Criteria for Depression 
Presence of at least Mild Depression which includes at least 1 of the first two 
symptoms and at least 4 of the others occurring over the last two weeks. 
1. Two weeks of abnormal depressed mood (feeling sad most of the time) D 
2. Loss of interest and/or pleasure ............................................................. D 
3. Change in appetite (weight loss or weight gain) ................................... D 
4. Sleep disturbance (insomnia or hypersomnia most days) ..................... D 
5. Psychomotor agitation or retardation ( observable by others) ............... D 
6. Fatigue or loss of energy (most days) ................................................... 0 
7. Feelings of worthlessness or guilt. .............................. ... ....................... 0 
8. Poor concentration, difficulty thinking & or memory disturbance ....... D 
9. Recurrent thoughts of death .................................................................. D 
10. Above symptoms cause distress & or impairment in functioning ...... D 
2. Criteria for sleep disturbance 
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History of sleep disturbance for about one month, including some of the following symptoms: 
In general describes sleep as poor. ............................................................. • 
In general, wakes feeling tired and not refreshed after a nights sleep ....... • 
Difficulty falling asleep ............................................................ .............. .... • 
Wakes several times during the night. ...................................... ......... ........ • 
Difficulty falling asleep after waking- toss and tum, lie there worrying ... • 
Insomnia .......... , ............................................................ .. ............................ • 
Hypersomnia ( excessive sleepiness) . ............................................ ............. 0 
History of night sweats ....................................... .. ........................... ..... ..... • 
History of night mares/night terrors ........................... .... ........... ... ...... ..... ... • 
Thrashes about when sleeping ................................................................... • 
Daytime fatigue and/or sleep episodes ......................................... ... ........... • 
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APPENDIXF 
Study 2 'Health Matters Questionnaire'. 
THE USE OF PHOTIC STIMULATION TO TREAT MOOD AND SLEEP PROBLEMS 
HEALTH MATTERS QUESTIONNAIRE (p.1) 
Name 
............................................................................................................................................. 
Address: ...................................................... . 
................................................................................. 
Occupatio11 .............................................................................................. Date: ........................... . 
Contact 111,mbers: home ................................................. work ................. ................................... . 
Other: ........................................................ . 
Sex: Male • Female • 
Date of Birth ................... ... Age 
Health Professional: 
In the event that your depression gets worse over the course of the study could you please give us 
the name of a health professional we can refer you to: 
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General Practitioner ............................................................................ Phone number ......... ............... . 
Please indicate any other health professionals involved in your care, such as Psychologist, 
Psychiatrist or Case Manager: 
THANK YOU FOR VOLUNTEERING TO PARTICIPATE IN TffiS RESEARCH. THE FOLLOWING 
QUESTIONS ASK ABOUT YOUR GENERAL HEALTH, HEAL TH BEHAVIOURS AND MOOD. 
PLEASE READ THE QUESTIONS CAREFULLY AND ANSWER TO THE BEST OF YOUR ABILITY. 
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HEAL TH MATTERS. (p.2) 
Please respond to the following questions by placing a tick in the appropriate box 
In the past year have you suffered from a medical condition which has resulted in you being 
hospitalised? Yes D No D 
If yes, what was the nature of this condition? .............................................................................. . 
.................................................................... ........................................ .......................................... . 
Do you suffer from a chronic illness Yes D No • 
If yes, what is the nature of your illness? .................................................................................... .. 
DEPRESSION HISTORY: (Please respond if applicable) 
How long have you had depression for? .................................................................................... .. 
What treatments have you tried in the past ................................................................................ .. 
Do you currently seek professional help for your depression? .................................................. .. 
MAJOR LIFE EVENTS 
In the last 3 months has there been any event which has had a major impact on your life? 
Yes D No D 
If yes, would you please describe the event? .............................................................................. .. 
....................................................................................................................................................... 
ALCOHOL AND DRUGS 
How often do you normally drink ALCOHOL? everyday or most days .......... D 
2-3 times per week ................ D 
less than 2 times per week ...... D 
never ....................................... D 
How much do you normally drink in any one session? 1-2 drinks .............. • 
3-6 drinks .............. • 
more than 6 drinks ......... D 
Do you smoke TOBACCO? Yes O No 0 
If yes, 
On average, how many cigarettes per day do you smoke? .................................... .. 
Are you currently taking any PRESCRIBED MEDICATION? Yes O No O (p.3) 
If yes, please indicate below the type of medication you are taking and the dosage: 
Drug Dosage 
Do you use RECREATIONAL DRUGS Yes • No • 
(for example; marijuana, speed, crack, heroin, etc.) 
If yes, 
What do you use? .................................... . 
How often would you use this/these drug(s)? 
SLEEP 
everyday or most days 
1-2 times per week 
less than once per week 
less than once per month 
Would you describe yourself as someone who has difficulties with sleep Yes D 
If yes, please indicate which of the following symptoms apply to you: 
• In general, would describe sleep as poor. ........ • 
• Difficulty falling asleep ................................... • 
• Difficulty falling asleep after waking- toss 
and tum, lie there worrying ............................. • 
• Night sweats ..................................................... • 
• Night mares .................. .................................... • 
• Wake up startled during the night, feeling 
anxious, racing heart and short of breath ........ • 
• Wake during the night and worry. . ................. • 
• Wake feeling tired ................ ............................ D 
• Nap often during the day .................................. • 
• Never seen1 to get enough sleep ....................... • 
• Tend to oversleep, but still feel tired ................ • 
• Snoring ........................................................ .. ... • 
• Other (please describe) .................................................... . 
.............. .................................................. ............................... . 
How often do you experience these symptoms: Most nights D 
Every other night D 
Only occasionally D 
• 
• 
• 
• 
No • 
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MOOD 
How DO YOU FEEL RIGHT NOW? (p.4) 
On a scale of !(feeling very relaxed & calm) to 10 (feeling very anxious & uptight) , please indicate, by 
circling one number only, how RELAXED AND CALM or ANXIOUS AND UPTIGHT you feel RIGHT NOW. 
1 2 
very relaxed 
&calm 
3 4 5 6 7 
FEELINGS & EMOTIONS 
8 9 10 
very uptight 
& anxious 
This scale consists of a number of words that describe different feelings and emotions. Read each 
item and then circle the appropriate answer next to the word. Indicate to what extent you have felt 
this way in the last WEEK, that is, how you feel on the average. Use the following scale to record 
your answers. 
1 
very slightly 
or not at all 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
2 
a little 
interested 
distressed 
excited 
upset 
strong 
guilty 
scared 
hostile 
enthusiastic 
proud 
4 5 3 
moderately quite a bit extremely 
1 2 3 4 5 irritable 
1 2 3 4 5 alert 
1 2 3 4 5 ashamed 
1 2 3 4 5 inspired 
1 2 3 4 5 nervous 
1 2 3 4 5 determined 
1 2 3 4 5 attentive 
1 2 3 4 5 jittery 
1 2 3 4 5 active 
1 2 3 4 5 afraid 
For Women Only: (p.5) 
Because feelings and emotions are affected by different stages of the menstrual cycle would you 
please indicate what stage of your cycle you are at: 
0 First week (menstruation) ..... .......... .... .... .. Dayl- 7 
D Second week ........... ............................ ...... Day 8-14 
0 Third week ...................................... .......... Day 15-21 
D Fourth week ....................................... .... ... Day22 to end of cycle 
0 No longer have periods. 
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What is the average length (in days eg.21, 28, or 32) of your menstrual cycle? ............ ... . 
If you have any questions, please don't hesitate to ask. 
THANK YOU FOR YOUR COOPERATION AND PARTICIPATION. 
NOTES: .......................................................................................................................... . ............... . 
······················································································································································· 
................................................................................................................................................. ... ... 
........................................................................................................................................ ............... 
······················································································································· ································ 
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APPENDIXG 
Study 2 Sleep Diary. 
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APPENDIXH 
Study 2 Light and Mood Diary. 
N a m e : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  L I G H T  T H E R A P Y  &  M O O D  D I A R Y  D A T E  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  .  
P l e a s e  u s e  t h i s  d i a r y  t o  r e c o r d  t h e  t i m e  o f  d a y  y o u  u s e  y o u r  l i g h t m a s k  a n d  t h e n  r a t e  y o u r  f e e l i n g  b e f o r e  a n d  a g a i n  a f t e r  u s i n g  t h e  m a s k .  
E x a m p l e  I  D a y  1  I  D a y  2  I  D a y  3  I  D a y  4  I  D a y  5  I  D a y  6  I  D a y  7  
R a t e  f e e l i n g  b e f o r e  
R a t e  f e e l i n g  a f t e r  
1 6  
u n s e t t l e d  
k · ; 2  " ? 7  ' " V w w  / ' ·  . _ , ,  · , y , " f ' l v l W A s u i L  . : + + : &  
T i m e  o f  d a  
R a t e  f e e l i n g  b e f o r e  
R a t e  f e e l i n g  a f t e r  
6  
C o m m e n t s  
r e l a x e d  
W e e k 3 +  
T i m e  o f  d a y  
9 . 1 5 p m  
R a t e  f e e l i n g  b e f o r e  
6  
R a t e  f e e l i n g  a f t e r  
6  
C o m m e n t s  
O K  
.  W e e k 4  
T i m e  o f  d a y  9 p m  
R a t e  f e e l i n g  b e f o r e  
7  
R a t e  f e e l i n g  a f t e r  
8  
C o m m e n t s  
g o o d  
* R a t e  y o u r  F e e l i n g  b e f o r e  a n d  a f t e r  u s i n g  t h e  l i g h t m a s k  f r o m  1  2  3  4  5  6  7  8  9  1 0  
( t h e  w o r s t  I  h a v e  e v e r  f e l t )  
( t h e  b e s t  I  h a v e  e v e r  f e l t )  
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APPENDIX I 
Lightmask TM manufacture's information sheet. 
The Li ·,htMask g ... ,., 
The LightMask 
The .Light!vfask is a lO\,V-cosJ device for flickering light therapy 
(photic stilnuiation), based on the research into PMS and 
n1igraine cond1i1cted by Dr. Duncan Anderson at the Royal 
Postgraduate l'vfedical School at J-fan1111e.rsn1ith Hospital in 
L{}ndon. 
:Dr. Andcrsorls flickering light treat1nent has been developed 
into a snutH portable device suitable fbr hoine use. The 
:tightw1ask looks sorne."vhat like a convenfional eye shade:. l't. 
I 
, ~ . 
1as a sott cotton outer cover and ,veighs less than t,vo ounces,, 
254 
innldng it corntbrtablc to \Vear. There are no \vires or s,vitches 
and the: Lightrvlask is turned on by pressing a concealed button, 
AJter fifteen rninutes it s,vitcbes off atrton1~1tically,, aHo\v1n2 it to be used \vhon going 
• ✓ ~ , - -h) sleep. Inside the Lightwlask a high-speed 1nicroprocessor and associated soft\vare 
i111ple.rncnt the t~ndc:rson Protocol; the flickering Hght sequences developed by Dr. 
A,nderson. The Lightl\·1ask is pO\V(}red by 'built=in batteries. The batteries do not nc,ed 
lo b10 re1)k,ced but evcrv fe,v ,veeks tbev need to be recharged bv p, ]uc"g1int"' the 
: '· ,, · •• ~- ·.: . .' • ; -· 
11 
· -:,= · ·· · ~-.:. " ,/ ·=· ·--:'to! ·· ·.·' • ·" af · ·' , · = •. • · · ... ·., ... r · .,_· '_ .,. b . ._.. , ... ,..~ ·· · 
t,.1ghtrvlask into a \Vall transJ:orrner. 
C• Uc[~ 1:,1ie1·e tn. 'R'efIP"I' •t;,o,··_ t\·1a·--iri ·rvleuu · ,,.. ' ' - : -: _.\, , .. , ·. _,/ · ' __ , . :. . i r.1 .... , :. · .. · .. · .... ,-l L .fil: . . -~ - , __ ;, .. .. ~.: ,J..i .. , -~ · ., ..... .. · ... ~ .. : · _; .. 
..... ..... . ._. ·-········ 
LighlMnsli; is J ,i,ri.d•.::mitr'k of Li.iht~"fosk Lfo1i rnd, .Arndt~-1}n Prtnn~o! h,: ;;i, ltli¾lk:n1i:lr,k a-f 1r.,11gr.1 Liitrat.tttuJtitf i~ 1i~ d u,i1N!cr lfcct}Cit.J!w 
iJ i;;tnM,isk ks n1;mu:fac1un,d tmdct ~kcmtc from ri.ti :~rn, Umi:tcd and its c.r:ivcn::d by UK Fa1cr11 NcL 2 I9t:442, US Palen! No. 50'92'669, 
and mJ~4'f potcu~s p~11,t1r1;£J, Pi1~1i1t~JfiJJ)lt}: b'y' l!':l Br:1rm fl. R;ihi.lJt., 
LightMask CE-, , "' .. ·= 
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APPENDIXJ 
Study 2, 'Participant Information Sheet'. 
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INFORMATION SHEET FOR PARTICIPANTS. 
THE USE OF PHOTIC STIMULATION TO TREAT MOOD AND SLEEP PROBLEMS. 
This research aims to assess the value of photic stimulation ( or light therapy) in the treatment of mood 
and sleep disorder. Photic stimulation involves the delivery of a flashing light stimulus of a particular 
frequency, through closed eyelids, using a mask with small lights on the inner surface of each eye 
cover. The purpose of this is to produce changes in the electrical activity of the brain. Research has 
shown that particular frequencies of light can be conducive to the production of positive mood states 
and assist in improving the quality of sleep. 
Photic stimulation is considered to be problem free for individuals who do not have epilepsy, or 
migraine and it is requested that you don't participate if you have a history of either of these 
conditions. As a further precaution you will not be permitted to join the study if you have bipolar 
disorder or psychosis. Because certain medications affect the EEG (electroencephalography) we 
regret we will not be able to admit you to the study if you are currently taking medication for 
depression or anxiety. 
The study runs over a 3month period and includes the following three phases: 
1. Initial phase: The initial assessment will include a 2hour session where you will be given 
information about the study and you can ask questions you have about the study and the people 
conducting it, and we will answer your questions to the best of our ability. We will give you details 
about the measurements taken, the equipment used, what is required of you during the study and your 
rights as a participant. You will then be asked to sign a consent form before starting the study. 
During this session baseline measures will be taken of your brainwave activity or EEG. You will also 
be asked to fill out questionnaires related to your mood, sleep habits, psychological functioning, and 
lifestyle factors such as drinking and smoking habits. In addition information and instructions about 
the treatn1ent schedule and the sleep diary requirements will be given to you. 
2. Intervention phase: The intervention phase will begin one week after the initial assessment. 
During this 4 week period you will be using a 'light mask' once per day for about 20minutes and 
keeping a diary of your mood and sleep patterns. If you are in the wait list group you will simply be 
keeping a sleep diary for the month. During this month measures of your brainwave activity and 
depression level will be taken at week 2 and again at week 4. Then there will be a 2month break 
before the final follow-up. 
3. Follow-up phase: At the end of the experiment, 2 months after using the light mask and/or keeping 
a sleep diary, final n1easures of your sleep patterns (sleep diary for 1 week), brainwave activity (EEG), 
mood and psychological functioning will be done. At this time you will be fully debriefed regarding 
the experin1ental condition you were in and the intended effects of the light stimulation you received. 
Your rights as a participant: 
• You have the right to withdraw from this study at any time. 
•You have the right to ask questions about the study, and that procedures be fully explained. 
• You have the right to expect that the researchers involved will behave in a professional and 
ethical manner and at no time knowingly put you at risk. 
If you have any questions regarding this study please ring Kerry Leahan on 6244 2648, or Carmel O'Sullivan on 6125 6536, 
at the Division of Psychology, The Australian National University, during office hours or you can contact Kerry after hours 
on 0419 281 698. ANU protocol number: 2000/104/ ACTCC Ethics ETH3/0l.l 14. Date 6/7/2001 
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APPENDIXK 
Means and standard deviations for study 2 variables. 
25 8 
Appendix K: Means and standard deviations (SD) for Study 2 variables: for waitlist (WL), and 
photic stimulation (PS) groups, continuous light (CL), 22Hz, 5Hz, & 13Hz. 
Mean (SD I log alpha power (µV2/Hz) across sessions (aloha asymmetry) 
group site baseline session2 session3 follow-up 
WL F3 1.66 (0.79) 1.50 (0.88) 1.68 (0.76) 1.64 (0.99) 
(n=l0) F4 1.61 (0.81) 1.49 (0.92) 1.63 (0.75) 1.67 (0.89) 
CL F3 1.22 (0.81) 1.34 (0.76) 1.38 (0.84) 1.43 (0.91) 
(n=l0) F4 1.17 (0.78) 1.27 (0.75) 1.23 (0.87) 1.31 (0.94) 
22Hz F3 1.27 (0.86) 1.28 (0.87) 1.31 (0.80) 1.44 (1.03) 
(n=9) F4 1.23 (0.89) 1.23 (0.92) 1.28 (0.85) 1.34 (1.04) 
5Hz F3 1.80 (0.66) 1.92 (0.56) 1.85 (0.62) 2.00 (0.70) 
(n=l 1) F4 1.79 (0.67) 1.90 (0.56) 1.87 (0.64) 2.01 (0.70) 
13Hz F3 1.49 (0.76) 1.66 (0.72) 1.63 (0.74) 1.61 (0.71) 
(n=l 1) F4 1.40 (0.71) 1.59 (0.71) 1.52 (0.73) 1.49 (0.67) 
Mean (SD) 1 0Hz EEG magnitude for eyes closed and 1 0Hz PS across EEG sites. 
eyes closed 
group site baseline session2 session3 follow-up 
WL Fpl 0.77 (0.37) 0.69 (0.47) 0.77 (0.42) 0.79 (0.47) 
(n=l0) Fp2 0.75 (0.38) 0.68 (0.50) 0.75 (0.42) 0.79 (0.45) 
F3 0.95 (0.40) 0.86 (0.49) 0.96 (0.41) 0.92 (0.55) 
F4 0.91 (0.42) 0.85 (0.54) 0.93 (0.41) 0.94(0.51) 
C3 1.09 (0.47) 1.00 (0.55) 1.10 (0.41) 1.10 (0.60) 
C4 1.06 (0.46) 1.02 (0.61) 1.11 (0.44) 1.09 (0.59) 
P3 1.39 (0.64) 1.32 (0.68) 1.38 (0.63) 1.45 (0.73) 
P4 1.42 (0.58) 1.37 (0.66) 1.42 (0.57) 1.43 (0.71) 
01 1.57(0.81) 1.60 (0.83) 1.60 (0.70) 1.70 (0.92) 
02 1.54 (0.74) 1.54 (0.79) 1.49 (0.67) 1.68 (0.84) 
CL Fpl 0.06 (0.50) 0.65 (0.49) 0.65 (0.53) 0.69 (0.58) 
(n=l0) Fp2 0.56 (0.51) 0.62 (0.48 0.60 (0.55) 0.68 (0.59) 
F3 0.82 (0.49) 0.85 (0.52) 0.85 (0.54) 0.93 (0.58) 
F4 0.78 (0.52) 0.83 (0.51) 0.78 (0.57) 0.87 (0.62) 
C3 1.10 (0.52) 1.05 (0.46) 1.03 (0.48) 1.14 (0.56) 
C4 0.94 (0.52) 0.98 (0.51) 0.92 (0.56) 1.06 (0.58) 
P3 1.33 (0.73) 1.42 (0.59) 1.3 8 (0.64) 1.48 (0.67) 
P4 1.04 (0.72) 1.46 (0.62) 1.38 (0.64) 1.47 (0.65) 
01 1.68 (0.85) 1.75 (0.64) 1.71 (0.69) 1.79 (0.72) 
02 1.66 (0.81) 1.72 (0.66) 1.73 (0.70) 1.76 (0.65) 
22Hz Fpl 0.67 (0.55) 0.67 (0.51) 0.68 (0.42) 0.80 (0.60) 
(n=9) Fp2 0.65 (0.53) 0.66 (0.49) 0.67 (0.43) 0.78 (0.61) 
F3 0.78 (0.51) 0.78 (0.53) .078 (0.43) 0.86 (0.61) 
F4 0.76 (0.53) 0.76 (0.55) 0.76 (0.48) 0.83 (0.62) 
C3 0.85 (0.50) 0.88 (0.55) 0.87 (0.44) 0.89 (0.63) 
C4 0.88 (0.50) 0.90 (0.55) 0.85 (0.47) 0.85 (0.60) 
P3 1.22 (0.77) 1.20 (0.78) 1.13 (0.64) 1.13 (0.86) 
P4 1.25 (0.66) 1.25 (0.73) 1.18 (0.60) 1.23 (0 :79) 
01 1.59 (0.93) 1.47 (0.88) 1.42 (0.80) 1.42 (1.02) 
02 1.57 (0.81) 1.47 (0.84) 1.40 (0.78) 1 .45 (0.89) 
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Appendix K: Means and standard deviations for Study 2 variables, continued. 
eyes closed continued: 
group site baseline session2 session3 follow-up 
SHz Fpl 1.00 (0.50) 1.08 (0.47) 1.07 (0.40) 1.10(0.47) 
(n=l 1) Fp2 1.01 (0.48) 1.09 (0.45) 1.05 (0.40) 1.09 (0.46) 
F3 1.15 (0.47) 1.21 (0.40) 1.19 (0.44) 1.20 (0.44) 
F4 1.18 (0.46) 1.22 (0.42) 1.22 (0.45) 1.25 (0.44) 
C3 1.34 (0.45) 1.38 (0.43) 1.37 (0.53) 1.38 (0.44) 
C4 1.41 (0.46) 1.45 (0.40) 1.47 (0.51) 1.47 (0.48) 
P3 1.84 (0.57) 1.96 (0.61) 1.87 (0.67) 1.97 (0.58) 
P4 1.95 (0.56) 2.06 (0.62) 1.99 (0 .67) 2.04 (0.56) 
01 2.24 (0.65) 2.35 (0.68) 2.21 (0.67) 2.30 (0.63) 
02 2.19 (0.60) 2.30 (0.70) 2.19 (0.65) 2.27 (0.61) 
13Hz Fpl 0.74 (0.39) 0.84 (0.41) 0.78 (0.41) 0.78 (0.41) 
(n=l 1) Fp2 0.70 (0.39) 0.82 (0.39) 0.77 (0.41) 0.77 (0.38) 
F3 0.93 (0.45) 1.04 (0.45) 1.00 (0.44) 0.99 (0.41) 
F4 0.88 (0.44) 1.00 (0.45) 0.95 (0.43) 0.94 (0.41) 
C3 1.13 (0.54) 1.25 (0.58) 1.18 (0.54) 1.18 (0.48) 
C4 1.12 (0.56) 1.24 (0.59) 1.17 (0.57) 1.15 (0.53) 
P3 1.38 (0.60) 1.51 (0.66) 1.46 (0.60) 1.44 (0.51) 
P4 1.45 (0.65) 1.59 (0.67) 1.57 (0.66) 1.52 (0.59) 
01 1.61 (0.57) 1.71 (0.64) 1.76 (0.56) 1.61 (0.50) 
02 1.71 (0.53) 1.78 (0.61) 1.86 (0.59) 1.73 (0.54) 
photic stin1ulation 
WL Fpl 1.03 (0.30) 1.06 (0.28) 0.99 (0.29) 0.88 (0.35) 
(n=l0) Fp2 1.01(0.31) 1.03 (0.28) 0.98 (0.29) 0.85 (0.34) 
F3 1.13 (0.34) 1.26 (0.30) 1.12 (0.31) 1.00 (0.44) 
F4 1.10 (0.37) 1.22 (0.33) 1.12 (0.29) 1.04 (0.35) 
C3 1.21 (0.43) 1.35 (0.36) 1.23 (0.32) 1.21 (0.4 7) 
C4 1.24 (0.42) 1.32 (0.36) 1.26 (0.29) 1.17 (0.43) 
P3 1.50 (0.55) 1.58 (0.51) 1.60 (0.43) 1.55 (0.60) 
P4 1.58 (0.47) 1.61 (0.42) 1.64 (0.41) 1.57 (0.54) 
01 1.90 (0.41) 2.05 (0.44) 1.99 (0.36) 1.96(0.51) 
02 1.89 (0.37) 1.94 (0.38) 1.94 (0.39) 1.96 (0.50) 
CL Fpl 1.01 (0.44) 1.05 (0.44) 1.09 (0.48) 1.11 (0.50) 
(n=l0) Fp2 0.98 (0.42) 1.05 (0.40) 1.08 (0.44) 1.13 (0.48) 
F3 1.13 (0.48) 1.18 (0.49) 1.24 (0.50) 1.26 (0.52) 
F4 1.14 (0.41) 1.21 (0.44) 1.22 (0.49) 1.24 (0.51) 
C3 1.26 (0.38) 1.27 (0.35) 1.39 (0.34) 1.39 (0.34) 
C4 1.21 (0.32) 1.27 (0.30) 1.34 (0.34) 1.34 (0.37) 
P3 1.72 (0.44) 1.69 (0.44) 1.78 (0.38) 1.73 (0.47) 
P4 1.69 (0.43) 1.77 (0.39) 1.78 (0.38) 1.73 (0.44) 
01 2.19 (0.54) 2.21 (0.53) 2.24 (0.50) 2.23 (0.51) 
02 2.14 (0.46) 2.13 (0.49) 2.21 (0.44) 2.17 (0.42) 
22Hz Fpl 0.93 (0.37) 0.92 (0.42) 1.04 (0.42) 0.97 (0.35) 
(n=9) Fp2 0.90 (0.39) 0.90 (0.42) 1.02 (0.43) 0.97 (0.36) 
F3 1.10 (0.35) 1.11 (0.45) 1.19 (0.42) 1.13 (0.31) 
F4 1.08 (0.37) 1.09 (0.47) 1.18 (0.42) 1.10 (0.34) 
C3 1.17 (0.35) 1.18 (0.45) 1.23 (0.40) 1.20 (0.33) 
C4 1.17 (0.37) 1.18 (0.48) 1.25 (0.39) 1.20 (0.33) 
P3 1.49 (0.56) 1.49 (0.60) 1 .45 (0.58) 1.44 (0.51) 
P4 1.56 (0.45) 1.51 (0.61) 1.50 (0.53) 1.54 (0.41) 
01 2.07 (0.54) 2.03 (0.54) 2.05 (0.44) 1.96 (0.48) 
02 2.13 (0.42) 2.07 (0.54) 2.09 (0.52) 2.01 (0.34) 
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Appendix K continued: Means and standard deviations for Study 2 variables. 
photic sti1nulation continued: 
group site baseline session2 session3 follow-up 
EC 
5Hz Fpl 1.09 (0.19) 1.20 (0.28) 1.21 (0.21) 1.29 (0.26) 
(n=l 1) Fp2 1.08 (0.20) 1.16 (0.29) 1.19(0.21) 1.28 (0.23) 
F3 1.15 (0.18) 1.28 (0.28) 1.28 (0.21) 1.35 (0.22) 
F4 1.18 (0.20) 1.30 (0.30) 1.33 (0.24) 1.38 (0.21) 
C3 1.41 (0.31) 1.50 (0.3 7) 1.51 (0.33) 1.48 (0.36) 
C4 1.44 (0.36) 1.61 (0.32) 1.57 (0.27) 1.60 (0.39) 
P3 2.04 (0.45) 2.13 (0.49) 2.09 (0.57) 2.19 (0.39) 
P4 2.13 (0.49) 2.29 (0.45) 2.19 (0.54) 2.29 (0.42) 
01 2.49 (0.51) 2.56 (0.41) 2.51 (0.50) 2.61 (0.33) 
02 2.45 (0.54) 2.59 (0.40) 2.54 (0.48) 2.62 (0.35) 
13Hz Fpl 0.85 (.047) 0.97 (0.43) 0.91 (0.43) 0.95 (0.47) 
(n=l 1) Fp2 0.85 (0.44) 0.95 (0.42) 0.95 (0.43) 0.92 (0.47) 
F3 1.05 (0.51) 1.13 (0.42) 1.11 (0.43) 1.17(0.45) 
F4 1.04 (0.49) 1.13 (0.36) 1.11 (0.39) 1.17(0.41) 
C3 1.28 (0.50) 1.33 (0.44) 1.30 (0.42) 1.35 (0.46) 
C4 1.35 (0.51) 1.39 (0.40) 1.37 (0.42) 1.38 (0.46) 
P3 1.60 (0.52) 1.75 (0.47) 1.70 (0.42) 1.65 (0.45) 
P4 1.75 (0.63) 1.87 (0.51) 1.81 (0.52) 1.78 (0.51) 
01 2.01 (0.56) 2.05 (0.57) 2.11 (0.51) 1.97 (0.60) 
02 2.01 (0.61) 2.10 (0.58) 2.15 (0.58) 2.03 (0.60) 
M (SD) t d ll b . b f ean ra e we - e1ng e ore an d ft PS ( a er range 1 =wors 0 - es t t 10 b t) 
group time weekl week2 week3 week4 
CL before 4.32 (1.42) 4.59 (1.19) 4.95 (1.45) 4.78 (1 .45) 
(n=l0) after 5.04 (1.04) 5.06 (1.21) 5.40 (1.55) 5.27 (1.52) 
22Hz before 5.21 (.71) 5.37 9.76) 5.37 (.48) 5 .48 (.67) 
(n=l0) after 5.87 (.84) 6.00 (1.26) 6.06 (.76) ( 6.13 (.90) 
5Hz before 5.18(1.15) 5.02 (.95) 5.46 (1.14) 5.54 (1.33) 
(n=l 1) after 5.48 (1.33) 5.64 (1.26) 6.07 (1.59) 6.09 (1.68) 
13Hz before 4.96 (.86) 5.36 (.71) 5.44 (.82) 5.44 (1.20) 
(n=9) after 5.16 (.97) 5.56 (.83) 5.64 (.87) 5.57 (1.26) 
Mean (SD) subjective relaxation across sessions 
(range· 1 = very uptight & anxious to 10 very relaxed & calm) 
group baseline session 2 session 3 follow-up 
WL 6.40 6.00 6.40 6.80 
(n=l0) (2.27) (1.89) (1.65) (1.55) 
CL 7.10 5.70 6.90 5.90 
(n=l0) (1.73) (1.89) (1.52) (2.02) 
22Hz 5.60 5.20 6.00 5.60 
(n=l0) (2.22) (1.75) (1.25) (2.17) 
5Hz 6.73 6.45 7.09 6.27 
(n=l 1) (2.45) (1.75) (2.17) (1.62) 
13Hz 5.55 6.45 6.09 6.91 
(n=l 1) (1.51) (1.57) (1.81) (1.64) 
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Appendix K continued: Means and standard deviations for Study 2 variables. 
M (SD) 'f ff t (PANAS) ean posi ive a ec across sessions ( range: 10-50). 
group baseline session 2 session 3 follow-up 
WL 25.50 26.90 29.70 30.00 
(n=l0) (10.54) (7.96) (8.18) (10.98) 
CL 21.33 28.11 26.33 27.44 
(n=9) (8.80) (8.37) (6.12) (8.37) 
22Hz 25.33 27.55 27.33 27.77 
(n=9) (6.20) (5.41) (4.97) (6.65) 
5Hz 29.33 28.83 31.42 29 .16 
(n=l2) (8.20) (7.67) (6.21) (7.92) 
13Hz 24.64 28.64 25.91 30.18 
(n=l l) (7.42) (5.77) (6.93) (7.08) 
ean M (SD) nega ive a ec f ff t (PANAS) across sessions ( ) range: 10-50 . 
group baseline session 2 session 3 follow-up 
WL 26.40 22.80 21.80 20.30 
(n=l0) (7.66) (7.84) (5.61) (7.48) 
CL 26.20 20.10 16.50 18.20 
(n=l0) (9.39) (8.16) (8.63) (5.95) 
22Hz 26.20 23.40 21.60 23 .60 
(n=l0) (7.74) (11.11) (9.75) (9.22) 
5Hz 31.66 25.67 21.17 23.67 
(n=l2) (8.01) (7.44) (8.63) (8.80) 
13Hz 24.18 20.00 19.82 20.36 
(n=l l) (8.31) (6.21) (4.04) (8.16) 
M (SD) d ean epression eve s -. l l (BDI II) across sessions ( range: 0 63) -
group baseline session 2 session 3 follow-up 
WL 22.88 (11.14) 19.11 (7.41) 14.33 (7.62) 15.11 (12.10) 
(n=l0) 
CL 26.50 (13.01) 11.00 (9.14) 12.50 (9.63) 15.00(11.20) 
(n=l0) 
22Hz 24.50 (12.03) 14.00 (9.51) 14.40 (13.66) 14.60 (11.24) 
(n=l0) 
5Hz 20.17 (10.47) 13.08 (9.89) 8.42 (7.77) 13.75 (10.63) 
(n=l 1) 
13Hz 24.90 (10.22) 14.64 (7.28) 17 .09 (11.06) 12.45 (8.81) 
(n=9) 
Mean (SD) 'sleep onset latency' in minutes for six weeks of sleep diary. 
group baseline week 1 week2 week3 week4 follow-up 
WL 21.57 30.26 19.20 19.24 15.88 18.20 
(n=l0) (13 .05) (25.70) (13.49) (15.10) (8.38) (10.60) 
CL 44.73 32.34 34.10 25.04 30.25 20.76 
(n=l0) (37.20) (21.38) (28.11) (27.68) (34.59) (15.90) 
22Hz 42.07 46.44 40.71 33.74 45.42 47.07 
(n=l0) (70.57) (89 .46) (71.41) (50.05) (94.30) (77.91) 
5Hz 46.81 24.83 . 29.86 24.31 23.17 41.60 
(n=12) (72.59) (21.10) (25.28) (22.57) (28.85) (58.30) 
13Hz 20.80 23.43 22.07 18.53 17.40 16.02 
(n=l0) (14.67) (15.39) (12.80) (12.85) (15.96) (8.70) 
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Appendix K: Means and standard deviations for Study 2 variables, continued. 
Mean (SD) number of night wakings for six weeks of sleep diary. 
group baseline week 1 week2 week3 week4 follow-up 
WL 1.69 (2.45) 1.35(1.11) 1.05 (0.81) 1.38 (0.97) 1.55 (1.48) 0.86 (0.75) 
(n=l0) 
CL 1.39 (0.84) 1.27 (1.16) 0.93 (1.05) 1.00 (1.00) 0.94 (0.96) 0.92 (0.88) 
(n=l0) 
22Hz 1.68 (1.12) 1.16 (0.85) 1.09 (0.88) 1.05 (0.84) 1.01 (1.14) 0.84 (0.73) 
(n=l0) 
5Hz 1.64 (1.02) 1.62 (1.03) 1.19 (0.96) 104 (0.86) 1.36 (0.95) 1.36 (0.98) 
(n=12) 
13Hz 1.30 (0.84) 1.20 (1.01) 1.19 (0.96) 1.00 (8.86) 1.02 (0.83) 1.07 (0.72) 
(n=l0) 
Mean (SD) 'sleep efficiency' (percentap,;e) across six weeks of sleep diary. 
group baseline week 1 week2 week3 week4 follow-up 
WL 91.17 88.72 91.45 91.35 93.19 93.28 
(n=l0) (4.12) (6.53) (4.53) (5 .68) (2.59) (4.25) 
CL 82.43 87.25 87.95 87.01 87.72 90.71 
(n=l0) (11.96) (8.18) (9 .21) (12.41) (10.48) (7.06) 
22Hz 81.88 84.87 86.42 86.06 84.51 87.25 
(n=l0) (17.24) (18.05) (17.67) (15.33) (20.97) (16.11) 
5Hz 78.88 81.92 84.57 84.79 85.52 81.77 
(n=12) (15.20) (12.70) (10.92) (10.15) (13.05) (16.86) 
13Hz 87.58 91.29 90.07 90.71 90.22 90.01 
(n=l0) (9.55) (5.96) (8.66) (7.45) (7.95) (8.00) 
Mean (SD) 'waking mood' across six weeks of sleep diary. 
group baseline week 1 week2 week3 week4 follow-up 
WL 3.99 4.59 4.65 4.88 4.68 5.12 
(n=l0) (0.73) (1.03) (1.05) (1.11) (0.98) (1.35) 
CL 3.98 4.20 4.14 4.47 4.46 4.65 
(n=l0) (0.65) (1.11) (1.13) (1.13) (1.26) (1.10) 
22Hz 4.18 5.01 5.45 5.38 5.57 5.82 
(n=l0) (1.11) (0.91) (0.68) (1.09) (1.49) (0.83) 
5Hz 4.40 4.93 5.13 5.23 5.58 5.10 
(n=12) (1.40) (1.17) (1.24) (1.29) (1.80) (1.48) 
13Hz 4.48 4.92 5.11 5.25 5.15 5.31 
(n=l0) (0.57) (0.88) (0.78) (0.89) (1.10) (0.88) 
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APPENDIXL 
Ranges for Pearson's correlation coefficients ranges for Study 2 variables. 
Appendix L: Ranges for Pearson's correlation coefficients across sessions for study 2 variables across sessions. 
1 2 3 4 5 6 7 8 9 
1 global theta 1.0 
2 global alpha [.71 **, .77* *] 1.0 
3 global beta [.60**, .63**] [.77**, .79**] 1.0 
4 PS response [- .01, .18] [-.05 , .14] [-.13 , .10] 1.0 
5 subj ective relaxation [- .17, .04] [- .37*, .03] [- .27*, .09] [- .30*, .10] 1.0 
6 depression [-.19, .02] [-.19, .05] [-.13, .05] [- .12, .05] [-.55**, -.34*] 1.0 
7 anxiety [.01, .01] [- .19, -.11] [-.14, -.08] [.03, .11] [-.41 **, -.34**] [.51 **, .66**] 1.0 
8 global severity index [-.13 , -.01] [-.20, -.14] [- .22, -.08] [-.08, .06] [-.45**, -.37**] [.69**, .76**] [.83 **, .84**] 1.0 
9 positive affect [- .03, .16] [.03 , .17] [- .04, .18] [-.01, .08] [.16, .50**] [-.59**, -.34**] [-.22, -.14] [-.39** ,-.30*] 1.0 
10 negative affect [-.12, .15] [- .09, .09] [-.06, .03] [-.12 , .13] [-.46**, -.27*] [.41 **, .61 **] [.58**, .69**] [.50**,.55**] [-.24,.14] 
11 s Jeep onset [- .08, -.0 1] [-.15, -.02] [-.09, .13] [-.01 , .34*] [- .25, .01] [- .10, .32*] [.13 , .17] [.15, .19] [-.31*, .02] 
12 number of wakings [.12, .26] [.16, .3 1 *] [.15, .30*] [-.19, .15] [- .02, .11] [-.28* , .04] [- .34**, -.03] [-.38**, -.10] [.04, .22] 
13 sleep efficiency [-.07, .07] [-.13,-.01] [-.20, -.06] [-.30*, -.11] [-.11, .25] [- .2 1, .16] [- .11 , -.07] [-.07 , -.05] [.14, .29*] 
14 alpha asymmetry [- .08, .07] [- .16, .01] [.03, .07] [- .04, .17] [-.11 ,-.02] [.07 , .14] [.23, .26] [.16, .26] [- .08,. 12] 
15 menstrual cycle [. l O] [.28] [.17] [.05] [-.19] [-.1 7] [-.17] [-.19] [.08] 
(n =23) 
* significance LE . 05 ** significance LE . 01 
10 
1.0 
[- .08, .21] 
[- .11 , .15] 
[- .12, .13 ] 
[.02, .27*] 
[- .0 1] 
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11 12 13 14 
1.0 
[-.21,- .05] 1.0 
[- .85**,-.78**][-.10, .06] 1.0 
[.05, .29*] 
[.24] 
[-.19,.11] [-.29* ,-.05] 1.0 
[- .18] [- .03] [.15] 
